0001721868-18-000081.txt : 20180202 0001721868-18-000081.hdr.sgml : 20180202 20180202134635 ACCESSION NUMBER: 0001721868-18-000081 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 54 CONFORMED PERIOD OF REPORT: 20161231 FILED AS OF DATE: 20180202 DATE AS OF CHANGE: 20180202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALR TECHNOLOGIES INC. CENTRAL INDEX KEY: 0001087022 STANDARD INDUSTRIAL CLASSIFICATION: COMMUNICATIONS EQUIPMENT, NEC [3669] IRS NUMBER: 880225807 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-30414 FILM NUMBER: 18569864 BUSINESS ADDRESS: STREET 1: 7400 BEAUFONT SPRINGS DRIVE STREET 2: SUITE 300 CITY: RICHMOND STATE: VA ZIP: 23225 BUSINESS PHONE: (804) 554-3500 MAIL ADDRESS: STREET 1: 7400 BEAUFONT SPRINGS DRIVE STREET 2: SUITE 300 CITY: RICHMOND STATE: VA ZIP: 23225 FORMER COMPANY: FORMER CONFORMED NAME: ALR TECHNOLOGIES INC DATE OF NAME CHANGE: 19990524 10-K 1 f2alr10k012618.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
  ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2016

 

Commission file number 000-30414

 

ALR TECHNOLOGIES INC.

(Exact name of registrant as specified in its charter)

 

NEVADA

(State or other jurisdiction of incorporation or organization)

 

88-0225807

(I.R.S. Employer Identification No.)

 

7400 Beaufont Springs Dr, Suite 300

Richmond, Virginia 23225

(Address of principal executive offices, including zip code.)

 

(804) 554-3500

(telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act: Securities registered pursuant to section 12(g) of the Act:
NONE Common Stock

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. YES [ ] NO [X]

 

Indicate by check mark if the registrant is required to file reports pursuant to Section 13 or Section 15(d) of the Act: YES [X] NO [ ]

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES [ ] NO [X]

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES [ ] NO [X]

 
 

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [ ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

  Large Accelerated Filer [   ] Accelerated Filer [   ]
  Non-accelerated Filer [   ] Smaller Reporting Company [X]
  (Do not check if a smaller reporting company)    

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). YES [ ] NO [X]

 

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter. $0.00 as at June 30, 2017.

 

Indicate the number of shares outstanding of each of the registrant’s classes of common equity, as of the latest practicable date. As at February 2, 2018, 242,777,909 shares of the registrant’s common stock were outstanding.

 
 

 

TABLE OF CONTENTS

 

    Page No.
     
  PART I  
     
Item 1. Business 3
Item 1A. Risk Factors 12
Item 1B. Unresolved Staff Comments 12
Item 2. Properties 12
Item 3. Legal Proceedings 12
Item 4. Mine Safety Disclosure 13
     
     
  PART II  
     
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 14
Item 6. Selected Financial Data 14
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations 15
Item 7A. Quantitative and Qualitative Disclosures About Market Risk 27
Item 8. Financial Statements and Supplementary Data 28
Item 9. Changes In and Disagreements With Accountants on Accounting and Financial Disclosure 54
Item 9A. Controls and Procedures 54
Item 9B. Other Information 56
     
     
  PART III  
     
Item 10. Directors, Executive Officers and Corporate Governance 57
Item 11. Executive Compensation 62
Item 12. Security Ownership of Certain Beneficial Owners and Management and  Related Stockholder Matters 67
Item 13. Certain Relationships and Related Transactions, and Director Independence 69
Item 14. Principal Accountant Fees and Services 70
     
     
  PART IV  
     
Item 15. Exhibits, Financial Statement Schedules 71
  Signatures 72

 

 

 
 

PART I

 

ITEM 1.BUSINESS.

 

Background

 

ALR TECHNOLOGIES, INC. (the “Company” or “ALRT”) was incorporated under the laws of the State of Nevada on March 24, 1987 as Mo Betta Corp. In April 1998, the Company changed its business purpose to marketing a pharmaceutical compliance device.

 

On October 21, 1998, the Company entered into an agreement with A Little Reminder Inc. (“ALR”) whereby the Company would have the non-exclusive right to distribute certain products of ALR described below.

 

In December 1998, the common shares of the Company began trading on the Bulletin Board operated by the National Association of Securities Dealers Inc. under the symbol “MBET.” On December 28, 1998, the Company changed its name from Mo Betta Corp. to ALR Technologies Inc. Subsequently the symbol was changed to “ALRT.”

 

In April 1999, the Company acquired 99.9% (36,533,130) of the issued and outstanding Class A shares of common stock of ALR in exchange for 36,533,130 shares of the Company’s common stock thereby making ALR a subsidiary corporation of the Company. ALR also had outstanding 124,695 shares of Class B common stock, none of which was owned by the Company.

 

ALR was incorporated pursuant to the Company Act of British Columbia on May 24, 1996. ALR owned one subsidiary corporation, Timely Devices, Inc. (“TDI”). TDI was founded in Edmonton, Alberta, Canada on July 27, 1994. ALR owned all of the total outstanding shares of TDI. TDI had only one class of common stock outstanding.

 

On July 31, 2000, the Company sold all of its shares of ALR. From that point onward, the Company focused on developing its own technology, products and performed its own marketing.

 

On April 15, 2008, the Company incorporated a wholly-owned subsidiary in Canada under the name Canada ALRTech Health Systems Inc. This subsidiary was wound up during 2016.

 

In late 2011, the Company relocated its headquarters to 7400 Beaufont Springs Drive, Suite 300, Richmond, Virginia, 23225.

 

During 2011, the Company received FDA clearance and achieved HIPPA compliance for its Diabetes Management System. With these key achievements and successful clinical trials completed, the Company began implementing its commercialization strategy which included a pilot program with patients in Kansas in 2014. The Company obtained significant findings from this pilot program which led to the development of its Insulin Dosage Adjustment, for which it received FDA clearance in 2017, and Predictive A1C, for which it has submitted for worldwide patent application under the patent cooperation treaty to the World Intellectual Property Organization. The Company is actively seeking to commence revenue generating activities.

 3 

 

 

 

Products

 

ALR Technologies products utilize internet-based technologies to facilitate healthcare provider’s ability to monitor their patient’s health and ensure adherence to health maintenance activities.

 

The ALRT Diabetes Management System is a remote monitoring and care facilitation program that allows patients to upload the blood glucose data from their glucometers. ALRT Health Data Monitors monitor that data and, based on clinician approved protocols, provide advice, support and interventions when patients show blood glucose readings that are out of an acceptable range or if they are failing to test their blood glucose as prescribed. The ALRT System has been successfully proven in a clinical trial that demonstrated this type of remote care is associated with significant lowering of A1c levels. The study concluded that continuing intervention using an internet based glucose monitoring system is an effective way of improving glucose control compared to conventional care. A second clinical trial demonstrated that this type of Internet-based Blood Glucose Monitoring System (IBGMS) was associated with comparable reductions in A1c levels with that of more expensive Continuing Glucose Monitoring Systems (CGMS).

 

In the future, the Company may seek to adapt its System to be used in the management of other chronic diseases. The Company may be required to obtain additional clearance from the FDA prior to commencing selling activities in the United States for other disease states.

 

ALRT Diabetes Management System for Diabetes Monitoring

 

Diabetes is a leading cause of death, serious illness and disability across North America. In the United States, it is estimated that 26 million people have diabetes, with 4.5 million people being classified as insulin dependent. By the year 2030, it is expected that 1 in 10 adults, globally, will have diabetes (diagnosed and undiagnosed instances). By the year 2050, it is expected that 1 in 3 United States adults will have diabetes (diagnosed and undiagnosed instances). We believe diabetes is a global pandemic.

 

As a result, medical costs due to diabetes and its complications are enormous. In the United States, such costs are estimated to be over $245 billion a year. In Canada, where it is estimated there are 2 million people with diabetes, healthcare costs associated with diabetes is estimated to be more than $13 billion annually.

 

Diabetes is a lifelong chronic disease with no cure. However, people with diabetes can take steps to control their disease and reduce the risk of developing the associated serious complications, thereby controlling healthcare costs. The Canadian Diabetes Association Clinical Practice Guidelines Expert Committee reports that “Successful diabetes care depends on the daily commitment of persons with diabetes mellitus to self-manage through the balance of lifestyle and medication. Diabetes care should be organized around a multi- and interdisciplinary diabetes healthcare team that can establish and sustain a communication network between the person with diabetes and the necessary healthcare and community systems.”

 

However, as noted in Patrick Connole, “UnitedHealthcare, Other Large Insurers Seek Better Adherence to Diabetes Care”, Health Plan Week, February 11, 2013 Volume 23 Issue 5, 80% of United States patients with diabetes do not follow their prescribed care plan.

 

Furthermore, in Treatment intensification for patients with type 2 diabetes and poor glycaemic control by Fu and Sheenan, it was noted that out 11,525 patients investigated with an A1c greater than 8% patients received intensification as follows:

  • 37% within 6 months;
  • 11% within 6-12 months, and
  • 52% never

 4 

 

ALRT Diabetes Management System (continued)

A study in 2013 by Khunti, Wolden, Thorstead, Anderson and Davies entitled Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people found that patients it took on average 19 months to escalate patients with an average A1c of 8.7% from single medication to dual therapy and 82 months to escalate patients with an average A1c of 8.8% from dual medication to triple therapy. Furthermore, they found that it took approximately 20 years to advance patients with an average A1c of over 9% to insulin. At the end of the study, less than 50% of the patients had their treatment intensified.

 

The Company’s Diabetes Management System provides an affordable and easy to use tool to provide the communication network as recommended by the Committee. Our Diabetes Management System includes a communications software platform that also enables health professionals to remotely monitor the health progress to patients with diabetes. This facilitates more timely and effective communication and coordination of care to these patients. This also results in positive behavior patterning, or re-patterning, of the patients.

 

The Diabetes Management System and the Company’s universal upload cable, are compatible with the majority of the major brands of glucose meters available for sale in the United States.

 

In August 2010, the Company received the results of a clinical trial conducted by Dr. Hugh Tildesley using the ALRT Health-e-Connect System. The trial showed A1c dropping from 8.8% to 7.6% for the Intervention Group using ALRT’s Health-e-Connect System as part of a diabetes management program. The A1c test is important in diabetes treatment management as a long-term measure of control over blood glucose for diabetes patients. According to Center for Disease Control and Prevention, “In general, every percentage drop in A1c blood test results (e.g. from 8% to 7%), can reduce the risk of microvascular complications (eye, kidney and nerve diseases) by 40%.”The trial served as the basis for an article titled “Effect of Internet Therapeutic Intervention on A1c Levels in Patients with Type 2 Diabetes Treated with Insulin” was published in the August 2010 Diabetes Care publication.

 

In July 2011, the follow-up results of the Dr. Tildesley clinical trial were published in the Canadian Journal of Diabetes. Dr. Tildesley conducted a 12 month study using Health-e-Connect System as an Internet Based Blood Glucose Monitoring System (IBGMS) to provide intensive blood glucose control to determine the effects of internet based blood glucose monitoring on A1c levels in patients with type 2 diabetes treated with insulin. Dr Tildesley concluded that, “While IBGMS intervention was not a substitute for the patient–physician interaction in a clinical setting, it significantly improved A1c and, over time, we observed better glycemic control and patient satisfaction.”

 

In October 2011, the Company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Diabetes Management System (then known as the Health-e-Connect System) for remote monitoring of patients in support of effective diabetes management programs. The 510(k) clearance enables the Company to commence with the United States marketing and sales launch of its Health-e-Connect System.

 

On July 28, 2014, the Company entered into a pilot service agreement with Kansas City Metropolitan Physician Association (KCMPA), one of the nation's premier Accountable Care Organizations (ACO). Under the agreement, KCMPA, which made diabetes management a key focus of its Quality Improvement Plan, enrolled up to 200 of its patients with Type 2 diabetes into ALRT's Diabetes Management System. The pilot service agreement was effective nine months from the beginning date of patient enrollment and the intent was to allow 6 months of use for each patient enrolled in the system. The pilot program between ALRT and KCMPA represented the first commercial deployment of ALRT's Diabetes Management System. On September 9, 2014, the Company began enrolling patients with Type 2 diabetes and A1c levels above 8 percent into the pilot program trialing the Diabetes Management System.

 5 

 

ALRT Diabetes Management System (continued)

 

In September 2014, the Company initiated its pilot program with one of the Kansas City Metropolitan Physician Association clinics to deploy its Diabetes Management System for up to 200 patients that fit certain criteria. As a result of the pilot program findings and general industry trends, the Company proceeded with developing three new innovations:

·Insulin Dosage Adjustment uses both American Diabetes Association (ADA) and American Association of Clinical Endocrinologists (AACE) guidelines for adjusting insulin, and
·Predictive A1c, which converts blood glucose data uploaded into our Diabetes Management Systems and converts the large amount of data into a predicted or simulated A1C
·Diabetes Therapy Review allows the healthcare providers to change care plans for patients on a timely basis based on the results of Predictive A1c and overall how patients are managing their diabetes

 

On January 1, 2015, the Center for Medicaid and Medicare Services began reimbursing physicians for the non-face-to-face management of Medicare patients with two or more serious chronic diseases. Physicians would be paid a per-patient-per-month fee for “Chronic Care Management” and the examination of data from a remote monitoring platform is considered a reimbursable activity by CMS. Therefore, the company modified its System to conform to the requirements of the CMS reimbursement. These modifications permit the company to market to medical groups throughout the United States with a product that will help physicians to draw down this new reimbursement as well as to potentially improve the outcomes of their patients.

On February 18, 2015, the Company filed a 510(k) application with the FDA to add a remote insulin dosing recommendation feature to the Company’s Diabetes Management System. The company utilized the publicly available algorithm of the AACE & ADA. This feature allows the company to regularly run a patient’s blood glucose data (and other key data) through the AACE and ADA algorithm. When the algorithm indicated that the patient’s dose may not be optimal, the Diabetes Management System would provide the heathcare provider that a dose change may be warranted and what the change would be based on AACE and ADA guidelines. The decision about the dose change would rest entirely with the healthcare provider. However, this new feature may make a significant contribution to improving the outcomes of diabetes patients if it allowed healthcare provider to keep their patients at the optimal dose for longer periods.

 

Preliminary data from the KCMPA pilot program indicated that a number of patients had achieved reductions in their A1c levels. On April 17, 2015, the company signed a commercial contract with one of the KCMPA clinics, the Clay-Platte Family Medicine Clinic, to provide remote monitoring services. The Company has provided these services to date to Clay-Platte at no charge as it has provided the Company with continuous users as a sample population for its own strategic planning and business plan. The Company continues to actively provide services to Clay-Platte for certain of its patients.

 

On June 20, 2017, the Company filed a worldwide patent application under the PCT for its Predictive A1c feature to the World Intellectual Property Office.

 

On September 18, 2017, the Company received clearance from the FDA for its Insulin Dosage Adjustment feature within the Company’s Diabetes Management System.

 

 6 

 

Potential Benefits of ALRT Diabetes Management System

 

Our Diabetes Management System resolves the expensive and complex care requirements with diabetes by taking an unique approach.  While the science of diabetes care is well established and understood, there are disconnects in applying theory into practice.  Our System is designed to connect the gap between the theory and practice of diabetes care. We believe the main gaps between theory and practice are:

 

  1. Type 2 diabetes patients are well known for non-adherence to care plans; however, central to conventional diabetes care is patient self-management. A natural contradiction.
  2. From review of published papers, we came to the conclusion that healthcare providers are also responsible for unacceptable outcomes in diabetes care.

 

However, the challenges faced by healthcare providers are not related to their ability, rather:

 

  1. they face a lack of timely and reliable blood glucose data, resulting in delays to advance therapy and sub-optimal insulin dosing.
  2. when reliable blood glucose data is available, there is "too much information" for a healthcare provider to analyse in a 15 minute clinical visit.

 

Based on our clinical trials and pilot, the platform will improve patient outcomes and with the new features will be able to track performance of the healthcare providers as well as patients. Patients utilizing the ALRT Diabetes Management System can realize many benefits. They can expect:

·More timely health care provider attention and action to existing or developing health conditions.
·Maximization of benefits from health management activities and medication.
·Improved health outlook.

Health care providers can expect:

·More timely access to patient blood glucose data and trends
·Better understanding of factors that affect patient condition and efficacy of prescribed health management program.
·Increased ability to influence patient compliance behavior.
·Higher reimbursements resulting from better documentation of post-consultation health care services and potential improvements in diabetes quality scores

Employer, Insurers, and other entities that help manage patient’s health also benefit when their health care providers or patients use the ALRT Diabetes Management System from:

·Improved health outlook for high cost diabetes patients.
·Healthier and more productive employees.
·Reduced number of claims and claims amounts for redundant or ineffective health management activities and medication.
·Regular monitoring, supervision, and disease-related information provided to high-cost patients.
·More effective wellness and disease management programs.
·Ability to base co-pay amount or premium amount on level of compliance.

Our system monitors compliance of disease management activities, such as treatments, medications and diagnostic tests, alerts designated parties when a patient is noncompliant. Our system also facilitates intervention if the patient is deemed at-risk. Often, physicians and caregivers do not detect noncompliance until the next medical appointment when a patient comes to the clinic. We believe more timely intervention should result in substantial health benefits to the patient and significant cost savings. The ongoing monitoring of compliance data will also allow for evaluation of compliance behavior over time, resulting in behavior modification or education efforts when appropriate.

 

 7 

 

Potential Benefits of ALRT Diabetes Management System (continued)

 

Industry data indicates that 50% or more of people on medications do not take them as prescribed, and that this non-compliance contributes to 10% of hospitalizations and billions of dollars spent annually in excessive and preventable healthcare costs. Reminding a person to take an action is the first step in our system; monitoring their actions and their data is the second and intervention when needed is the important follow-up.

 

With a specific focus on diabetes treatment plans, a recent study from the Temple University School of Pharmacy indicates that the U.S. could save over $9 billion annually by improving patient adherence. Currently, there is inadequate oversight around the buying, selling and appropriate use of diabetes self-glucose testing supplies. Attempts at oversight are fragmented, primarily paper-based, and rely on unverifiable patient reporting. We feel that policies requiring electronic verification of test supply utilization prior to providing refills of test strips, will improve accountability. The ALRT Diabetes Management System has the capability to monitor and document the results of testing to verify that accountability.

 

We believe the ALRT Diabetes Management System can provide solutions to overcome numerous obstacles and inefficiencies in the healthcare system, potentially saving the United States billions of dollars while providing improved healthcare levels, as measured by A1c, for its citizens.

 

Reimbursement for Health Professionals

 

The Company continues to work to obtain confirmation that the Diabetes Management System will allow for services to be provided by physicians that will be reimbursed by health insurance companies. The reimbursement will be a breakthrough as physicians will be paid to provide these important new services to their patients with chronic conditions.

 

Business Development and Marketing Strategy

 

The Company is focusing the majority of its efforts in introducing and marketing its Health-e-Connect System for medical clinics and health professionals to provide direct care to patients and be reimbursed by the patients’ health benefit plans as well as to employers due to the significant return on investment they can achieve by keeping employees/plan members healthy.

 

The Company is first targeting customers located in United States because of the large market potential but will also seek to obtain regulatory clearance and establish selling operations/agreements for sales and distribution in Canada, Europe, Australia and selected countries in Asia and South America.

 

 8 

 


Other Products

 

The Company’s main product is its Diabetes Management System.

 

Selling Activities

 

The Company is actively seeking alliances with health care organizations, pharmaceutical companies, insulin providers and other health care companies that can act as catalysts to effect positive change for containing health care costs and improving health outcomes. We will work with these types of organizations to introduce the ALRT Diabetes Management System to their network and seek to start significant pilot projects that will lead to revenue generating arrangements.

 

Manufacturers

 

The Company does not have any designated manufacturers at this time.

 

Patents and Trademarks

 

-US Patent D446, 740 received on August 21, 2001 for Ornamental design of a Medication Alert Device in the shape of a heart.

 

-US Patent D446,739 received on August 21, 2001 for Ornamental Design of a Medication Alert Device in the shape of a dog bone.

 

-US Patent D447,074 received on August 28, 2001 for Ornamental Design of a Medication Alert Device in the shape of a stylized paw.

 

-US Patent 6,934,220 received on August 23, 2005 entitled Portable Programmable Medical Alert Device.

 

-US Patent 7,607,431 issued October 27, 2009 for patient compliance and remote monitoring of patient’s use of nebulizer compressors.

 

The Company has the following patent applications pending:

 

-Provisional Patent Application serial number 61/271,852 filed on July 27, 2009. Title is Patient Care Coordination System Including Home Use of Medical Apparatus.

 

The Company has the following patent applications under the PCT:

 

-PCT/CA2017/050753 dated June 27, 2017. Title is “method and system for monitoring a diabetes treatment plan”.

 

Competition

 

The Company competes with other corporations that produce diabetes compliance devices and monitoring systems, some of whom have greater financial, marketing and other resources than we do. A few companies currently offer compliance monitoring systems but either a) at much higher prices b) have fewer benefits than our system or c) they do not have FDA clearance. The Company’s competition includes, but is not limited to, Glooko, WellDoc, Medtronics, iGlucose and Microsoft Healthvault.

 

We feel none of these companies currently offer a comprehensive compliance system that offers the full spectrum of benefits and features that our Diabetes Management System does with the potential cost efficiencies.

 9 

 

 

Employees and Independent Contractors

 

The Company has no employees and 17 personnel under independent contractor and consulting arrangements. The consultants of the Company have contracts which outline their roles and responsibilities as independent contractor, as well as outlines the confidentiality requirements for all matters pertaining to the Company.

 

Recent Developments

 

On January 15, 2016, the Company announced that it has not been successful in finding follow on financing and accordingly reduced its operating budget by reducing its United States based sales and marketing program and diabetes care facilitation workforce. On January 31, 2016, the Company received the resignation of Mr. William Smith from the positions of President and member of the board of directors of the Company.

 

On June 21, 2016, the Company accepted a proposal from Sidney Chan, the Chairman and Chief Executive Officer of the Company, to amend the existing credit agreement between the two parties to increase the borrowing limit on the line of credit provided to the Company from $7,000,000 to $8,500,000. All other terms and conditions remain unaltered. Mr. Chan and the Company had previously entered into a credit agreement on March 6, 2011, which was subsequently amended by amending agreements dated October 24, 2011, June 15, 2012, December 28, 2012, April 1, 2014 and May 29, 2015 whereby Mr. Chan agreed to make available to the Company a credit line equal to an aggregate of $7,000,000 for the Company’s corporate purposes. Under the terms of the arrangement, the amount borrowed by the Company bears simple interest at a rate of 1% per month. The amount borrowed is secured by a general security agreement over the assets of the Company and is due on demand.

 

Under the terms of the proposal, in exchange for Mr. Chan making available the additional loan of $1,500,000 to the Company, the Company would be required to:

·reduce the exercise price of the 466,666,667 shares of common stock under option to Mr. Chan from $0.015 to $0.002;
·grant Mr. Chan the right and option to purchase, an additional 3,783,334,200 shares of common stock at a price of $0.002 per share for a term of five years from the date of execution of the amended credit agreement.
·reduce the exercise price of the 93,333,400 shares of common stock under option to the spouse of Mr. Chan, Ms. Christine Kan, from $0.015 to $0.002;
·grant Ms. Kan the right and option to purchase, an additional 606,667,100 shares of common stock at a price of $0.002 per share for a term of five years from the date of execution of the amended credit agreement

 

On December 20, 2016, certain stockholders who beneficially owned 122,998,482, or approximately 50.66%, of the combined voting power of the common stock consented in writing to increase the number of authorized shares of common stock from two billion shares (2,000,000,000) to ten billion shares (10,000,000,000) shares, par value $0.001 per share. The Company filed a preliminary information statement with the SEC but has not filed its definitive statement due to its deficient reporting status.

 

Recent Developments – Subsequent to December 31, 2016

 

On January 27, 2017, the Company’s Board of Directors approved a 100:1 reverse share split of the Company’s common stock. The Company cannot complete its stock split due to its deficient reporting status with the SEC.

 

On November 27, 2017, the Company’s Board of Directors approved the grant of the option to 8,700,000 shares of common stock of the Company at a price of $0.015 per share for a term of five years. 2,200,000 of the approved options were to a director of the Company and 6,500,000 were to consultants of the Company.

 

 10 

 

On January 31, 2018, the Company’s Board of Directors approved the following grants:

 

·the option to acquire 47,000,000 shares of common stock of the Company at a price of $0.015 per share for a term of five years to 9 consultants of the Company, and
·the option to acquire 200,000 shares of common stock of the Company at a price of $0.015 per share until April 19, 2019 to 1 consultant of the Company.

 

Of the options granted with a term of five years, options to acquire a total of 11,000,000 shares of common stock were granted to three relatives of the Chairman of the Board.

 

ITEM 1A.

RISK FACTORS

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.

 

ITEM 1B.UNRESOLVED STAFF COMMENTS

 

None.

 

ITEM 2.PROPERTIES

 

None.

 

 

 11 

 

ITEM 3.LEGAL PROCEEDINGS.

 

Accounts payable and accrued liabilities as of December 31, 2016 include $180,666 (December 31, 2015 - $180,666) of amounts owing to a supplier, which the Company has previously disputed and has refused to provide payment. The amount payable stems from services provided during 2004. The vendor has not sought any actions to collect the amounts and management does not expect to ever pay this amount. Management asserts that the Company has no obligation to the vendor as the vendor did not perform the work sought as expected and the Company never took possession of the end product. The outcome of this matter cannot be determined at this time. Any additional liability realized, if any, will be recognized once the amount is determinable. Any gain on settlement of the account payable will be recorded in the period that an agreement with the supplier is reached and the amount becomes determinable.

 

Included in notes payable and accrued interest payable, are the following recognized liabilities which have involved legal proceedings:

 

1)        Mr. H. Gordon Niblock

During 2009, the following judgment was rendered: Niblock Financial Systems, Inc. et al v. ALR Technologies, Inc. Forsyth County North Carolina File Number 0-9-CVS-2220. The judgment against the Company was in the amount of $600,000 in favor of Niblock Financial Systems, Inc. and $550,000 in favor of H. Gordon Niblock, plus court costs and attorney’s fees. The judgment was rendered as a result of the Company’s failure to pay amounts due under several promissory notes. On September 30, 2009, subject to the entry of that judgment, the Company reached a Settlement Agreement with the two plaintiffs, resulting in a cash payment, a credit to the judgment and an assignment of the Judgment to Christine Kan.

 

As part of the Settlement Agreement Mr. Stan Cruitt, a Director of the Company at the time assigned unsecured advances payable by the Company totaling $425,000 with no stated terms of interest or repayment to the plaintiffs. As part of the Settlement Agreement, the Company agreed to the following repayment terms:

 

-       $300,000 repayable at a rate of $25,000 per month evidenced by a promissory note and

-       $125,000 repayable in whole by January 15, 2011.

 

The plaintiffs (Niblock Financial Systems, Inc. et al) filed a motion of default against the Company (ALR Technologies, Inc.) in the Superior Court of Forsyth County, North Carolina (case number 10-CVS-685) for failure to meet the repayment terms of the $300,000 promissory note. On October 26, 2010, case 10-CVS-685 was heard and the court found in favor of the plaintiff, meaning the Company was ordered to repay full principle of $300,000 along with $11,000 of accrued interest from the original settlement date, being September 30, 2009. While the interest rate was not included in the original settlement agreement, the Company did not contest the inclusion of interest in the judgment.

 

On December 18, 2013, the Company was served with a civil summons from H. Gordon Niblock in respect of a complaint for breach of agreement to repay the promissory note of $125,000 due on by January 15, 2011, plus interest at the legal rate of eight percent per annum from the date of maturity of the note until the amount is repaid plus reasonable attorney fees of the proceedings. On February 5, 2014, case 13-CVS-7736 for the plaintiff’s motion for entry of default and default judgment was heard in the Superior Court Division of Forsyth Country, North Carolina. The court found in favor of the plaintiff, ruling that the Company was in default of its agreement with the Plaintiff and that the Plaintiff is eligible to seek affirmative relief against the defendant.

 

The Company has not made any repayments under the terms of the settlement agreement for either the loans (and accrued interest) totaling $486,000 or any costs of the judgment reached against the Company.

 12 

 

ITEM 3.LEGAL PROCEEDINGS (continued).

 

 

2)        Ms. Irene Ho

The Company owes a promissory note to Ms. Irene Ho which was demanded for repayment on December 14, 2010. This amount has not been repaid and interest continues to accrue at the legal rate. The total principal and interest owing to Ms. Irene Ho is approximately $486,000.

 

3)        Mr. Stan Link

Mr. Stan Link holds a note from the Company, which is in arrears. The matter was reduced to a Consent Judgment in the amount of $43,608 on April 13, 2009. This full amount is still outstanding and continues to accrue interest at the stated rate of the note. The total principal and interest owing to Mr. Stan Link is approximately $67,000.

 

On March 27, 2017 the United States District Court granted the motion to dismiss a complaint filed by MyHealth, Inc. against the Company in case 2:16-CV-00535-RWS. The court ordered, adjudged and decreed that My Health, Inc.’s complaints against ALR Technologies, Inc. were dismissed with prejudice. MyHealth, Inc. originally filed a motion of appeal, which subsequently MyHealth, Inc. dismissed. On May 19, 2016 MyHealth, Inc filed a complaint against the Company that it engaged in willful and knowing patent infringement against MyHealth, Inc.

 

ITEM 4.MINE SAFETY DISCLOSURES

 

Not applicable.

 

 

 

 13 

 

PART II

 

ITEM 5.MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

The Company’s Common Stock is quoted on the Bulletin Board (OTCQB) operated by the Federal Industry Regulatory Authority (“FINRA”) under the symbol “ALRT.” The following table sets forth the high and low sales prices for our common stock for each quarter within the last two fiscal years:.

 

Quarter Ended High Bid [1] Low Bid [1]
     
December 31, 2016 0.00 0.00
September 30, 2016 0.00 0.00
June 30, 2016 0.00 0.00
March 31, 2016 0.00 0.00
December 31, 2015 0.01 0.00
September 30, 2015 0.01 0.00
June 30, 2015 0.02 0.00
March 31, 2015 0.02 0.01

 

[1]       These quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not represent actual transactions.

 

At December 31, 2016, there were 242,777,909 common shares of the Company issued and outstanding.

 

As at December 31, 2016, there were 136 registered holders of record of the Company’s common shares and an undetermined number of beneficial holders.

 

No cash dividends has been declared by the Company nor is any intended to be declared. The Company is not subject to any legal restrictions respecting the payment of dividends, except that they may not be paid to render the Company insolvent. Dividend policy will be based on the Company’s cash resources and needs and it is anticipated that all available cash will be needed for working capital.

 

Securities Authorized From Issuance under Equity Compensation Plans

 

The Company does not have any equity compensation plans and accordingly the Company does not have any securities authorized for issuance under an equity compensation plan.

 

Recent Sales of Unregistered Securities

 

There were no issuance of securities that were not under a registration statement during the year ended December 31, 2016 and the subsequent period to the date of this Form 10K.

 

Purchases of Equity Securities by the Company and Affiliated Purchasers

 

Neither the Company nor an affiliated purchaser of the Company purchased common shares of the Company in the year ended December 31, 2016.

 

ITEM 6.SELECTED FINANCIAL DATA

 

The Company is a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and is not required to provide the information under this item.

 14 

 

 

 

ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

General

 

The Company’s business is focused on enhancement of adherence to disease and healthcare management programs through monitoring, reminders and improved communications. The Company’s primary business markets are the providers of health insurance and the providers of disease and case management services, including the home care industry.

 

The largest potential for sustainable long term growth and value generation lies with the market segments that have the most influence on the end-user and the most to gain from improved healthcare results. These market segments are the health insurance providers, and the medical clinics and physicians who provide the care for people with chronic disease. Our focus is on penetrating the full cycle of health care services including medical clinics, hospitals and health plans with diabetics being the initial patient targets.

 

Revenue

 

The Company did not generate any revenue in 2016 or 2015. For the past several years, the Company has been devoting its efforts to developing and commercializing its Diabetes Management System, a patient monitoring, compliance and communications platform to allow health professionals and case managers to communicate as needed to the patient and/or to other health professionals. In October 2011, the Company announced that it had received FDA clearance to sell its Diabetes Management System in the United States. Since receiving FDA clearance, the Company’s senior leadership team has been presenting how the Diabetes Management System uniquely supports mutual priorities around improved patient care, healthcare cost-containment, accountability, and job creation based on the results from the clinical trials conducted and applied to studies surrounding diabetes management by numerous sources.

 

Product Development

 

During the 2016 fiscal year, the majority of the Company’s product development efforts were expended to:

·further development IDA;
·respond to questions from the FDA for its 510K clearance application for IDA;
·design, develop and advance Predictive A1c;
·prepare for additional functionality to enhance care facilitation activity;
·implement advances as a result of pilot program feedback, and
·other general advances of the Diabetes Management System.

 

            With the completion of the Diabetes Management System, the Company is currently focusing its efforts on the commercial launch plans of the product and conducting research activities for future attributes and applications for the Diabetes Management System.

 

Product development and research costs were $565,804 in 2016 and $522,918 in 2015.

 15 

 

 

Operating Capital

 

The Company has no revenues and has not generated any revenues since creating its Diabetes Management System. The Company is funding operations through the line of credit financing it has available. The majority of the Company’s expenditures go towards product development, professional fees and administrative activities. The Company incurs significant amounts of interest expense from its debts outstanding and from time to time, the grant of stock options in exchange for either 1) deferred payment 2) agreements of note extensions and 3) increased borrowing limits provided. All stock options granted related to the debts of the Company have been recorded at their fair value using the Black-Scholes option pricing model and are expensed over the agreed upon term of the debt instrument where applicable. Where the debt of the Company is a line of credit arrangement with no fixed terms of repayment, the stock option expense is fully recognized at the time of grant.

 

There is no certainty of the timing or amount of cash flows from sales, and if sales do begin, there is no certainty that it will reach the level necessary to cover operating costs and costs to service the company’s debts. The Company has limited resources and is seeking to penetrate markets with indirect competition with much greater resources. The Company is seeking to displace generally accepted processes for diabetes management which means it is directly entering into an unestablished market. Management is evaluating alternatives to penetrate both existing and new marketplaces in order to generate cash flows. Management believes the business plan of the Company will give it the best opportunity to achieve commercial feasibility but due to the current acceptance levels of the Diabetes Management System, there is substantial uncertainty over the Company’s ability to execute the plan, the level of success associated with the execution of its business plan or the actual timeline to execute the plan. If the actual timeline for the execution of the business plan is substantially longer than planned, it could jeopardize the Company’s long term success. For these reasons the Company is seeking additional financing.

 

The Company has an operating lines of credit with a borrowing limit of $10,500,000. As at December 31, 2016, the Company had borrowing available of approximately $872,000 on its line of credit. The Company does not have any other facilities readily available at this time. Management will seek to acquire additional financing to allow the Company to become a commercially viable enterprise, whereby it can generate sufficient cash flow from the sales of its HeC product to support its cost of operations, overhead and repay its obligations.

 

There is no certainty that the Company will ever be able to achieve the level of sales necessary to cover operating costs or achieve the level of sales before the borrowing limits on the lines of credit financing are reached. During 2016, the Company increased the borrowing limit from $9,000,000 to $10,500,000 with the expectation of achieving substantial sales during the 2016 fiscal year, which did not materialize. The Company may require additional financing in the future for which there is no guarantee it will receive, furthermore, even if the Company is able to achieve sufficient cash flows to support operations, it will need to service its debt obligations, which as of December 31, 2016 were $23,234,761. A total of approximately $18,200,000 is owed to the Chairman and his family.

 

Operating Issues

 

The Company has expended significant efforts introducing the Health-e-Connect System to specified retail chains, pharmaceutical manufacturers, contract research organizations, health management organizations, pharmacy benefits managers and certain clinics treating specific disease conditions. The Company has not had sales for several years. During the 2015 and 2016 fiscal years, the Company has devoted 100% of its efforts to developing the Diabetes Management System for commercial launch. Management plans for the Company to become a commercially viable enterprise through sales of the Health-e-Connect Remote Diabetes Management Program.

 

If management is not successful in its plans, they may be required to raise additional funds from its existing and prospective shareholders or debtholders, which it may not be able to accomplish on satisfactory terms for the Company.

 16 

 

 

Management Compensation

 

During 2015, the Company’s two officers were paid from the line of credit financing available.

-Sidney Chan, Chief Executive Officer, accrues $15,800 per month, all of which was recorded as an increase to the borrowings on the lines of credit provided by himself.
-William Smith, President, was paid $15,500 per month.

 

Mr. Chan’s compensation for 2016 was the same as disclosed for 2015 above. Effective January 31, 2016 William Smith resigned from his position was President. During the 2016 fiscal year, William Smith was paid $15,500.

 

The Company issues stock options as compensation from time to time. No directors of the Company earn service fees for their position as Director of the Company. Those Directors that hold a position as Officer or consultant of the Company earn fees for those services provided. During 2015 and 2016, the Company did not grant any incentive options to its directors for services. The Company granted Mr. Chan the option to acquire shares of common stock in exchange for increasing the borrowing limit on the line of credit he has provided to the Company.

 

Capital Structure

 

As of the date of this Form 10K:

 

Authorized Common Stock

2,000,000,000 shares of common stock with a par value of $0.001 per share.

 

On December 20, 2016, certain stockholders who beneficially owned 122,998,482, or approximately 50.66%, of the combined voting power of the common stock consented in writing to increase the number of authorized shares of common stock from two billion shares (2,000,000,000) to ten billion shares (10,000,000,000) shares, par value $0.001 per share. The Company has not completed its Definitive 14C filing with the SEC due to its status as being deficient with its reporting requirements.

 

On January 27, 2017, the Company’s Board of Directors approved a 100:1 reverse share split of the Company’s common stock. The Company has filed the amendment to its articles to effect the reverse split with the State of Nevada. The Company did not file its final Schedule 14C due to its deficient reporting status with the SEC.

 

Issued Common Stock

242,777,909 shares of common stock are issued and outstanding.

 

Authorized Preferred Stock

500,000,000 shares of preferred stock with a par value of $0.001 per share.

 

Issued Preferred Stock

No shares of preferred stock have been issued

 

Stock Options

Options to acquire 4,962,301,500 shares of common stock are outstanding.

 17 

 

 

Results of Operations

 

December 31, 2016 compared to December 31, 2015

 

          Amount ($) Percentage (%)  
    2016   2015 Increase / Increase /  
          (Decrease) (Decrease)  
Operating Expenses              
General and administrative $ 354,948 $ 836,756 (481,808) (58)  
Product development   565,804   522,918 42,886 8  
Professional fees   108,275   217,454 (109,179) (50)  
    1,029,027   1,577,124 (548,101) (35)  
               
Other items              
  Foreign exchange gain   -   (3,483) 3,483 100  
  Interest expenses   9,064,706   4,795,168 4,269538 89  
  Recovery of expense   -   (70,000) 70,000 100  
                
Net Loss $ 10,093,733 $ 6,298,813 (3,794,920) (60)  

 

The net loss for the Company’s year ended December 31, 2016 and December 31, 2015 was significantly impacted by the grant of options to obtain additional debt financing:

 

 

Year Ended

December 31, 2016

Year Ended

December 31, 2015

Options Granted as Consideration 4,390,001,300 230,000,100
Value of Options Granted as Consideration $ 7,318,539 $ 3,184,459
Percentage of Net Loss 73% 51%

 

The net loss for the year ended December 31, 2016 increased by 60% ($3,794,920) from prior year as a result of the grant of options with a fair value of $7,318,539 as consideration for receiving an increase in the borrowing limit of the primary line of credit facility the Company has available. During the same period in the previous year, the Company incurred expense of $3,184,459 with respect to options granted for increasing the borrowing limit on the line of credit facility the Company had available. The additional fair value of the options granted in 2016 accounted for 109% of the total increase in net loss from the same period in the prior year. At the operating expenses level, the Company had a significant reduction in net loss attributed to a reduction in the sales, marketing and diabetes care facilitators in the United States effective January 31, 2016.

 

General and Administrative

General and administrative costs incurred consist of salaries and consulting fees of management personnel, stock-based compensation for options granted to management personnel, travel and trade show costs, rent of the Company’s corporate office, website development costs and general costs incurred through day-to-day operations.

 18 

 

 

Results of Operations (continued)

 

During the year the Company had a significant reduction in the general and administrative expenses incurred by type of general and administrative cost, the variance can be seen as follows:

 

              Amount ($)  
      2016   2015   Increase /  
              (Decrease)  
                 
General and administrative:                
Management salaries & consulting fees   $ 256,000 $ 602,000   (346,000)  
Stock based compensation     3,000   20,000   (17,000)  
Travel and trade-shows       52,000   110,000   (58,000)  
Rent of corporate office     9,000   23,000   (14,000)  
Website & information technology       24,000   37,000   (13,000)  
Other general & administrative costs     11,000   45,000   (34,000)  
Total $ 355,000 $ 837,000   (482,000)  

 

The cash-based general & administrative expenditure decreased by approximately $465,000 during the 2016 fiscal year as compared to the 2015 fiscal year. During the 2016 fiscal year, the Company reduced its general and administrative operating expenditures as compared to 2015 as it reduced its sales and marketing team in the United States. We anticipate that operating expenses for 2017 will be similar to the amounts in 2016, before any new endeavors or projects.

 

Product development

Substantially all of the product development costs incurred related to a) services provided by contractors of the Company b) expenses incurred for product development and c) stock-based compensation for options granted to members of the product development team. The increase from the prior year is related to the level of services required by the development team of the Company and for additional developers and testers retained. For the 2016 fiscal year, the Company was anticipating a 5% increase in product development costs from 2015 which was in line with the actual percentage increase as a result of the full year from new full-time personnel that were hired part way through 2015.

 

For the 2017 fiscal year, the Company is anticipating similar or reduced overall development expenditures as the number of individuals under contract was lower for the 2017 fiscal year as compared to 2016.

 

Interest expense

Interest expense was incurred from the following sources for years ended December 31, 2016 and 2015:

         

Amount ($)

Increase /

(Decrease)

 
Interest Expense:   2016   2015  
           
               
Interest expense incurred on promissory notes   494,000   516,000 $ (12,000)  
Interest expense incurred on lines of credit   1,102,000   944,000   158,000  
Imputed interest on zero interest loans   148,000   149,000   (1,000)  
Stock options granted for promissory notes     7,319,000   3,184,000   4,135,000  
Other   2,000   2,000   -  
Total $ 9,065,000 $ 4,795,000 $ 4,270,000  

 

Interest on Promissory Notes

Interest on promissory notes was the same as the prior year as there were no repayments, issuances or changes, in any of the promissory notes from December 31, 2015 to December 31, 2016, with the exception of the interest rate on promissory notes totaling 695,000 was reduced from 12% per annum to 6% per annum effective January 1, 2015. The full amount of the reduction for 2015 and 2016 was recognized in the 2016 fiscal year.

 19 

 

 

Results of Operations (continued)

 

Interest Expense (continued)

 

Interest on Lines of Credit

The Company has two line of credit facilities with balances as follows:

    Dec 31   Dec 31

Amount ($)

Increase /

 
Lines of Credit:   2016   2015  
               
Line of Credit provided by Sidney Chan   $ 7,628,000 $ 6,627,000 $ 1,001,000  
Line of Credit provided by Christine Kan   2,000,000   2,000,000   -  
Total $ 9,628,000 $ 8,627,000 $ 1,001,000  

 

Interest on Lines of Credit

The Company interest expense on the lines of credit as follows:

    Year Ended   Year Ended   Amount ($)  
Interest Expense on Line of Credit :   2016   2015   Increase /  
               

Interest expense incurred on line of credit from

Sidney Chan during the year

 

$

 

862,000

 

$

 

704,000

 

$

 

158,000

 

Interest expense incurred on line of credit from

Christine Kan during the year

 

 

240,000

 

 

240,000

 

 

-

 
Total $ 1,102,000 $ 944,000 $ 158,000  

 

During the 2016 fiscal year, the Company had borrowed an additional $1,001,000 from its line of credit facilities (interest rates of 1% per month on the borrowed balance). In addition to incurring interest for a full year on the amounts borrowed during the 2015 fiscal year, this borrowing during 2016 resulted in significantly higher interest incurred on the lines of credit for the year ended. During 2017, the Company financed its operations through line of credit borrowing facilities which as a result, its interest expense related to the line of credit facilities further increased.

 

Imputed Interest

During the 2016 and 2015 fiscal years, the Company had certain zero interest promissory notes and accounts payable in excess of one year. Pursuant to the company’s accounting policy, these zero interest amounts are considered to be financing items in nature and are assigned a deemed interest rate (1% per month). The interest incurred on these is expensed as imputed interest; instead of increasing the liabilities of the Company, imputed interest expense is allocated to equity under the financial statement line item “additional paid-in capital”. The Company’s zero interest instruments were as follows as at December 31, 2016 and 2015:

 

         

Amount ($)

(Decrease)

 
Zero Interest Instruments:   2016   2015  
           
               
Accounts Payable (older than one year) $ 666,000 $ 665,000 $ 1,000  
Promissory Notes to unrelated parties   571,000   571,000   -  
Total $ 1,237,000 $ 1,236,000 $ 1,000  

 

The Company incurred imputed interest as follows:

         

Amount ($)

Increase /

(Decrease)

 
Imputed Interest Expense:   2016   2015  
           
               
Accounts Payable (older than one year) $ 80,000 $ 80,000 $ -  
Promissory Notes to unrelated parties   68,000   68,000   -  
Total $ 148,000 $ 148,000 $ -  

 

Moving forward, we anticipate the expense to be consistent with the amount incurred in the 2016 fiscal year unless accounts payable or promissory notes payable without interest materially change.

 20 

 

Results of Operations (continued)

 

Interest Expense (continued)

 

Stock Based Compensation

 

On July 1, 2016, the Company and the Chief Executive Officer of the Company agreed to amend the existing credit agreement to increase the borrowing limit on the line of credit provided to the Company from $7,000,000 to $8,500,000 (Note 4). In exchange for Mr. Chan making available the additional loan of $1,500,000 to the Company, the Company:

·reduced the exercise price of the 560,000,200 shares of common stock under option to Mr. Chan and his spouse from $0.015 to $0.002;
·granted Mr. Chan and his spouse the right and option to purchase, an additional 4,390,001,300 shares of common stock at a price of $0.002 per share for a term of five years

 

The interest expense recognized related to the option grant was $7,318,539.

 

On May 29, 2015, the Company and Sidney Chan, the Chairman of the Board and Chief Executive Officer of the Company, agreed to amend the existing credit agreement between the two parties to increase the borrowing limit on the line of credit provided to the Company from $5,500,000 to $7,000,000. In exchange for Mr. Chan making available the additional loan of $1,500,000 to the Company, the Company:

·reduced the exercise price of the 183,333,400 shares of common stock under option to Mr. Chan from $0.03 to $0.015;
·extended the expiry date of the 183,333,400 shares of common stock under option to Mr. Chan to be five years from the date of execution of the amended credit agreement
·granted Mr. Chan the right and option to purchase, an additional 283,333,400 shares of common stock at a price of $0.015 per share for a term of five years from the date of execution of the amended credit agreement.
·reduced the exercise price of the 46,666,700 shares of common stock under option to the Ms. Christine Kan (Spouse of Mr. Chan) from $0.03 to $0.015;
·extended the expiry date of the 46,666,700 shares of common stock under option to Ms. Kan to be five years from the date of execution of the amended credit agreement; and
·granted Ms. Kan the right and option to purchase, an additional 46,666,700 shares of common stock at a price of $0.015 per share for a term of five years from the date of execution of the amended credit agreement.

 

As a result of these stock option grants, the Company incurred $3,184,000 of stock based compensation expense which was allocated to interest expense. As the options were fully vested, and the debt facility was a revolving line of credit, due on demand, the full amount was expensed at the time of the grant of the options.

During the 2017 fiscal year, the Company did not grant any options as compensation for financing and therefore does not anticipate any related interest expense.

 21 

 

 

Results of Operations (continued)

 

Professional Fees

Professional fees expense consist of consulting and advisory fees of certain professionals retained, audit fees, legal fees, diabetes care facilitators fees and stock-based compensation for options granted to professionals.

 

During the year, there was not a significant reduction in the total expense incurred. By type of professional fee expense, the variance can be seen as follows:

 

          Amount ($)  
 Professional Fees:   2016   2015 Increase /  
          (Decrease)  
             
Legal Fees      50,000   35,000 15,000  
Diabetes care facilitators     7,000   88,000 (81,000)  
Professional advisors retained      51,000   53,000 (2,000)  
Corporate auditor - Year-end and quarterly review     -   37,000 (37,000)  
Stock based compensation   -   4,000 (4,000)  
Total $ 108,000 $ 217,000 (109,000)  

 

The the decrease in professional fees for the 2016 year from the prior year can be attributed to

a) the Company reducing its US based budget for sales, marketing and diabetes care facilitators;

b) the Company retaining additional legal counsel to respond to the complaint and filing against the Company by MyHealth, and

c) the Company becoming deficient with its SEC reporting requirements and not completing its quarterly reviews or year-end audit during the fiscal year.

 

During the 2017 fiscal year, the Company is anticipating the professional fees to increase as it incurred legal fees in winning its case with MyHealth and incurred audit fees as part of the process of becoming compliant with the reporting requirements of the SEC.

 22 

 

Liquidity and Capital Resources

 

Cash Balances

 

The Company’s cash balance was $2,607 at December 31, 2016 and $52,688 at December 31, 2015.

 

Short and Long Term Liquidity

 

Working Capital
   

As At

December 31, 2016

 

As At

December 31,

2015

 

Amount ($)

Increase / (Decrease)

Percentage (%)

Increase / (Decrease)

Current Assets $ 4,000 $ 54,000   (50,000) (93)
Current Liabilities $ 23,235,000 $ 20,676,000   2,559,000 12
Working Deficiency $  (23,231,000) $  (20,622,000)   (2,609,000) 12

 

The Company has a severe working capital deficiency. It does not have ability to service is current liabilities for the next twelve months and is reliant on its line of credit facilities to meet its on-going operations. Until the Company has revenue producing activities that exceed its operating requirements, it will be unable to service its current liabilities and the working capital deficit will continue to increase. As of the date of this management discussion and analysis, the Company has not commenced revenue generating activities, nor does it know when they will commence. There is substantial doubt about the Company’s ability to repay its current liabilities in the near term or anytime in the future which could ultimately lead to business failure.

 

Current Liabilities

 

The Company has current liabilities of $23,235,000 as at December 31, 2016 as compared to $20,676,000 as at December 31, 2015. Current liabilities were as follows:

    December 31, 2016   December 31, 2015  

Change

($)

Change

(%)

Accounts payable and accrued liabilities $ 943,000 $ 982,000   (39,000) (4)
Interest payable $ 3,630,000 $ 3,136,000   494,000 16
Line of credit $ 13,376,000 $ 11,272,000   2,104,000 19
Promissory notes to related parties $ 2,892,000 $ 2,892,000   - -
Promissory notes to arm’s length parties $ 2,394,000 $ 2,394,000   - -
Total current liabilities $ 23,235,000 $ 20,676,000   2,559,000 12

 

Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities consists of the trade payables and unclassified vendors of the Company.

 

Interest Payable

Interest payable relates to the accumulated, unpaid interest expense incurred on the promissory notes to related parties and promissory notes to arm’s length parties. The change from December 31, 2016 to December 31, 2015 is equal to the interest expense incurred on both categories of promissory notes during the 2016 fiscal year.

 

Promissory Notes to Related Parties and Promissory Notes Payable to Arm’s Length Parties

The Company has promissory notes with 20 individuals or corporations that relate to historical amounts borrowed. There has been no new activity for several years. All of these promissory notes are past due and continue to accrue interest at their respective legal rates of interest (mostly 1% per month). During the 2015 fiscal year, a promissory note and related accrued interest totaling $39,000 was assigned to Christine Kan as a result of a private transaction.

 23 

 

Current Liabilities (continued)

 

Line of Credit

As of December 31, 2016, the Company has borrowed a total of $9,628,219 (2015 - $8,626,993) and has outstanding accrued interest of $3,747,343 (2015 - $2,645,101). During 2016, the Company borrowed $1,001,226 (2015 - $1,529,720) and incurred interest of $1,102,243 (2014 - $944,010).

 

Line of Credit from Ms. Christine Kan

The Company obtained a line of credit of US$1,000,000 from Ms. Christine Kan (the spouse of the Chairman of the Board and Chief Executive Officer of the Company) on March 2010 (the terms of which were finalized in May 2010). The loan was unsecured with interest payable on funds borrowed at 1% per month. These proceeds were to be put towards working capital and the continued development of the Company’s product line. On January 3, 2011, the Creditor granted the Company an increase in the borrowing limit from $1,000,000 to $2,000,000. As of December 31, 2016, the Company has borrowed $2,000,000 (2015 - $2,000,000) and has accrued interest outstanding of $1,256,385 (2014 - $1,016,385). During the 2016 fiscal year, the Company borrowed $nil (2015 - $nil) and incurred interest of $240,000 (2014 - $240,000).

 

Line of Credit from Mr. Sidney Chan

On March 6, 2011, the Company obtained a $2,500,000 line of credit from Sidney Chan (the Chairman of the Board and Chief Executive Officer of the Company). Under the terms of the arrangement, the amount borrowed by the Company bears simple interest at a rate of 1% per month. The amount borrowed is secured by a general security agreement over the assets of the Company and is due on demand. Originally, the line of credit was for a comprehensive marketing program, but subsequently was amended to be for general corporate purposes. On April 1, 2014, Mr. Chan and the Company executed an amending agreement whereby Mr. Chan increased the borrowing limit of the line of credit he has provided to the Company from $4,000,000 to $5,500,000. On May 29, 2015, the borrowing limit was further increased to $7,000,000. On July 1, 2016, the borrowing limit was further increased to $8,500,000. As of December 31, 2016, the Company has borrowed $7,628,219 (2015 - $6,626,993) and has accrued interest outstanding of $2,490,958 (2015 - $1,628,716). During 2016 the Company borrowed $1,001,226 (2015 - $1,529,720) and incurred interest of $862,242 (2015 - $704,010).

 

Short and Long Term Liquidity

 

The Company has incurred significant operating losses over the past several fiscal years (2016 - $10,093,733; 2015 - $6,298,813), is currently unable to self-finance its operations, has a working capital deficit of $23,230,725 (2015 - $20,621,972), an accumulated deficit of $71,686,050 (2015 - $61,592,317), limited resources, no source of operating cash flow, no assurances that sufficient funding will be available to conduct further product development and operations and no assurance the Company’s current projects will be commercially viable or profitable.

 

All of the Company’s debt financing is past due or due on demand. The Company will seek to replace this financing with funds generated by operations, replacement debt or from equity financings through private placements or the exercise of options. While certain of the Company’s creditors have agreed not to demand immediate payment. There is no assurance that they will continue to do so in the future. As the Company is past due or in default on its promissory notes payable and accrued interest payable, there is substantial risk of future legal action against the Company. The Company has faced consent judgements and demand notices against it for overdue promissory notes. Failure to obtain either replacement financing or creditor consent to delay the repayment of existing financing could result in the Company having to cease operations.

 24 

 

 

Short and Long Term Liquidity (continued)

 

Tabular Disclosure of Contractual Obligations:

  Payments due by period
        Less           More
        than 1   1-3   3-5   Than 5
    Total   year   years   years   Years
Accounts payable & accrued liabilities $ 943,000 $ 943,000 $ - $ - $ -
Interest payable $ 3,630,000 $ 3,630,000   -   -   -
Line of credit $ 13,376,000 $ 13,376,000   -   -   -
Promissory notes to related parties $ 2,892,000 $ 2,892,000   -   -   -
Promissory notes to arm’s length parties $ 2,394,000 $ 2,394,000   -   -   -
  $ 23,235,000 $ 23,235,000 $ - $ - $ -

 

Cash Flows        
    Year Ended   Year Ended
    December 31, 2016    December  31, 2015
Cash Flows used in Operating Activities $ (1,051,000) $ (1,536,000)
Cash Flows provided by Financing Activities   1,001,000   1,530,000
Net decrease in Cash During Period $ (50,000) $ (6,000)

 

Cash Used in Operating Activities

 

Cash used by the Company in operating activities during the year ended December 31, 2016 totaled $1,051,000 as compared to $1,535,000 for year ended December 31, 2015. The Company’s cash used in operating activities can be reconciled from net loss as follows:

 

           
Cash Used in Operating Activities Reconciliation   2016   2015  
           
         
Net loss $ (10,093,733) $ (6,298,813)
         
Stock-based compensation incurred for interest, product development, professionals and management personnel   7,336,554   3,222,992
Non-cash imputed interest expenses   148,426   148,620
Increase (decrease) in prepaid expenses from realization (purchase) of prepaid expenses   136   5,145
Net purchases (net repayments) with balances owing in accounts payable and accrued liabilities   (39,102)   (73,399)
Accrued interest on lines of credit   1,102,242   944,010
Accrued interest from promissory notes     494,170   515,571
         
Cash used in operating activities   (1,051,307)   (1,535,874)
                   

 

Cash Proceeds from Financing Activities

 

During the year ended December 31, 2016, the Company borrowed $1,001,000 (2015 - $1,530,000) by drawing down on its operating line of credit from the Chairman of the Company.

 25 

 

Off-Balance Sheet Arrangements

 

There are no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

 

Critical Accounting Policies

 

The preparation of our consolidated financial statements in conformity with US generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reported periods. Actual results may differ from these estimates under different assumptions or conditions. The Company believes the accounting polices that are most critical to its financial condition and results of operations and involve management’s judgment and/or evaluations of inherent uncertain factors are as follows:

 

Options and warrants issued in consideration for debt. The Company allocates the proceeds received from long-term debt between the liability and the options and warrants issued in consideration for the debt, based on their relative fair values, at the time of issuance. The amount allocated to the options or warrants is recorded as additional paid in capital and as a discount to the related debt. The discount is amortized to interest expense on a yield basis over the term of the related debt.

 

Stock-based compensation. The Company follows Statement of Financial Accounting Standards No. 123R, “Share Based Payment” (“SFAS 123R”). SFAS 123R requires companies to estimate the fair value of share-based payment awards on the date of grant using an option pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service period in the Company’s consolidated financial statements. Stock-based compensation recognized during the period is based on the value of the portion of the stock-based payment awards that are ultimately expected to vest during the period. The Company estimates the fair value of the stock options using the Black-Scholes Option Pricing Model, consistent with the provisions of SFAS 123R. The Black-Scholes valuation model requires the input of highly subjective assumptions, including the option’s expected life and the price volatility of the underlying stock. The expected stock price volatility assumption was determined using historical volatility of the Company’s common stock.

 

Recent Accounting Pronouncements

 

i.       Adopted

 

In August 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-15, “Presentation of Financial Statements – Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU 2014-15”). ASU 2014-15 requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern for each annual and interim reporting period. If substantial doubt exists, additional disclosure is required. This new standard was effective for the Company for annual and interim periods beginning after December 15, 2016. Adoption of this pronouncement did not have a material impact on the Company’s consolidated financial statements.

 

In March 2016, the FASB issued ASU No. 2016-09, Compensation — Stock Compensation: Improvements to Employee Share-Based Payment Accounting (“ASU 2016-09”). The new guidance will change how companies account for certain aspects of share-based payments to employees. Under existing accounting guidance, tax benefits and certain tax deficiencies arising from the vesting of share-based payments are recorded in additional paid-in-capital. The new guidance will require such benefits or deficiencies to be recognized as income tax benefits or expenses in the statement of operations. Companies are required to apply the new guidance prospectively. The new standard is effective for fiscal years beginning after December 15, 2016. Adoption of this pronouncement did not have a material impact on the Company’s consolidated financial statements.

 

 26 

 

 

ii.Issued

 

In January 2016, the FASB issued ASU 2016-01, Financial Instruments - Overall: Recognition and Measurement of Financial Assets and Financial Liabilities. This new standard provides guidance on how entities measure certain equity investments and present changes in the fair value. This standard requires that entities measure certain equity investments that do not result in consolidation and are not accounted for under the equity method at fair value and recognize any changes in fair value in net income. ASU 2016-01 is effective for fiscal years beginning after December 31, 2017.

 

In June 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The new standard requires financial assets measured at amortized cost be presented at the net amount expected to be collected, through an allowance for credit losses that is deducted from the amortized cost basis. The standard will be effective for the Company beginning January 1, 2020, with early application permitted. This standard is not expected to have a material impact on our financial position, results of operations or statement of cash flows upon adoption.

 

In August 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. The new standard will make eight targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. The standard will be effective for the Company beginning January 1, 2018, with early application permitted. The standard will require adoption on a retrospective basis unless it is impracticable to apply, in which case we would be required to apply the amendments prospectively as of the earliest date practicable.

 

The Company has implemented all new accounting pronouncements that are in effect and may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or statement of operations.

 

 

ITEM 7A.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

The Company is a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and is not required to provide the information under this item.

 27 

 

ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

 

ALR TECHNOLOGIES INC.

Consolidated Financial Statements

December 31, 2016 and 2015

 

 

 

Index Page
   
Report of Independent Registered Public Accounting Firm F-1
   
Consolidated Balance Sheets F-2
   
Consolidated Statements of Operations F-3
   
Consolidated Statements of Changes in Stockholders’ Deficit F-4
   
Consolidated Statements of Cash Flows F-5
   
Notes to Consolidated Financial Statements F-6 – F-25

 

 
 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

 

To the Stockholders and Board of Directors of ALR Technologies Inc.

 

We have audited the accompanying consolidated balance sheets of ALR Technologies Inc. (the “Company”) as at December 31, 2016 and 2015 and the related consolidated statements of operations, changes in stockholders’ deficit and cash flows for the years then ended. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform an audit to obtain reasonable assurance whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

 

In our opinion, based on our audits, these consolidated financial statements present fairly, in all material respects, the financial position of the Company as at December 31, 2016 and 2015 and the results of its operations and its cash flows for the years then ended in conformity with accounting principles generally accepted in the United States of America.

 

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, to date the Company has reported losses since inception from operations, negative cash flows from operations, working capital deficiencies, has promissory notes payable and related interest payable past due and has no established commercial viability of its products. These factors raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in this regard are described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

 

Dale Matheson Carr-Hilton LaBonte LLP

Chartered PROFESSIONAL Accountants

 

Vancouver, Canada

February 2, 2018

 

 F-1 

 

ALR TECHNOLOGIES INC.

Consolidated Balance Sheets

($ United States)

December 31, 2016 and 2015

 

       
   2016  2015
       
Assets          
Current assets:          
Cash  $2,607   $52,688 
Prepaid expenses   1,429    1,565 
Total assets  $4,036   $54,253 
           
Liabilities and Stockholders' Deficit          
Current liabilities:          
Accounts payable and accrued liabilities  $942,967   $982,069 
Promissory notes payable due to related parties   2,891,966    2,891,966 
Promissory notes payable due to unrelated parties   2,394,353    2,394,353 
Interest payable   3,629,913    3,135,743 
Lines of credit from related parties   13,375,562    11,272,094 
Total liabilities   23,234,761    20,676,225 
           
Stockholders' Deficit          
Preferred stock:          
Authorized: 500,000,000 shares of preferred stock (2015 - 500,000,000) with a par value of $0.001 per share          
Shares issued and outstanding: No shares of preferred stock (2015: No) were issued and outstanding          
Common stock          
Authorized: 2,000,000,000 shares of common stock (2015 - 500,000,000) with a par value of $0.001 per share          

Shares issued and outstanding: 242,777,909 shares of common stock

(2015 - 242,777,909 shares of common stock).

   242,777    242,777 
Additional paid-in capital   48,212,548    40,727,568 
Accumulated deficit   (71,686,050)   (61,592,317)
Stockholders’ deficit   (23,230,725)   (20,621,972)
Total liabilities and stockholders’ deficit  $4,036   $54,253 

  

 

See accompanying notes to consolidated financial statements

 

 F-2 

 

ALR TECHNOLOGIES INC.

Consolidated Statements of Operations

($ United States)

Years Ended December 31, 2016 and 2015

 

       
   2016  2015
       
Operating Expenses          
Product development  $565,804   $522,918 
Professional fees   108,275    217,454 
Selling, general and administration   354,948    836,756 
Operating Loss   1,029,027    1,577,128 
Foreign exchange gain   —      (3,483)
Recovery of expense   —      (70,000)
Interest expense   9,064,706    4,795,168 
Net Loss    (10,093,733)   (6,298,813)
           
Weighted average number of shares of common stock outstanding, basic and diluted   242,777,909    242,777,909 
           
Loss per share, basic and diluted  $(0.04)  $(0.03)

  

 

See accompanying notes to consolidated financial statements

 F-3 

 

ALR TECHNOLOGIES INC.

Consolidated Statements of Changes in Stockholders’ Deficit

($ United States)

From December 31, 2015 to December 31, 2016

 

 

             
   Common Stock  Additional     Total
   Number of     Paid-in  Accumulated  Stockholders’
   Shares  Amount  Capital  Deficit  Deficit
                
Balance, December 31, 2014   242,777,909   $242,777   $37,355,956   $(55,293,504)  $(17,694,771)
Imputed interest   —      —      148,621    —      148,621 
Stock options granted as compensation   —      —      3,222,992    —      3,222,992 
Net loss for the year   —      —           (6,298,813)   (6,298,813)
Balance, December 31, 2015   242,777,909    242,777    40,727,569    (61,592,317)   (20,621,972)
Imputed interest   —      —      148,426    —      148,426 
Stock options granted as compensation   —      —      7,336,554    —      7,336,554 
Net loss for the year   —      —           (10,093,733)   (10,093,733)
Balance, December 31, 2016   242,777,909   $242,777   $48,212,548   $(71,686,050)  $(23,230,725)

 

 

 

 

See accompanying notes to consolidated financial statements

 F-4 

 

 

ALR TECHNOLOGIES INC.

Consolidated Statements of Cash Flows

($ United States)

Years Ended December 31, 2016 and 2015

 

 
    
    2016    2015 
           
OPERATING ACTIVITIES          
Net loss  $(10,093,733)  $(6,298,813)
Stock-based compensation-product development   14,268    14,374 
Stock-based compensation-interest expenses   7,318,539    3,184,459 
Stock-based compensation-selling, general and admin   3,170    20,355 
Stock-based compensation-professional fees   577    3,804 
Unpaid interest expense on line of credit   1,102,243    944,010 
Non-cash imputed interest expense   148,426    148,620 
Non-cash gain on reversal of accrual   —      (70,000)
Changes in assets and liabilities:          
Decrease in prepaid expenses   136    5,145 
Increase in accounts payable and accrued liabilities   (39,102)   (3,399)
Increase in interest payable   494,170    515,571 
           
Net cash used in operating activities   (1,051,307)   (1,535,874)
           
FINANCING ACTIVITIES          
Proceeds from lines of credit   1,001,226    1,529,720 
           
Net cash provided by financing activities   1,001,226    1,529,720 
           
Decrease in cash   (50,081)   (6,154)
Cash, beginning of year   52,688    58,842 
Cash, end of year  $2,607   $52,688 
           

 

See accompanying notes to consolidated financial statements

 F-5 

 

 

ALR TECHNOLOGIES INC.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2016 and 2015

($ United States)

 

 

1.       Basis of presentation, nature of operations and going concern

 

ALR Technologies Inc. (the “Company”) was incorporated under the laws of the state of Nevada on March 24, 1987. The Company has developed a compliance monitoring system that will allow for health care professionals to remotely monitor patient health conditions and provide patient health management. On October 17, 2011 the Company announced that it had received Section 510(k) clearance from the United States Food and Drug Administration for its Health-e-Connect System. The Company is currently seeking pilot programs to deploy its product.

 

These consolidated financial statements have been prepared in accordance with Generally Accepted Accounting Principles in the United States of America (“U.S. GAAP”) in U.S dollars and on a going-concern basis, which presumes the realization of assets and the discharge of liabilities and commitments in the normal course of operations for the foreseeable future. Several adverse conditions cast substantial doubt on the validity of this assumption. The Company has incurred significant losses over the past several fiscal years (2016 - $10,093,733; 2015 - $6,298,813), is currently unable to self-finance its operations, has a working capital deficit of $23,230,725 (2015 - $20,621,972), accumulated deficit of $71,686,050 (2015 - $61,592,317), limited resources, no source of operating cash flow, and no assurance that sufficient funding will be available to conduct continued product development activities. If the Company is able to finance its required product development activities, there is no assurance the Company’s current projects will be commercially viable or profitable. The Company has debts comprised of accounts payable, interest, lines of credit and promissory notes payable totaling $23,234,762 currently due, due on demand or considered delinquent. There is no assurance that the Company will not face additional legal action from creditors regarding delinquent accounts payable, payroll payable, promissory notes and interest payable. Any one or a combination of these above conditions could result in the failure of the business and cause the Company to cease operations.

 

The Company’s ability to continue as a going-concern is dependent upon the continued financial support of its creditors and its ability to obtain financing to fund working capital and overhead requirements, fund the development of the Company’s product line and ultimately, the Company’s ability to achieve profitable operations and repay overdue obligations. Management has obtained short-term financing from related parties through lines of credit facilities with available borrowing in principal amount up to $10,500,000. As of December 31, 2016 the total principal balance outstanding was $9,628,210. The resolution of whether the Company is able to continue as a going concern is dependent upon the realization of management’s plans. If additional financing is required, the Company plans to raise needed capital through the exercise of share options and by future common share private placements. There can be no assurance that the Company will be able to raise any additional debt or equity capital from the sources described above, or that the lenders in the line of credit arrangements will maintain the availability of borrowing from the line. If management is unsuccessful in obtaining short-term financing or achieving long-term profitable operations, the Company will be required to cease operations.

 

 F-6 

 

ALR TECHNOLOGIES INC.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2016 and 2015

($ United States)

 

 

1.       Basis of presentation, nature of operations and going concern (continued)

 

All of the Company’s debt is either due on demand or is in default, while continuing to accrue interest at its stated rate. The Company will seek to obtain creditors’ consents to delay repayment of the outstanding promissory notes payable and related interest thereto, until it is able to replace this financing with funds generated by operations, recapitalization with replacement debt or from equity financings through private placements. While some of the Company’s creditors have agreed to extend repayment deadlines in the past, there is no assurance that they will continue to do so in the future. In the past, creditors have successfully commenced legal action against the Company to recover debts outstanding. In those instances, the Company was able to obtain financing from related parties to cover the verdict or settlement; however, there is no assurance that the Company would be able to obtain the same financing in the future. If the Company is unsuccessful in obtaining financing to cover any potential verdicts or settlements, the Company will be required to cease operations.

 

The Company’s activities will necessitate significant uses of working capital beyond 2016. Additionally, the Company’s capital requirements will depend on many factors, including the success of the Company’s continued product development and distribution efforts. The Company plans to continue financing its operations with the lines of credit it has available.

 

While the Company strongly believes that its capital resources will be sufficient in the near term, there is no assurance that the Company’s activities will generate sufficient revenues to sustain its operations without additional capital or if additional capital is needed, that such funds, if available, will be obtainable on terms satisfactory to the Company.

 

2.       Significant accounting policies

 

a)Principles of consolidation

 

These consolidated financial statements include the accounts of the Company and its integrated wholly-owned subsidiary, Canada ALRTech Health Systems Inc., which was incorporated on April 15, 2008 in Canada. All significant inter-company balances and transactions have been eliminated.

 

b)Stock-based compensation

 

The Company follows the fair value method of accounting for stock-based compensation. The Company estimates the fair value of share-based payment awards on the date of grant using an option pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service period in the Company’s consolidated financial statements. The Company estimates the fair value of the stock options using the Black-Scholes Option Pricing Model. The Black-Scholes Option Pricing Model requires the input of highly subjective assumptions, including the option’s expected life and the price volatility of the underlying stock.

 F-7 

 

ALR TECHNOLOGIES INC.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2016 and 2015

($ United States)

 

 

2.       Significant accounting policies (continued)

 

c)Income taxes

 

Income taxes are accounted for under the asset and liability method. Deferred income tax assets and liabilities are recognized for the differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis, and operating loss carry-forwards that are available to be carried forward to future years for tax purposes.

 

Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred income tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. When it is not considered to be more likely than not that a deferred income tax asset will be realized, a valuation allowance is provided for the excess.

 

The Company follows the accounting requirements associated with uncertainty in income taxes using the provisions of Financial Accounting Standards Board (“FASB”) ASC 740, Income Taxes. Using that guidance, tax positions initially need to be recognized in the financial statements when it is more-likely-than-not the positions will be sustained upon examination by the tax authorities. It also provides guidance for derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. As of December 31, 2016, the Company has no uncertain tax positions that qualify for either recognition or disclosure in the financial statements.

 

d)Use of estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, the measurement of stock-based compensation, the fair value of financial instruments and the reported amounts of revenues and expenses during the reporting period. Management believes the estimates are reasonable; however, actual results could differ from those estimates.

 

e)Loss per share

 

Basic loss per common share is calculated by dividing net loss by the weighted average number of common shares outstanding during the year. Diluted loss per common share is calculated by dividing the net loss by the sum of the weighted average number of common shares outstanding and the dilutive common equivalent shares outstanding during the year. Common equivalent shares consist of the shares issuable upon exercise of stock options and warrants calculated using the treasury stock method. Common equivalent shares are not included in the calculation of the weighted average number of shares outstanding for diluted loss per common shares when the effect would be anti-dilutive.

 F-8 

 

 

ALR TECHNOLOGIES INC.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2016 and 2015

($ United States)

 

 

2.       Significant accounting policies (continued)

 

f)Comprehensive income

 

Comprehensive income is the overall change in the net assets of the Company for a period, other than changes attributable to transactions with stockholders. It is made up of net income and other comprehensive income. Other comprehensive income consists of net income and other gains and losses affecting stockholders' equity that under generally accepted accounting principles are excluded from net income. The Company has no items of other comprehensive income (loss) in any period presented. Therefore, as presented in the Company's consolidated statements of loss, net loss equals comprehensive loss.

 

g)Fair value of financial instruments

 

The Company’s financial instruments include cash, accounts payable, promissory notes payable and lines of credit. The fair values of these financial instruments approximate their carrying values due to the relatively short periods to maturity of these instruments. For fair value measurement, U.S. GAAP establishes a three-tier hierarchy which prioritizes the inputs used in the valuation methodologies in measuring fair value:

 

Level 1 — observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.

 

Level 2 — include other inputs that are directly or indirectly observable in the marketplace.

 

Level 3 — unobservable inputs which are supported by little or no market activity.

 

h)      Recently adopted and issued accounting pronouncements

 

i.       Adopted

 

In August 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-15, “Presentation of Financial Statements – Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entitiy’s Ability to Continue as a Going Concern” (“ASU 2014-15”). ASU 2014-15 requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern for each annual and interim reporting period. If substantial doubt exists, additional disclosure is required. This new standard was effective for the Company for annual and interim periods beginning after December 15, 2016. Adoption of this pronouncement did not have a material impact on the Company’s consolidated financial statements.

 

In March 2016, the FASB issued ASU No. 2016-09, Compensation — Stock Compensation: Improvements to Employee Share-Based Payment Accounting (“ASU 2016-09”). The new guidance will change how companies account for certain aspects of share-based payments to employees. Under existing accounting guidance, tax benefits and certain tax deficiencies arising from the vesting of share-based payments are recorded in additional paid-in-capital. The new guidance will require such benefits or deficiencies to be recognized as income tax benefits or expenses in the statement of operations. Companies are required to apply the new guidance prospectively. This new standard was effective for the Company for annual and interim periods beginning after December 15, 2016. Adoption of this pronouncement did not have a material impact on the Company’s consolidated financial statements.

 F-9 

 

 

ALR TECHNOLOGIES INC.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2016 and 2015

($ United States)

 

 

2.       Significant accounting policies (continued)

 

h)       Recently adopted and issued accounting pronouncements

 

ii.Issued

 

In January 2016, the FASB issued ASU 2016-01, Financial Instruments - Overall: Recognition and Measurement of Financial Assets and Financial Liabilities. This new standard provides guidance on how entities measure certain equity investments and present changes in the fair value. This standard requires that entities measure certain equity investments that do not result in consolidation and are not accounted for under the equity method at fair value and recognize any changes in fair value in net income. ASU 2016-01 is effective for fiscal years beginning after December 31, 2017.

 

In June 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The new standard requires financial assets measured at amortized cost be presented at the net amount expected to be collected, through an allowance for credit losses that is deducted from the amortized cost basis. The standard will be effective for the Company beginning January 1, 2020, with early application permitted. This standard is not expected to have a material impact on the Company’s financial position, results of operations or statement of cash flows upon adoption.

 F-10 

 

 

 

ALR TECHNOLOGIES INC.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2016 and 2015

($ United States)

 

 

2.       Significant accounting policies (continued)

 

h)       Recently adopted and issued accounting pronouncements

 

ii.Issued

 

In August 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. The new standard will make eight targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. The standard will be effective for the Company beginning January 1, 2018, with early application permitted. The standard will require adoption on a retrospective basis unless it is impracticable to apply, in which case we would be required to apply the amendments prospectively as of the earliest date practicable.

 

The Company has implemented all new accounting pronouncements that are in effect and may impact its financial statements. The Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or statement of operations.

 

3.       Promissory notes and interest payable

 

a)       Promissory notes payable to related parties:

 

A summary of the promissory notes payable to related parties is as follows:

 

 

Promissory Notes Payable to Related Parties

 

December 31,

2016

 

December 31,

2015

     
         
Promissory notes payable to relatives of directors collateralized by a general security agreement on all the assets of the Company, due on demand:        
             
  i. Interest at 1% per month $ 580,619 $ 580,619
             
  ii. Interest at 1.25% per month   51,347   51,347
             
  iii. Interest at the U.S. bank prime rate plus 1%   100,000   100,000
             
  iv. Interest at 0.5% per month   695,000   695,00
         
Promissory notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, due on demand   1,465,000   1,465,000
Total Promissory Notes Payable to Related Parties $ 2,891,966 $ 2,891,966

 

 F-11 

 

ALR TECHNOLOGIES INC.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2016 and 2015

($ United States)

 

 

3.       Interest, advances and promissory notes payable (continued)

 

b)       Promissory notes payable to unrelated parties

 

A summary of the promissory notes payable to unrelated parties is as follows:

 

Promissory Notes Payable to Unrelated Parties  

 

December 31,

  December 31,
    2016   2015
         
Unsecured promissory notes payable to unrelated lenders:        
             
  i. Interest at 1% per month, repayable on March 31, 2009, due on demand $ 450,000 $ 450,000
             
  ii. Interest at 1% per month, with $50,000 repayable on December 31, 2004, $75,000 repayable on August 18, 2007, $75,000 repayable on November 19, 2007 and the balance due on demand. All are due on demand, accruing interest at the same rate.   887,455   887,455
             
  iii. Interest at 0.625% per month, with $50,000 repayable on October 5, 2004, $40,000 repayable on December 31, 2004, and $60,000 repayable on July 28, 2006, all due on demand   150,000   150,000
             
  iv. Non-interest-bearing, repayable on July 17, 2005, due on demand   270,912   270,912
             
  v. Non-interest-bearing loan repayable at $25,000 per month beginning October 2009, none repaid to date   310,986   310,986
             
  vi. Interest at 0.667% per month, with $125,000 due January 15, 2011   125,000   125,000
           
Promissory notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month   200,000   230,000
Total Promissory Notes Payable to Unrelated Parties $ 2,394,353 $ 2,394,353

 

 F-12 

 

ALR TECHNOLOGIES INC.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2016 and 2015

($ United States)

 

 

3.       Interest, advances and promissory notes payable (continued)

 

c)       Interest payable

 

A summary of the interest payable activity is as follows:

 

    
Balance, December 31, 2014  $2,620,172 
Interest incurred on promissory notes payable   515,571 
      
Balance, December 31, 2015   3,135,743 
Interest incurred on promissory notes payable   494,171 
      
Balance, December 31, 2016  $3,629,913 

 

 

       
   December 31,  December 31,
   2016  2015
       
Related parties (relatives of the Chairman)  $1,956,403   $1,667,977 
Non-related parties   1,673,511    1,467,766 
           
   $3,629,913   $3,135,743 

 

The payment terms, security and any interest payable are based on the underlying promissory notes payable that the Company has outstanding.

 

d)       Interest expense

 

During the year ended December 31, 2016, the Company incurred interest expense of $9,064,906 (2015: $4,795,168) substantially as follows:

-$494,170 (2015: $515,571), including interest incurred on promissory notes (note 3(a)) and other payables;
-$1,102,242 (2015: $944,010) incurred on lines of credit payable as shown in note 4;
-$148,426 (2015: $148,620) incurred from the calculation of imputed interest on accounts payable outstanding for longer than one year, advances payable and promissory notes payable, which had no stated interest rate; and
-$7,318,539 (2015: $3,184,459) incurred on stock options granted to creditors (note 6(a)).

 

 F-13 

 

ALR TECHNOLOGIES INC.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2016 and 2015

($ United States)

 

 

4.        Lines of credit

 

As of December 31, 2016, the Company has two lines of credit as follows:

 

Creditor Interest Rate Borrowing Limit Repayment Terms Principal Borrowed Accrued Interest

Total

Outstanding

Security Purpose
Chairman and CEO 1% per Month $8,500,000 Due on Demand $   7,628,219 $  2,490,958 $10,119,177 General Security over Assets General Corporate Requirements
Wife of Chairman 1% per Month $2,000,000 Due on Demand $   2,000,000 $  1,256,385 $ 3,256,385 General Security over Assets General Corporate Requirements
Total   $10,500,000   $   9,628,219 $  3,747,343 $13,375,562    

 

 

On July 1, 2016, the Company and the Chief Executive Officer of the Company agreed to amend the existing credit agreement to increase the borrowing limit on the line of credit provided to the Company from $7,000,000 to $8,500,000.

 

As of December 31, 2015, the Company has two lines of credit as follows:

 

Creditor Interest Rate Borrowing Limit Repayment Terms Principal Borrowed Accrued Interest

Total

Outstanding

Security Purpose
Chairman and CEO 1% per Month $7,000,000 Due on Demand $   6,626,993 $  1,628,716 $ 8,255,708 General Security over Assets General Corporate Requirements
Wife of Chairman 1% per Month $2,000,000 Due on Demand $   2,000,000 $  1,016,385 $ 3,016,385 General Security over Assets General Corporate Requirements
Total   $9,000,000   $   8,626,993 $  2,645,101 $11,272,093    

 

On May 29, 2015, the Company and the Chief Executive Officer of the Company agreed to amend the existing credit agreement to increase the borrowing limit on the line of credit provided to the Company from $5,500,000 to $7,000,000.

 

5.       Capital stock

 

a)Authorized share capital

 

i.Common Stock

 

During the year ended December 31, 2016:

 

On December 21, 2016, the Company’s shareholders holding a majority of the issued capital stock consented in writing to increase the authorized shares of common stock of the Company from two billion shares (2,000,000,000) to ten billion shares (10,000,000,000) shares. The increase in the authorized shares of common stock of the Company is pending approval from the Securities and Exchange Commission (“SEC”).

 F-14 

 

 

ALR TECHNOLOGIES INC.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2016 and 2015

($ United States)

 

 

5.       Capital stock (continued)

 

a)Authorized share capital (continued)

 

i.Common Stock (continued)

 

During the year ended December 31, 2015:

 

On June 25, 2015, the Company’s articles of incorporation were amended to increase the authorized shares of common stock from 500,000,000 to 2,000,000,000 shares with a par value of $0.001 per share.

 

ii.Preferred Stock

 

500,000,000 shares of preferred stock with a par value of $0.001 per share.

 

b)Issued share capital

 

During the years ended December 31, 2016 and December 31, 2015:

 

There was no activity during the period.

 

6.        Additional paid-in capital

 

a)Stock options

 

A summary of stock option activity is as follows:

 

     
  Year Ended Year Ended
  December 31, 2016 December 31, 2015
    Weighted Average   Weighted Average
  Number of Options

Exercise

Price

Number of

Options

Exercise

Price

Outstanding, beginning of period 579,000,200 $ 0.015 245,700,100 $ 0.030
Granted 4,390,001,300   0.002 334,500,100   0.015
Cancelled (6,700,000)   (0.030) -   -
Expired -   - (1,200,000)   (0.250)
Exercised -   - -   -
Outstanding, end of period 4,962,301,500 $ 0.004 579,000,200 $ 0.015
             
Exercisable, end of period 4,960,101,500 $ 0.004 575,650,200 $ 0.015

 

 F-15 

 

ALR TECHNOLOGIES INC.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2016 and 2015

($ United States)

 

 

6.        Additional paid-in capital (continued)

 

a)Stock options (continued)

 

During the year ended December 31, 2016:

 

On July 1, 2016, the Company and the Chief Executive Officer of the Company agreed to amend the existing credit agreement to increase the borrowing limit on the line of credit provided to the Company from $7,000,000 to $8,500,000 (Note 4). In exchange for Mr. Chan making available the additional loan of $1,500,000 to the Company, the Company:

·reduced the exercise price of the 560,000,200 shares of common stock under option to Mr. Chan and his spouse from $0.015 to $0.002;
·granted Mr. Chan and his spouse the right and option to purchase, an additional 4,390,001,300 shares of common stock at a price of $0.002 per share for a term of five years

 

The interest expense recognized related to the option grant was $7,318,539.

 

The Company recorded a further $18,014 in compensation expense related to vesting of stock options granted in previous years.

 

During the year ended December 31, 2015:

 

On January 30, 2015, the Company granted options to acquire 4,500,000 shares of common stock at a price of $0.03 per share to 14 individuals. The fair value of the options granted was $42,858. During the year the Company recognized fair value of $10,964 and will recognize the balance over the vesting period for the unvested options.

 

On April 22, 2015, our Board of Directors approved the modification of the exercise price to acquire 12,400,000 shares of common stock of the Company from $0.03 per share to $0.015 per share held by 20 individuals. There was no increase in the fair value of the options from this modification. None of these option agreements have been executed.

 

On May 29, 2015, the Company and the Chief Executive Officer of the Company agreed to amend the existing credit agreement to increase the borrowing limit on the line of credit provided to the Company from $5,500,000 to $7,000,000 (Note 4). In exchange for Mr. Chan making available the additional loan of $1,500,000 to the Company, the Company:

·reduced the exercise price of the 230,000,100 shares of common stock under option to Mr. Chan and his spouse from $0.03 to $0.015;
·extended the expiry date of the 230,000,100 shares of common stock under option to Mr. Chan to be five years from the date of execution of the amended credit agreement;
·granted Mr. Chan the right and option to purchase, an additional 329,999,967 shares of common stock at a price of $0.015 per share for a term of five years from the date of execution of the amended credit agreement.

 

The interest expense recognized related to the option grant was $3,184,459.

 F-16 

 

ALR TECHNOLOGIES INC.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2016 and 2015

($ United States)

 

6.        Additional paid-in capital (continued)

 

a)Stock options (continued)

 

During the year ended December 31, 2015: (continued)

 

The Company recorded a further $27,569 in compensation expense related to vesting of stock options granted in previous years.

 

The options outstanding at December 31, 2016 and 2015 were as follows:

 

           
    December 31, 2016   December 31, 2015
Expiry Date   Options   Exercise Price   Intrinsic Value   Options   Exercise Price Intrinsic Value
                       
May 4, 2016   - $ -   -   1,000,000 $ 0.050 -
May 23, 2016   - $ -   -   100,000 $ 0.030 -
May 27, 2017   400,000 $ 0.030   -   400,000 $ 0.030 -
May 31, 2017   500,000 $ 0.050   -   500,000 $ 0.050 -
August 16, 2017   250,000 $ 0.030   -   250,000 $ 0.030 -
December 28, 2017   1,000,000 $ 0.030   -   1,000,000 $ 0.030 -
January 28, 2018   1,500,000 $ 0.030   -   2,300,000 $ 0.030 -
March 26, 2018   500,000 $ 0.030   -   500,000 $ 0.030 -
April 9, 2018   1,000,000 $ 0.030   -   1,000,000 $ 0.030 -
October 1, 2018   - $ -   -   500,000 $ 0.030 -
February 7, 2019   - $ -   -   700,000 $ 0.030 -
April 18,2019   - $ -   -   2,000,000 $ 0.030 -
May 21, 2019   500,000 $ 0.030   -   500,000 $ 0.030 -
July 25, 2019   1,000,000 $ 0.030   -   1,000,000 $ 0.030 -
August 1, 2019   1,250,000 $ 0.030   -   1,250,000 $ 0.030 -
August 26, 2019   1,500,000 $ 0.030   -   1,500,000 $ 0.030 -
January 30, 2020   2,900,000 $ 0.030   -   4,500,000 $ 0.030 -
May 29, 2020   560,000,200 $ 0.002   -   560,000,200 $ 0.015 -
July 21, 2021   4,390,001,300 $ 0.002       - $ -  
Total   4,962,301,500 $ 0.002   -   579,000,200 $ 0.015 -

Weighted Average Remaining

Contractual Life

  4.81           4.37  

 

 

The Company uses the fair value method for determining stock-based compensation for all options granted during the fiscal periods. The fair value was determined using the Black-Scholes Option Pricing Model based on the following weighted average assumptions:

 F-17 

 

 

ALR TECHNOLOGIES INC.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2016 and 2015

($ United States)

 

 

6.        Additional paid-in capital (continued)

 

a)Stock options (continued)

 

 

       
  

December 31,

2016

 

December 31,

2015

       
Risk-free interest rate   1.68%   1.68%
Expected life   5 years    5 years 
Expected dividends   0%   0%
Expected volatility   210%   194%
Forfeiture rate   0%   0%

 

The weighted average fair value for the options granted during 2016 was $0.002 (2015: $0.010).

 

The fair value of the stock options granted was allocated as follows:

       
   December 31, 2016 

December 31,

2015

       
Interest expense  $7,318,539   $3,184,459 
Product development expense   14,267    14,374 
Professional expense   577    3,806 
Selling, general and administration expenses:   3,170    20,355 
           
   $7,336,553   $3,222,992 

 

 

 F-18 

 

ALR TECHNOLOGIES INC.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2016 and 2015

($ United States)

 

 

7.       Related party transactions and balances

 

a)Related party transactions

 

           
      Year End December 31, 2016   Year End December 31, 2015
           
Related party transaction included within interest expense:          
Interest expenses on promissory notes issued to relatives of the Chairman & Chief Executive Officer of the Company   $ 288,426 $ 309,826
Interest expense on lines of credit payable to the Chairman & Chief Executive Officer of the Company and his spouse   $ 1,102,242

 

$

944,010
Stock based compensation related to stock options granted to the Chairman & Chief Executive Officer for increasing the borrowing limit on the line of credit available to the Company   $ 7,318,539

 

 

$

3,184,459
           
Related party transactions including within selling, general and administration expenses:          
Consulting fees to the Chairman & Chief Executive Officer of the Company accrued on the line of credit available to the Company   $ 189,600 $ 189,600
Consulting fees paid to the President of the Company   $ 15,500 $ 186,000

 

Interest on promissory notes payable to related parties, management compensation and compensation paid to a relative of a director have been recorded at the exchange amount, which is the amount agreed to by the parties. Options granted to related parties have been recorded at their estimated fair value.

 

b)Related party balances

 

Included in accounts payable is $nil (2015: $15,529) due to a Director of the Company.

 

8.       Commitments and contingencies

 

a)Contingencies

 

The Company has had three judgments against it relating to overdue promissory notes and accrued interest and a fourth creditor has demanded repayment of an overdue promissory note and accrued interest. To date, the Company has not repaid any of these promissory notes and related accrued interest and could be subject to further action. The legal liability, totaling $1,076,168, of these promissory notes and related accrued interest have been fully recognized and recorded by the Company.

 F-19 

 

 

ALR TECHNOLOGIES INC.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2016 and 2015

($ United States)

 

 

8.       Commitments and contingencies (continued)

 

b) Commitments

 

The Company has a consulting arrangement with Mr. Sidney Chan, Chief Executive Officer and Chairman of the Board of Directors of the Company. Under the terms of the contract, Mr. Chan will be paid $180,000 per annum for services as Chief Executive Officer. The contract can be terminated at any time with thirty days’ notice and the payment of two years annual salary. Should the contract be terminated, all debts owed to Mr. Chan and his spouse must be immediately repaid. The initial term of the contract is for one year and automatically renews for continuous one year terms. Also under the terms of the contract are the following:

 

i.Incentive Revenue Bonus

 

Mr. Chan will be entitled to a 1% net sales commission from the sales of any of the Company’s products at any time during his life, regardless if Mr. Chan is still under contract with the Company.

 

ii.Sale of Business

 

If more than 50% of the Company’s stock or assets are sold, Mr. Chan will be compensated for entering into non-compete agreements based on the selling price of the Company or its assets as follows:

 

-2% of sales price up to $24,999,999 plus
-3% of sales price between $25,000,000 and $49,999,999 plus
-4% of sales price between $50,000,000 and $199,999,999 plus
-5% of sales price in excess of $200,000,000

 

 F-20 

 

ALR TECHNOLOGIES INC.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2016 and 2015

($ United States)

 

 

9.       Financial instruments

 

The Company’s financial instruments consist of cash, accounts payable, interest payable, promissory notes payable to unrelated parties and promissory notes payable to related parties.

 

a)Fair value

 

The fair values of cash and certain accounts payable and accrued liabilities approximate their carrying values due to the relatively short periods to maturity of these instruments.

 

Certain accounts payable have been outstanding longer than one year. The Company has recorded imputed interest at a rate of 1% per month over the period the payables have been outstanding for longer than one year, with a corresponding amount recognized in additional paid-in capital. The calculated amount represents the implicit compensation for the use of funds beyond a reasonable term for regular trade payables.

 

For the purposes of fair value analysis, promissory notes payable to related parties and promissory notes payable to unrelated parties can be separated into two classes of financial liabilities.

 

i.       Interest-bearing promissory notes, lines of credit and related interest payable

ii.       Non-interest-bearing promissory notes past due

 

The interest-bearing promissory notes payable are all delinquent and have continued to accrue interest at their stated rates. The Company currently does not have the funds to extinguish these debts and will continue to incur interest until such time as the liabilities are extinguished. There is not an active market for delinquent loans for a Company with a similar financial position. Management asserts the carrying values of the promissory notes and related interest payable are a reasonable estimate of fair value as they represent the Company’s best estimate of their legal obligation for these debts. As there is no observable market for interest rates on similar promissory notes, the fair value was estimated using level 2 inputs in the fair value hierarchy.

 

The Company has three non-interest-bearing promissory notes payable past due. The first is several years delinquent and there have been no renegotiated repayment terms. There is not an active market for default loans not bearing interest nor is there an observable market for lending to companies with a financial position similar to the Company. The Company has recorded imputed interest at a rate of 1% per month over the life of the promissory notes, with a corresponding amount recognized in additional paid-in capital representing the implicit compensation for the use of funds.  Management asserts the payment date for these amounts cannot be reasonably determined. Management further asserts there is not a determinable interest rate for arm’s-length borrowings based on the current financial position of the Company and asserts the carrying value is the best estimate of the Company’s legal liability and represents the fair value for the promissory note. This would be considered a level 2 input in the fair value hierarchy.

 F-21 

 

 

ALR TECHNOLOGIES INC.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2016 and 2015

($ United States)

 

 

9.       Financial instruments (continued)

 

b)Credit risk

 

Financial instruments that potentially subject the Company to credit risk consist of cash. The Company only has an immaterial cash balance and is not exposed to significant credit risk.

 

c)Market risk

 

Market risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices.  Market risk comprises two types of risk: interest rate risk and foreign currency risk.

 

i.       Interest rate risk

 

Interest rate risk consists of two components:

 

a)        Cash flow risk

 

To the extent that payments made or received on the Company’s monetary assets and liabilities are affected by changes in the prevailing market interest rates, the Company is exposed to interest rate cash flow risk.

 

The Company is exposed to interest rate cash flow risk on promissory notes payable of $500,000, which incur a variable interest rate of prime plus 1%. A hypothetical change of 1% on interest rates would increase or decrease net loss and comprehensive loss by $5,000.

 

b)       Price risk

 

To the extent that changes in prevailing market interest rates differ from the interest rate on the Company’s monetary assets and liabilities, the Company is exposed to price risk.

 

The Company’s promissory notes payable consist of $500,000 of variable interest rate notes and $4,786,319 of fixed interest rate notes. All of these notes are past due and are currently due on demand while interest continues to accrue. Due to the delinquency of the fixed interest rate promissory notes payable, there is no active market for these instruments and fluctuations in market interest rates do not have a significant impact on their estimated fair values as of December 31, 2016.

 

At December 31, 2016, the effect on the net loss and comprehensive loss of a hypothetical change of 1% in market interest rate cannot be reasonably determined.

 F-22 

 

ALR TECHNOLOGIES INC.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2016 and 2015

($ United States)

 

 

9.       Financial instruments (continued)

 

c) Foreign currency risk

 

The Company incurs certain accounts payable and expenses in Canadian dollars and is exposed to fluctuations in changes in exchange rates between the US and Canadian dollars. As at December 31, 2016, the effect on net loss and comprehensive loss of a hypothetical change of 10% between the US and Canadian dollar would not be material. The Company has not entered into any foreign currency contracts to mitigate risk.

 

10.       Income taxes

 

The provision for income taxes differs from the result that would be obtained by applying the statutory tax rate of 34% (2015 - 34%) to income before income taxes. The difference results from the following items:

 

       
  

December 31,

2016

 

December 31,

2015

       
Computed expected benefit of income taxes  $(3,431,869)  $(2,141,596)
Stock-based compensation   2,494,428    1,095,817 
Non-deductible interest expense   50,465    50,531 
Increase in valuation allowance   886,976    995,248 
           
Income tax provision  $—     $—   

 

The components of the net deferred income tax asset, the statutory tax rate and the amount of the valuation allowance are as follows:

 

       
  

December 31,

2016

 

December 31,

2015

       
Net operating loss carried forward  $37,532,822   $34,924,072 
Tax rate   34%   34%
Deferred income tax assets   12,761,159    11,874,184 
Valuation allowance   (12,761,159)   (11,874,184)
           
Net deferred income tax asset  $—     $—   

 

 F-23 

 

ALR TECHNOLOGIES INC.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2016 and 2015

($ United States)

 

 

10.       Income taxes (continued)

 

The potential benefit of the deferred income tax asset has not been recognized in these financial statements since it cannot be assured that it is more likely than not that such benefit will be utilized in future years. The Company believes that the available objective evidence creates sufficient uncertainty regarding the realizability of the deferred income tax assets such that a full valuation allowance has been recorded.

 

The operating losses amounting to $37,532,822 for utilization in the United States of America, the jurisdiction where they were incurred, will expire between 2019 and 2036 if they are not used. The following table lists the fiscal year in which the loss was incurred and the expiration date of the operating loss carry-forwards:

 

Fiscal Year   Amount Expiry Date
1999 $ 88,022 2019
2000   4,425,866 2020
2001   3,681,189 2021
2002   2,503,951 2022
2003   2,775,900 2023
2004   1,250,783 2024
2005   1,304,283 2025
2006   1,532,322 2026
2007   1,479,818 2027
2008   1,599,919 2028
2009   1,723,146 2029
2010   822,678 2030
2011   1,746,615 2031
2012   1,638,421 2032
2013   2,568,328 2033
2014   2,855,631 2034
2015   2,927,200 2035
2016   2,608,750 2036
Total $ 37,532,822  

 

 

11.       Subsequent events

 

a)On January 27, 2017, the Company’s Board of Directors approved a 100:1 reverse share split of the Company’s common stock. The reverse share split is pending approval from the SEC and other regulatory bodies.

 

b)On November 27, 2017, the Company’s Board of Directors approved the grant of the option to 8,700,000 shares of common stock of the Company at a price of $0.015 per share for a term of five years. 2,200,000 of the approved options were to a director of the Company and 6,500,000 were to consultants of the Company.

 

 F-24 

 

ALR TECHNOLOGIES INC.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2016 and 2015

($ United States)

 

 

11.       Subsequent events (continued)

 

c)On January 31, 2018, the Company’s Board of Directors approved the following grants:
·the option to acquire 47,000,000 shares of common stock of the Company at a price of $0.015 per share for a term of five years to 9 consultants of the Company, and
·the option to acquire 200,000 shares of common stock of the Company at a price of $0.015 per share until April 19, 2019 to 1 consultant of the Company.

 

Of the options granted with a term of five years, options to acquire a total of 11,000,000 shares of common stock were granted to three relatives of the Chairman of the Board.

 

 F-25 

 

  

 

ITEM 9.CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

None

 

ITEM 9A.CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of the Company’s management, including the principal executive officer and principal financial officer, as of the end of the period covered by this report, the Company conducted an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures, as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”).

 

The Company’s disclosure controls and procedures are designed to provide reasonable assurance that the information required to be included in the Company’s reports to Securities and Exchange Commission (“SEC”) is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms relating to ALR Technologies Inc., including the Company’s consolidated subsidiaries, and was made known to them by others within those entities, particularly during the period when this report was being prepared. Based on that evaluation, the Principal Executive Officer and Principal Financial Officer have concluded that these disclosure controls and procedures are effective at these reasonable assurance levels.

 

Limitations on the Effectiveness of Controls

 

The Company’s management, including the CEO and CFO, does not expect that the Company’s Disclosure Controls and internal controls will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management or board override of the control.

 

The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

 

CEO and CFO Certifications

 

Appearing immediately following the Signatures section of this report there are Certifications of the CEO and the CFO. The Certifications are required in accordance with Section 302 of the Sarbanes-Oxley Act of 2002 (the Section 302 Certifications). This Item of this report, which you are currently reading is the information concerning the Evaluation referred to in the Section 302 Certifications and this information should be read in conjunction with the Section 302 Certifications for a more complete understanding of the topics presented.

 54 

 

 

 

Management’s Report on Internal Control over Financial Reporting

 

The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). The Company’s internal control over financial reporting is a process designed to provide reasonable assurance to our management and board of directors regarding the reliability of financial reporting and the preparation of the consolidated financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America.

 

Management’s Report on Internal Control over Financial Reporting (continued)

 

The Company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with accounting principles generally accepted in the United States of America, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the consolidated financial statements.

 

Because of its inherent limitations, internal controls over financial reporting may not prevent or detect misstatements. All internal control systems, no matter how well designed, have inherent limitations, including the possibility of human error and the circumvention of overriding controls. Accordingly, even effective internal control over financial reporting can provide only reasonable assurance with respect to financial statement preparation. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

The Company’s management assessed the effectiveness of our internal control over financial reporting as of December 31, 2016. In making this assessment, the management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework. Based on the management’s assessment, as of December 31, 2016, the Company’s internal control over financial reporting was not effective based on those criteria.

 

Based on this assessment, we found our internal control over financial reporting to be not effective for the following reason:

 

(1)insufficient written policies and procedures for reporting requirements and accounting and financial reporting with respect to the requirements and application of US GAAP and SEC disclosure requirements

 

Management of the Company believes that the material weaknesses set forth in (1) did not affect the Company’s financial results. The Company retains a consultant who has the technical expertise and knowledge to implement the proper segregation of duties and the development of effective internal controls over financial reporting. The Company is developing internal controls over financial reporting to meet its current and projected future needs.

 

In addition, management believes that preparing and implementing sufficient written policies and checklists will remedy that following material weaknesses: (i) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of the US GAAP and SEC disclosure requirements.

 

 55 

 

We will continue to monitor and evaluate the effectiveness of our internal controls and procedures and our internal controls over financial reporting on an ongoing basis and are committed to taking further action and implementing additional enhancements or improvements, as necessary and as funds allow.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in the Company’s internal control over financial reporting during the quarter ended December 31, 2016 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

ITEM 9B.OTHER INFORMATION

 

On January 31, 2018, the Company failed to file a Form 8K when the Board of Directors approved the grant of the option to acquire 47,200,000 shares of common stock at a price of $0.015 per share for a term of five years as follows:

 

·the option to acquire 47,000,000 shares of common stock of the Company at a price of $0.015 per share for a term of five years to nine (9) consultants of the Company as follows, and
·the option to acquire 200,000 shares of common stock of the Company at a price of $0.015 per share until April 19, 2019 to one (1) consultant of the Company.

 

Of the options granted with a term of five years, options to acquire a total of 11,000,000 shares of common stock were granted to three relatives of the Chairman of the Board.

 

 56 

 

PART III

 

ITEM 10.DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE.

 

As of the date of this Form 10K, the names, ages and positions held by each of the officers and directors of the Company are as follows:

 

Name Age Position Held
Sidney Chan 67

Chairman of the Board of Directors, Chief Executive Officer and

Chief Financial Officer

     
Kenneth James Robulak 69 A member of the Board of Directors
     
Dr. Alfonso Salas 57 A member of the Board of Directors
     
Ronald Cheng 68 A member of the Board of Directors
     
Peter Stafford 80 A member of the Board of Directors

 

All directors have a term of office expiring at the next annual general meeting of the Company, unless re-elected or earlier vacated in accordance with the By-laws of the Company. All officers have a term of office lasting until their removal or replacement by the board of directors.

 

Sidney Chan – Chairman of the Board of Directors, Chief Executive Officer and Chief Financial Officer.

Director since December 1999, Chairman of the Board of Directors since July 2010, Chief Executive Officer & Principal Accounting Officer since April 2000.

 

Mr. Chan joined ALR Technologies Inc. in August 1997. He has assisted the Company’s financing, product development and corporate development. Mr. Chan has led the Company’s product development of the HeC. Mr. Chan possesses in-depth knowledge of the equity markets and investment industry, as well as a strong fundamental background in the responsibilities of corporate development and operations. Mr. Chan is an engineer and obtained his Bachelor of Engineering (Mining) degree with distinction in Mineral Economics from McGill University in 1973.

 

Kenneth James Robulak - A member of the Board of Directors of the Company

Director since August 21, 2012

 

From December 14, 1999 to January 31, 2001, Mr. Robulak was a member of our board of directors and from April 4, 2000 to January 31, 2001 Mr. Robulak was our chief financial officer, secretary, treasurer and vice president. Mr. Robulak resigned as officer and director of the Company on January 31, 2001. At the time of his resignation, Mr. Robulak did not have any disagreements with us relating to our operations, policies, or practices. Since July 2007, Mr. Robulak has worked as a marketing consultant to Teco Metal Products, LLC, a technology based manufacturing Company with operations in Dallas, Texas and Guadalajera, Mexico. Mr. Robulak earned a Bachelor of Commerce degree in finance and marketing and is a Fellow of the Institute of Canadian Bankers.

 

 57 

 

 

Dr. Alfonso Salas – A member of the Board of Directors of the Company

Director since August 21, 2012

 

Dr. Salas graduated with distinction from Universidad Metroplitana of Barranquilla, Colombia in 1983 with a Doctor of Medicine degree. He began practicing in Santa Marta, Columbia in rural medical facilities and the opened a private practice in 1984. He then worked as a physician with a number of shipping companies and became Medical Director in the office of the Ministry of Social Security and Labor of Columbia in 1991 doing medical assessments for work related accidents. In 1993 Dr. Salas was appointed Director of a Medical Service Plan of Columbia and with a support staff of more than thirty people, maintained a caseload, provided assessment procedures and referral services to hospitals, clinics, and specialists and organized and monitored clinical trials and clinical research in the pharmaceutical and medical field. Since 1995 Dr. Salas has operated his own business in Vancouver, British Columbia, providing medical based consulting services for corporations with a focus on budgeting, research and medical services.

 

Peter Stafford – A member of the Board of Directors of the Company

Director since August 1, 2014

 

Mr. Stafford is a retired lawyer and business consultant, having practised with Fasken Martineau DuMoulin LLP, a major Canadian based international law firm, and its predecessor firms, from 1966 to 2013, except for several years spent as in-house counsel for clients of the firm. Mr. Stafford's experience is in the areas of corporate and securities law, including mergers and acquisitions. Mr. Stafford joined one of the predecessor firms of Fasken Martineau in 1966 and was a senior partner and former chair of the Business Law department of the Firm’s Vancouver office. From 1985 to 1986, Mr. Stafford was Vice-President, General Counsel and Secretary of the Bank of British Columbia and from 1987 to 1989 he was Vice-President and Chief Counsel to Kaiser Resources Ltd., a finance and investment company. From 1989 until his retirement from full-time practice in 2006, Mr. Stafford served as senior partner in Faskin Martineu DuMoulin LLP, including leading the start of its Johannesburg, South Africa office in 2003. Since August 2013, Mr. Stafford has served as director, secretary and audit committee chair of Russell Breweries Inc. (TSX-V: RB). He was a director and subsequently secretary of WEX Pharmaceuticals Inc. (TSX listed) from September 2001 to its amalgamation in May 2011, a director and board chair of BC Bancorp (TSX listed) from October 1986 until its merger with Canadian Western Bank in November 1996, a director of Nissho Iwai (Canada) Ltd. a subsidiary of Nissho Iwai Corp. (now Sojitz Corp.) from June 1997 until October 2003 and a director of China One Corporation (TSX-V listed) from March 2007 until it was acquired in December 2008. Mr Stafford also served as Director of two private companies, Pikes Peak Resources Inc. from 2007 to 2012 and Paraguay Minerals Inc., from 2007 to date. Mr. Stafford obtained his Bachelor of Arts from the University of Cape Town in 1957 and obtained an LL. B from the University of South Africa in 1960.

 

Ronald Cheng – A member of the Board of Directors of the Company

Director since January 30, 2015

 

Ronald Cheng is a lawyer retired from Osler, Hoskin and Harcourt LLP, a major Canadian based international law firm, where he practiced as a partner from 1980 until his retirement in March 2014. He regularly appeared as counsel before the Canadian International Trade Tribunal, Canadian federal courts and on NAFTA and WTO matters and advised on NAFTA and other trade agreements. He represented and provided strategic advice to corporations including startups, trade associations and governments in anti-dumping, countervail and safeguard litigation, customs matters, commodity tax and government procurement disputes, as well import and export monitoring and controls. Mr. Cheng was listed in the Lexpert® Guides to Leading US/Canada Cross-border Litigation Lawyers and with highest listings in other leading legal directories such as Chambers, Martindale-HubbellÒ and Best LawyersÒ. Mr. Cheng received his Bachelor of Arts from Amherst College in 1972 and a Juris Doctor degree from the University of Toronto in 1974. Mr. Cheng is an active member of the Canadian Bar Association, American Bar Association, International Bar Association and Inter Pacific Bar Association.

 58 

 

Involvement in Certain Legal Proceedings

 

During the past ten years, Chan, Robulak, Salas, Stafford and Cheng have not been the subject of the following events: 

 

1.         A petition under the Federal bankruptcy laws or any state insolvency law was filed by or against, or a receiver, fiscal agent or similar officer was appointed by a court for the business or property of such person, or any partnership in which he was a general partner at or within two years before the time of such filing, or any corporation or business association of which he was an executive officer at or within two years before the time of such filing;

 

2.         Convicted in a criminal proceeding or is a named subject of a pending criminal proceeding (excluding traffic violations and other minor offenses);

 

3.         The subject of any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining him from, or otherwise limiting, the following activities;

 

i)          Acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator,  floor broker, leverage transaction merchant, any other person regulated by the Commodity Futures Trading Commission, or an associated person of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person, director or employee of any investment company, bank, savings and loan association or insurance company, or engaging in or continuing any conduct or practice in connection with such activity;

 

ii)         Engaging in any type of business practice; or

 

iii)        Engaging in any activity in connection with the purchase or sale of any security or commodity or in connection with any violation of Federal or State securities laws or Federal commodities laws;

 

4.         The subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any Federal or State authority barring, suspending or otherwise limiting for more than 60 days the right of such person to engage in any activity described in paragraph 3.i in the preceding paragraph or to be associated with persons engaged in any such activity;

 

5.         Was found by a court of competent jurisdiction in a civil action or by the Commission to have violated any Federal or State securities law, and the judgment in such civil action or finding by the Commission has not been subsequently reversed, suspended, or vacated;

 

6.         Was found by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated any Federal commodities law, and the judgment in such civil action or finding by the Commodity Futures Trading Commission has not been subsequently reversed, suspended or vacated; 

 59 

 

Involvement in Certain Legal Proceedings (continued)

 

7.         Was the subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of:

 

i)          Any Federal or State securities or commodities law or regulation; or

 

ii)         Any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or

 

iii)        Any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or

 

8.         Was the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26))), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29))), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member. 

 

Compliance with Section 16(a) of the Exchange Act.

 

Based solely upon a review of Forms 3, 4 and 5 furnished to the Company during the fiscal year 2015, all officers, directors and affiliates have filed their Forms 3, 4 and 5, on a timely basis except as follows:

 

The options granted to Mr. Chan and his spouse on July 1, 2016 were not reported in a form 4 until January 2018. These options were announced in a Form 10K dated December 8, 2017 and a Preliminary Schedule 14(c) dated January 11, 2017.

 

Audit Committee and Charter

 

The Company has an audit committee and audit committee charter. The Company’s audit committee is composed of Mr. Sidney Chan, Mr. Kenneth Robulak and Dr. Alfonso Salas. Mr. Robulak and Dr. Salas are deemed independent. Mr. Chan, as Chief Executive Officer is not independent. Mr. Robulak acts as the Chair of the Audit Committee. The Company’s audit committee is responsible for: (1) selection and oversight of its independent accountant; (2) establishing procedures for the receipt, retention and treatment of complaints regarding accounting, internal controls and auditing matters; (3) establishing procedures for the confidential, anonymous submission by company employees of concerns regarding accounting and auditing matters; (4) engaging outside advisors; and, (5) funding for the outside auditory and any outside advisors engagement by the audit committee.

 

Audit Committee Financial Expert

 

The board has determined that Messrs. Chan and Robulak and Dr. Salas qualify as audit committee financial experts

 60 

 

Nomination and Compensation Committees

 

The Company has a standing nomination committee composed of Mr. Sidney Chan, Mr. Kenneth Robulak and Dr. Alfonso Salas. Mr. Robulak acts as the Chair of the nomination committee.

 

The Company has a standing compensation committee composed of Mr. Sidney Chan, Mr. Kenneth Robulak and Dr. Alfonso Salas. Mr. Robulak acts as the Chair of the compensation committee.

 

Code of Ethics

 

The Company has adopted a corporate code of ethics. The Company believes its code of ethics is reasonably designed to deter wrongdoing and promote honest and ethical conduct; provide full, fair, accurate, timely and understandable disclosure in public reports; comply with applicable laws; ensure prompt internal reporting of code violations; and provide accountability for adherence to the code.

 

Disclosure Committee

 

The Company has a disclosure committee and disclosure committee charter. The Company’s disclosure committee is comprised of all of its officers and directors. The purpose of the committee is to provide assistance to the Principal Executive Officer and the Principal Financial Officer in fulfilling their responsibilities regarding the identification and disclosure of material information about the Company and the accuracy, completeness and timeliness of the Company’s financial reports.

 

 61 

 

ITEM 11.EXECUTIVE COMPENSATION.

 

The following table sets forth information with respect to compensation paid by the Company to officers and directors during the three most recent fiscal years.

 

Summary Compensation Table

             Non-Equity Non-qualified    
        Stock Option  Incentive Deferred All  
Name and   Salary Bonus Awards Awards Plan Earnings Other Total
Principal Position Year (US$) (US$) (US$) (US$) (US$) (US$) (US$) (US$)
(a) (b) (c) (d) (e) (f) (g) (h) (i) (j)
Sidney Chan [1] [2] 2016 180,000 0 0 0 0 0 9,600 189,600
Chief Executive Officer 2015 180,000 0 0 0 0 0 9,600 189,600
& Chief Financial 2014 180,000 0 0 0 0 0 9,600 189,600
Officer                  
                   
Lawrence Weinstein [3] 2016 0 0 0 0 0 0 0 0
Former President & 2015 0 0 0 0 0 0 0 0
Chief Operating Officer 2014 59,000 0 0 0 0 0 0 59,000
                   
Mr. William Smith [4] 2016 15,000 0 0 0 0 0 500 15,500
Former President 2015 180,000 0 0 0 0 0 6,000 186,000
  2014 160,000 60,000 0 0 0 0 6,000 226,000

 

[1] All other compensation includes automobile allowance.
   
[2] Salaries and other annual compensation for fiscal 2016, 2015 and 2014 totaling $189,600 for each year remain unpaid and are included in the line of credit payable of the Company. Options granted and vested to Sidney Chan for providing a line of credit are not included in the table above.
   

[3]

 

 

Resigned as President, Chief Operating Officer and member of the Board of Directors effective May 19, 2014.

 

[4] Resigned as President and member of the Board of Directors effective January 31, 2016. Other compensation is an office and administrative allowance.

 

 

 62 

 

Outstanding Equity Awards at December 31, 2016

 

             

Equity Incentive

Plan Awards:

Number of

Unearned Shares,

Units that

have not vested

 

Number of

Securities

Underlying

Unexercised

Options

Exercisable

 

Equity Incentive

Plan Awards:

Securities

Underlying

Unexercised

Unearned

Options

     
 

Number of

Securities

Underlying

Unexercised

Options

Unexercisable

     
 

Option

Exercise

Price

Option

Expiration

Date

Number of

Shares

Or Units of Stock

that have not

Vested

 
 
 
Name

 

(a) (b) (c) (d) (e) (f) (g) (h)
Sidney Chan 4,950,001,500 0 0 $0.002 2020/21 0 0
Dr. Alfonso Salas - 0 0 - - 0 0
Kenneth Robulak 250,000 0 0 $0.015 2019 0 0
Ronald Cheng 500,000 0 0 $0.015 2019 0 0
Peter Stafford 500,000 0 0 $0.015 2019 0 0

 

Mr. Sidney Chan

On March 6, 2011, Mr. Chan was granted the option to acquire 20,000,000 shares of common stock of the Company, exercisable at $0.125 per share. For each dollar, the Company borrows on the line of credit from Mr. Chan, eight stock options became exercisable. The option to acquire the 20,000,000 shares was set to expire on March 5, 2016.

 

On June 27, 2012, the option granted to Mr. Chan on March 6, 2011 to acquire 20,000,000 shares of common stock was modified as follows:

-The options in respect of shares not vested was to vest immediately
-The exercise price of the option was reduced from $0.125 per share to $0.07 per share and subsequently reduced to $0.05 per share on December 28, 2012

 

On June 27, 2012, the Company granted Mr. Chan the option to acquire 15,750,000 shares of common stock of the Company with an exercise price of $0.07 per share until March 6, 2016. On December 28, 2012, the exercise price of this option granted on June 27, 2012 was reduced to $0.05 per share.

 

On December 28, 2012, the Company granted Mr. Chan the option to acquire:

  • 14,250,000 shares of common stock of the Company at an exercise price of $0.05 per share
  • 50,000,000 shares of common stock of the Company at an exercise price of $0.03 per share

The options in respect of the 64,250,000 shares vest immediately and expire on December 28, 2017

 

On April 1, 2014, the Company and Mr. Chan agreed to increase the borrowing limit on the line of credit available by $1,500,000 in exchange for:

  • granting Mr. Chan the option to acquire 83,333,400 shares of common stock of the Company at a price of $0.03 per share for a term of five years,
  • modifying the exercise price of Mr. Chan’s option to acquire 35,750,000 shares of common stock of the Company, granted June 2012, from $0.05 per share to $0.03 per share,
  • modifying the exercise price of Mr. Chan’s option to acquire 14,250,000 shares of common stock of the Company, granted December 2012, from $0.05 per share to $0.03 per share,
  • modifying the exercise price of the option granted January 2011 to the spouse of Mr Chan (Ms. Kan), to acquire 20,000,000 shares of common stock of the Company from $0.05 per share to $0.03 per share, and
  • granting Ms. Kan the option to acquire 26,666,700 shares of common stock of the Company at an exercise price of $0.03 per share for a term of five years.

 63 

 

Outstanding Equity Awards at December 31, 2016 (continued)

 

On May 29, 2015, the Company and Mr. Chan agreed to amend the existing credit agreement to increase the borrowing limit on the line of credit provided to the Company from $5,500,000 to $7,000,000. In exchange for Mr. Chan making available the additional loan of $1,500,000 to the Company, the Company:

·reduced the exercise price of the 230,000,100 shares of common stock under option to Mr. Chan and his spouse from $0.03 to $0.015;
·extended the expiry date of the 230,000,100 shares of common stock under option to Mr. Chan to be five years from the date of execution of the amended credit agreement;
·granted Mr. Chan the right and option to purchase, an additional 329,999,967 shares of common stock at a price of $0.015 per share for a term of five years from the date of execution of the amended credit agreement.

 

On July 1, 2016, the Company and Mr. Chan agreed to amend the existing credit agreement to increase the borrowing limit on the line of credit provided to the Company from $7,000,000 to $8,500,000. In exchange for Mr. Chan making available the additional loan of $1,500,000 to the Company, the Company:

·reduced the exercise price of the 560,000,200 shares of common stock under option to Mr. Chan and his spouse from $0.015 to $0.002;
·granted Mr. Chan and his spouse the right and option to purchase, an additional 4,390,001,300 shares of common stock at a price of $0.002 per share for a term of five years

 

Dr. Alfonso Salas

Dr. Salas was granted an option to acquire 250,000 shares of common stock at an exercise price of $0.07 per share, for five years which expire on August 21, 2017. On December 28, 2017, the exercise price was re-priced from $0.07 to $0.05 per share. On April 1, 2014, the exercise price of the option to acquire 250,000 shares of common stock was reduced from $0.05 to $0.03 per share. On July 25, 2014, the Company granted Dr. Salas the option to acquire 1,000,000 shares of common stock at a price of $0.03 for a term of five years. On August 15, 2014, the option to acquire 1,250,000 shares was exercised.

 

Mr. Peter Stafford

On August 1, 2014, the Company granted Mr. Stafford the option to acquire 500,000 shares of common stock at a price of $0.03 for a term of five years. On April 22, 2015, the exercise price of the option to acquire 500,000 shares of common stock of the Company was reduced from $0.03 per share to $0.015 per share.

 

Mr. Kenneth Robulak

Mr. Robulak was granted an option to acquire 250,000 shares of common stock at an exercise price of $0.07 per share, for five years which expire on August 21, 2017 and an option to acquire 100,000 shares of common stock at $0.07 per share which expire May 23, 2016. On December 28, 2012, the exercise price to for the option to acquire 350,000 shares of common stock was amended from $0.07 per share to $0.05 per share. On April 1, 2014, the exercise price of the option to acquire 350,000 shares of common stock was reduced from $0.05 to $0.03 per share. On July 25, 2014, the Company granted Mr. Robulak the option to acquire 1,000,000 shares of common stock at a price of $0.03 for a term of five years. On April 22, 2015, the exercise price of the option to acquire 1,450,000 shares of common stock of the Company was reduced from $0.03 per share to $0.015 per share.

 

Mr. Ronald Cheng

On August 1, 2014, the Company granted Mr. Cheng the option to acquire 500,000 shares of common stock at a price of $0.03 for a term of five years. On April 22, 2015, the exercise price of the option to acquire 500,000 shares of common stock of the Company was reduced from $0.03 per share to $0.015 per share.

 

 64 

 

 

 

Option Exercises and Stock Vested for the year ended December 31, 2016

  Number of   Number of Value
  Shares Acquired Value Realized Shares Acquired Realized on
  On Exercise On Exercise On Vesting Vesting
Name (#) ($) (#) ($)
(a) (b) (c) (d) (e)
Sidney Chan 0 0 0 0
William Smith 0 0 0 0
Peter Stafford 0 0 0 0
Alfonso Salas 0 0 0 0
Ronald Cheng 0 0 0 0
Kenneth Robulak 0 0 0 0

 

The Company does not have any long-term incentive plans except as disclosed below. The Company has contractual compensation arrangements with the following individuals:

 

Sidney Chan

The Company has a consulting arrangement with Mr. Sidney Chan, Chief Executive Officer and Chairman of the Board of Directors of the Company. Under the terms of the contract, Mr. Chan will be paid $180,000 per annum for services, receive a vehicle allowance of $800 per month, receive health care insurance and receive club allowances. The contract can be terminated at any time with thirty days’ notice and the payment of two years annual salary. Should the contract be terminated, all debts owed to Mr. Chan and his spouse must be immediately repaid. The initial term of the contract is for one year and automatically renews for continuous one year terms. Also under the terms of the contract are the following:

 

i.Incentive Revenue Bonus

Mr. Chan will be entitled to a 1% net sales commission from the sales of any of the Company’s products at any time during his life, regardless if Mr. Chan is still under contract with the Company.

 

ii.Sale of Business

 

If more than 50% of the Company’s stock or assets are sold, Mr. Chan will be compensated for entering into non-compete agreements based on the selling price of the Company or its assets as follows:

-2% of sales price up to $24,999,999 plus
-3% of sales price between $25,000,000 and $49,999,999 plus
-4% of sales price between $50,000,000 and $199,999,999 plus
-5% of sales price in excess of $200,000,000

 

 65 

 

Compensation of Directors

 

The Board of Directors consists of five members, Mr. Sidney Chan, Mr. Kenneth James Robulak, Dr. Alfonso Salas, Mr. Peter Stafford and Mr. Ronald Cheng. Mr. Kenneth Robulak, Dr. Alfonso Salas, Mr. Cheng and Mr. Stafford are independent directors.

 

The Company’s Board of Directors unanimously resolved that members receive no cash compensation for their services; however, they are reimbursed for travel expenses incurred in serving on the Board of Directors. Independent directors are compensated from time to time through the grant of options to purchase shares of common stock of the Company. Directors whom are also Officers or consultants of the Company are compensated for those positions as disclosed under Executive Compensation for those positions.

 

No additional amounts are payable to the members of the Company’s Board of Directors for committee participation or special assignments.

 

 

  Fees       Nonqualified    
   Earned or     Non-Equity Deferred    
  Paid in Stock Option Incentive Plan Compensation All Other  
  Cash Awards Awards Compensation Earnings Compensation Total
Name (US$) (US$) (US$) (US$) (US$) (US$) (US$)
(a) (b) (c) (d) (e) (f) (g) (h)
Sidney Chan 0 0 0 0 0 0 0
Kenneth Robulak 0 0 0 0 0 0 0
Mr. Peter Stafford 0 0 0 0 0 0 0
Dr. Alfonso Salas 0 0 0 0 0 0 0
Mr. Ronald Cheng 0 0 0 0 0 0 0
Mr. William Smith 0 0 0 0 0 0 0

 

 

 66 

 

ITEM 12.SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

Securities Authorized for Issuance under Equity Compensation Plans

 

The following table sets out information as at the end of the Company’s financial year ended December 31, 2016 with respect to compensation plans under which equity securities of the Company are authorized for issuance.

 

Plan Category Number of securities to be issued upon exercise of outstanding options, warrants and rights Weighted-average exercise price of outstanding options, warrants and rights Number of securities remaining available for future issuance under equity compensation plan (excluding securities reflected in column)

Equity compensation plans

approved by security holders

0 0 0
Equity compensation plans not approved by security holders 4,955,801,500 $0.003 4,794,670,591
Total: 4,955,801,500 $0.003 4,794,670,591

 

Security Ownership of Certain Beneficial Owners

 

The following table sets forth, as of December 31, 2016, the beneficial shareholdings of persons or entities holding five percent or more of the Company’s common stock, each director individually, each named executive officer and all directors and officers of the Company as a group. Each person has sole voting and investment power with respect to the shares of Common Stock shown, and all ownership is of record and beneficial.

 

  Direct Amount of     Percent
Name of Beneficial Owner Beneficial Owner   Position of Class
Sidney Chan    5,068,498,982[1]   Chief Executive Officer, Chief Financial Officer, Member and Chairman of the Board of Directors

97.4%

 

         
Dr. Alfonso Salas        1,577,738[2]   Member of the Board of Directors 0.0%
         
Kenneth Robulak        1,440,000[3]   Member of the Board of Directors 0.0%
         
Peter Stafford        1,000,000[4]   Member of the Board of Directors 0.0%
         
Ronald Cheng            1,705,800[5]   Member of the Board of Directors 0.0%
         
All Officers and Directors        
as a group (5 people)* 5,074,222,520     97.5%

 

 

 67 

 

Security Ownership of Certain Beneficial Owners (continued)

 

[1]Mr. Chan owns 14,845,000 shares of common stock and holds the following options to acquire shares of common stock at an exercise price of $0.002 per share:
·466,666,800 until May 29, 2020
·3,783,334,200 until July 1, 2021

 

Mr. Chan’s spouse owns 103,653,482 shares of common stock and holds the following options to acquire shares of common stock at an exercise price of $0.03 per share:

·93,333,400 until May 29, 2020
·606,667,100 until July 1, 2021

 

[2]Dr. Salas owns 1,577,738 shares of common stock.

 

[3]Mr. Robulak owns 1,190,000 shares of common stock. Mr. Robulak holds the option to acquire 250,000 shares of common stock of the Company until August 21, 2017

 

[4]Mr. Stafford owns 500,000 shares of common stock. Mr. Stafford holds the option to acquire 500,000 shares of common stock at a price of $0.03 per share until August 1, 2019.

 

[5]Mr. Cheng owns 1,205,800 shares of common stock. Mr. Cheng holds the option to acquire 500,000 shares of common stock at a price of $0.03 per share until August 1, 2019.

 

 

Changes in Control

 

Mr. Chan and his wife hold the option options to acquire 4,950,001,500 shares of common stock, all of which are exercisable. If the options were to be exercised by Mr. Chan and his wife, they would own over 50% of the common shares of the Company.

 

 68 

 

ITEM 13.CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 

All transactions with related parties were incurred in the normal course of operations and measured at the exchange amount, which is the amount of consideration and agreed upon by the transaction parties.

 

Year Ended December 31, 2016

 

During the 2016 fiscal year, the Company incurred interest expense of $288,526 on $2,891,966 of promissory notes due to relatives of Sidney Chan and interest expense of $1,102,242 on $9,628,219 of amounts outstanding on the lines of credit payable to Sidney Chan and Christine Kan. As at December 31, 2016, the accrued interest on promissory notes owed to relatives of Sidney Chan was $1,956,403. As at December 31, 2016, the accrued interest on the lines of credit was $3,747,343.

 

Year Ended December 31, 2015

 

During the 2015 fiscal year, the Company incurred interest expense of $309,826 on $2,891,966 of promissory notes due to relatives of Sidney Chan and interest expense of $944,010 on $8,626,993 of amounts outstanding on the lines of credit payable to Sidney Chan and Christine Kan. As at December 31, 2015, the accrued interest on promissory notes owed to relatives of Sidney Chan was $1,667,976. As at December 31, 2015, the accrued interest on the lines of credit was $2,645,101.

 

Director Independence

 

The following directors are considered independent pursuant to § 229.407 (Item 407) Corporate governance and sit on the following board committees where indicated:

 

Kenneth Robulak, Audit Committee Chair, Nomination Committee Chair, Compensation Committee Chair

Alfonso Salas, Audit Committee, Nomination Committee, Compensation Committee

Peter Stafford (no committee appointment)

Ronald Cheng (no committee appointment)

 

Sidney Chan is not considered independent pursuant to § 229.407 (Item 407) Corporate governance and sits on the Audit Committee, Nomination Committee and Compensation Committee.

 

 69 

 

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

 

(1)       Audit Fees

 

The aggregate fees billed for each of the last two fiscal years for professional services rendered by the principal accountant for the Company’s audit of annual consolidated financial statements and review of consolidated financial statements included in the Company’s Form 10-Qs or services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for those fiscal years was:

 

2016 $ 20,000 Dale Matheson Carr-Hilton LaBonte LLP
2015 $ 20,000 Dale Matheson Carr-Hilton LaBonte LLP

 

(2)       Audit-Related Fees

 

The aggregate fees billed in each of the last two fiscal years for assurance and related services by the principal accountants that are reasonably related to the performance of the audit or review of the Company’s consolidated financial statements and are not reported in the preceding paragraph:

 

2016 $ 12,000 Dale Matheson Carr-Hilton LaBonte LLP
2015 $ 12,000 Dale Matheson Carr-Hilton LaBonte LLP

 

(3)       Tax Fees

 

The aggregate fees billed in each of the last two fiscal years for professional services rendered by the principal accountant for tax compliance, tax advice, and tax planning was:

 

2016 $  2,000 Dale Matheson Carr-Hilton LaBonte LLP
2015 $  2,000 Dale Matheson Carr-Hilton LaBonte LLP

 

(4)       All Other Fees

 

The aggregate fees billed in each of the last two fiscal years for the products and services provided by the principal accountant, other than the services reported in paragraphs (1), (2), and (3) was:

 

2016 $       0 Dale Matheson Carr-Hilton LaBonte LLP
2015 $       0 Dale Matheson Carr-Hilton LaBonte LLP

 

(5)       The Company’s audit committee’s pre-approval policies and procedures described in paragraph (c)(7)(i) of Rule 2-01 of Regulation S-X were that the audit committee pre-approve all accounting related activities prior to the performance of any services by any accountant or auditor.

 

(6)       The percentage of hours expended on the principal accountant’s engagement to audit the Company’s consolidated financial statements for the most recent fiscal year that were attributed to work performed by persons other than the principal accountant’s full time, permanent employees was 0%.

 

 70 

 

PART IV

 

ITEM 15.EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 

    Incorporated by reference  
Exhibit         Filed
No. Document Description Form Date Number herewith
           
3.1 Initial Articles of Incorporation. 10-SB 12/10/99 3.1  
           
3.2 Bylaws. 10-SB 12/10/99 3.2  
           
3.3 Articles of Amendment to the Articles of Incorporation, dated October 22, 1998. 10-SB 12/10/99 3.3  
           
3.4 Articles of Amendment to the Articles of Incorporation, dated December 7, 1998. 10-SB 12/10/99 3.4  
           
3.5 Articles of Amendment to the Articles of Incorporation, dated January 6, 2005. 8-K 1/20/05 3.1  
           
3.6 Amendment to Bylaws, dated October 13, 2011 8-K 10/13/11 3.6  
           
3.7 Amendment to Bylaws, dated April 10, 2012 8-K 4/16/12 3.7 X
           
10.1 Consulting Agreement with Endocrine Research Society Inc. 10KSB 10/01/13 10.1 X
14.1 Code of Ethics. 10-KSB 4/14/03 14.1  
           
31.1 Certification Pursuant to Rule 13a-14(a) or 15d-14(a) of the U.S. Securities Exchange Act of 1934 of the Principal Executive Officer and Principal Financial Officer       X
           
32.1 Section 1350 Certification of the Principal Executive Officer and Principal Financial Officer       X
           
99.1 Distribution Agreement with Mo Betta Corp. 10-SB 12/10/99 99.1  
           
99.2 Pooling Agreement. 10-SB 12/10/99 99.2  
           
99.3 Amended Pooling Agreement. 10-SB 12/10/99 99.3  
           
99.4 Lock-Up Agreement. 10-SB 12/10/99 99.4  
99.19 Audit Committee Charter. 10-KSB 3/31/14 99.1 X
99.20 Disclosure Committee Charter. 10-KSB 4/14/03 99.2  
99.30 Nomination Committee Charter 10-KSB 8/15/13 99.3  
99.40 Compensation Committee Charter 10-KSB 8/15/13 99.4  
             

 71 

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

  ALR TECHNOLOGIES, INC.
  (Registrant)
     
DATE: February 2, 2018 BY: “Sidney Chan”
    Sidney Chan
    Chairman, Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer and a member of the Board of Directors

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

 

Signatures Title Date
     
     
     
“Sidney Chan” Chairman, Principal Executive Officer, Principal February 2, 2018
Mr. Sidney Chan Financial Officer, Principal Accounting Officer and  
  a member of the Board of Directors  
     
     
“Peter Stafford” Member of the Board of Directors February 2, 2018
Mr. Peter Stafford     
     
     
“Kenneth J. Robulak” Member of the Board of Directors February 2, 2018
Mr. Kenneth J. Robulak     
     
     
“Alfonso Salas” Member of the Board of Directors February 2, 2018
Dr. Alfonso Salas     
     
     
“Ronald Cheng” Member of the Board of Directors February 2, 2018
Mr. Ronald Cheng    

 

 

 72 

 

 

 

 

EX-31.1 2 f2alr10k012618ex31_1.htm CERTIFICATION

 

EXHIBIT 31.1

 

CERTIFICATION

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Sidney Chan, certify that:

 

1.   I have reviewed this Form 10-K for the year ended December 31, 2016 of ALR Technologies, Inc.;

 

2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;

 

4.   The Company's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have

 

a.   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared

 

b.   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.   Evaluated the effectiveness of the Company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.   Disclosed in this report any change in the Company's internal control over financial reporting that occurred during the Company's most recent fiscal quarter (the Company's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting; and

 

5.   The Company's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company's auditors and the audit committee of the Company's board of directors (or persons performing the equivalent functions):

 

a.   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company's ability to record, process, summarize and report financial information; and

 

b.   Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company's internal control over financial reporting.

 

Date: February 2, 2018

 

By: /s/ Sidney Chan

Sidney Chan

Chief Executive Officer and Chief Financial Officer

 

EX-32.1 3 f2alr10k012618ex32_1.htm CERTIFICATION

EXHIBIT 32.1

 

CERTIFICATION

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C SECTION 1350)

 

In connection with the Annual Report of ALR Technologies Inc. (the “Company”) on Form 10-K for the year ended December 31, 2016, as filed with the Securities and Exchange Commission (the “Report”), I, Sidney Chan, Chief Executive Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to my knowledge:

 

1.   The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and
2.   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

This Certification has not been, and shall not be deemed, “filed” with the Securities and Exchange Commission.

 

Date: February 2, 2018

 

By: /s/ Sidney Chan 

Sidney Chan

Chief Executive Officer and Chief Financial Officer

 

GRAPHIC 4 alr_2.jpg GRAPHIC begin 644 alr_2.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# ," @," @,# P,$ P,$!0@%!00$ M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_ MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04 M%!04%!04%!04%!04%!04%!04%!04%!3_P 1" !A 2,# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#]4Z*** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BOSS_ &K/^2^>*/\ MU_])8:\EKYFMG7LJDJ?L[V; M6_;Y'['@/#OZ[A*.*^MVYXQE;DO:Z3M?G5[7/UFHHHKZ8_' HHHH **** "B MBB@#S/X[?M%>"OVM>)_\ M/2/@1_T$]:_\%4G^-?"__!3'XV?\+4_:(N]"LK@2Z)X/C.E0A#E6NLAKI_8[ MP(S_ -Q##!Z'!'8UZ37XV?\$P?C=_PK/X_IX8OI_+T7QC&M@0S85;Q< MM;,?4>E?LG7FXFC["IRK8EZ!1117((HZYK5EX;T34-7U*;[-IVGV\E MW#_&']KZ[= M)))#:?V9>0;E12['?+"JC"@GDU[77XI?\$R?^3O_ O_ ->=_P#^DTE?M;6. M*HQH5.2(GH%%%%<8@JMJ6H6^D:==7UW)Y5K:Q-/-)M+;44%F. ,G !Z59KG/ MB1_R3OQ3_P!@JZ_]$M0!X9_P\?\ V=?^BA_^434?_D>C_AX_^SK_ -%#_P#* M)J/_ ,CU^']%?1_V;2[O\/\ (OE/W _X>/\ [.O_ $4/_P HFH__ "/1_P / M'_V=?^BA_P#E$U'_ .1Z_#^BC^S:7=_A_D'*?O3X/_;6^!OCJ>*'2OB5HJS2 M':D>I.]@6.< 7"IR3T'?M7M-O<174,_-SXTE4G+; <^2Y_OICG&0PX//4RVRO3 M?WARG[SUP_Q>^-G@OX#^&[;7_'6L_P!AZ192I\]54Y:$GI7_#Q_\ 9U_Z*'_Y1-1_^1Z/^'C_ M .SK_P!%#_\ *)J/_P CU^']%>W_ &;2[O\ #_(KE/W _P"'C_[.O_10_P#R MB:C_ /(]'_#Q_P#9U_Z*'_Y1-1_^1Z_#^BC^S:7=_A_D'*?N!_P\?_9U_P"B MA_\ E$U'_P"1Z]7^$'QX\$_'G2KW4_ VJSZUIUG*();MM.NK6+S",[5::) Y M QD+G&1G&1G\?/V,_P!C/6_VH/%'VR\\_2? 6GR@:CJJKAIF&#]G@R,&0C&6 MY" Y.255OT$^,WQFT3X3^%X/A=\+H(-)L]/B^R37%CPMJH^]%&W4R$DEY"20 M2>2Q)7PLZ4MQ%:-1 M964#W,\OVZV;9&BEF; D). #P!FOIG]BG_DD-U_V%IO_ $7%7J/Q=_Y)/XU_ M[ E[_P"B'KY%9;1Q-)XJ3:W7%?G]7K7[*?_ "7SPO\ ]O7_ *2S5QX?-<34K0A)JS:6 MWF>]FG!&483 8C$4HRYH0E)>]U46T?H91117VI_.X4444 %>8_M+?&&#X#_! M'Q5XRD9/M=E:F.PC;GS;N0[(5QW&]E)_V0Q[5Z=7Y<_\%'/A=I\ M^ZWTI1JVJ*K9'VB12L"$=BL99O<3KZ5TX>E[:JH]!H_/6\O)]1O)[NZF>XN9 MY&EEFD.6=V.68GN2233&AD6%9C&PB9BBR%3M+ D ^H#+^8]:97Z7^-_V+SI M/_!-[3XELL>-=)SXRN?DQ(6D0>?">I^2VV @=7@'K7T]6M&CRI]78T/S9TW4 M;G1]1M;^RG>VO+659X)HSAHY%(96!]00#7]!'[//Q:M?CE\&?"OC2V*"34K- M3=Q)TBN4RDZ?02*V/48/>OY[J_1O_@D;\;#9ZQXF^%FH3_N;Q3K.E!CP)5"I M<1CW9!&X'0>6Y[UQYA2YZ?.MT3(_3NBBBOFR#B/CE_R1/X@_]B]J'_I-)7\\ M%?T/_'+_ )(G\0?^Q>U#_P!)I*_G@KWO?LE_"'1_CQ^T% MX5\"Z_BG MQ5I>K+XK\&"18I[KR/)N;%G;">:F2"A)51(#]XX*KD9^2Z_H"_:KCL)?V9_B MDNI[/LG_ C6H'YP#B00.8R ?XM^S'OBOY_:]S!5I5H/GW1:/O\ _P""17Q2 MO-+^)GBCP!-,S:5JU@=4@C8\)=0LBG:.VZ-SD_\ 3):^_/VE_P!G#0_VH/ E MAX5\0:GJ&E6=GJ4>II-IIC$AD2*6,*=ZL-N)F/3.0*_+#_@F-$\G[7OAMD1F M6.ROF-_=XCFCHR7N?!W_#H'X9_]#EXL_[[MO\ MXS1_PZ!^&?\ T.7BS_ONV_\ C-?>-%<_UNO_ #"NS^<'QEHL7AOQ=KFDP.\L M-A?3VJ/)CW%K;_P!DA5DAC_BVLP/S-SES\Q+$ MYR%/\ H/ZS^<7_ ,17TE17P5;"T<0^:K&[/6P&=9AED'#!U7!/ M5V2U_ ^)=6^+&M_LM^)M<\ ^&H=/U/2[6XCN5N-5A=YRTMO$S F-T7 [<5D^ M(_VQ/&?B?P]JFCW6F:%':ZA:RVDKPV\P=4D0HQ4F8C."<9!K#_:L_P"2^>*/ M^W7_ -)8:\EKX;$8JO2J3HPDU%-I+RN?TCEF2Y=CL)A\?B:*E5G&$G)[N3BF MW]Y]9_\ #!G_ %//_E(_^WUUOPI_9)_X5CX^TOQ+_P )7_:7V'S?]%_L[RM^ M^)X_O>:V,;\]#TKZ&HK["&6X2G)3C#5:[O\ S/P6OQAG>*HSH5:]XR337+#5 M-6>T;[!1117IGQH4444 8_C#Q5IW@7PGK'B/5YOL^EZ39RWMU+C.V.-"[8'< MX' [FOYZOBC\0M1^*_Q$\1>,-6/^GZS>R7CIN)$89OEC4G^%%VJ/917Z?_\ M!6#XW'PA\*=)^'FGS[-1\43>?>A#RME"P.#SD;Y=F.Q$<@K\EZ^@RZERP=1] M2XGNW[$WP7_X7G^T9X7T2YM_M&BV,G]JZJK %?LT)#%&!ZJ[F.,_]=*_=RXM MX[J"2":-989%*/&XR&4C!!'IBOPN_91_:XNOV4YO$-UIGA/3]?U#6%AC:ZO9 MWC:&*,L=B;1T8MD^NU?2OH?_ (?$>+?^B=Z+_P"!TW^%1C*%>M4O%:+T!IGR M3^TY\'Y?@3\<_%G@XHXLK.Z,M@[Y.^TD DA.>Y",%)_O*P[5SOP?^)6H?![X MG>&O&>E[C=Z->I<^6K;?.CSB2(G' ="Z'V8UZ#^U5^T_/^U-XFT77[_PM8^' MM4T^T:RDFLYWD^T1;]Z!MPXVEI/KO]J\.KU*:E*FHU%K;4H_I#\,^(]/\8>& M]+UW2;A;K2]3M8KRUG7I)%(@=&_$$5IU\/?\$I_C7_PFWP9O_ E]<;]4\)SY MMPQ)9K*8LR=>NV3S%XZ H/2ON&ODZM-TIN#Z&1Q'QR_Y(G\0?^Q>U#_TFDK^ M>"OZ'_CE_P D3^(/_8O:A_Z325_/!7L99M/Y%Q/JG_@F3_R=_P"%_P#KSO\ M_P!)I*_:VOQ2_P""9/\ R=_X7_Z\[_\ ])I*_:VN7,/XWR%+<****\PD*YSX MD?\ )._%/_8*NO\ T2U='7.?$C_DG?BG_L%77_HEJ:W _G,KV/\ 9"^+&B? M_P#:(\)^-O$:W3Z-I?VOSULHQ)+^\M)H5VJ2 ?FD7//3->.45]K**G%Q?4U/ MV)_X>P?!/_GV\4_^"V/_ ./4V7_@K'\%(XG=;+Q7*R@D(NG19;V&9@,_4U^/ M%%>;_9U'S)Y4?8O[8G_!0W5?VC- D\'>&](E\,^#9)5DNOM,H>[O]C!D63;\ ML:!@&V MDJ#N[5\=45]8_LQ_\$[_ (@?'#4++5/$=E=>"_!3,LDE]?1^7=74 M?4BWA89Y'21P%YR-^,5U_NL+#LA['M/_ 2)^#MU-KWBKXG7D+1V,%O_ &)I M[,.)979))V'^ZJQKG_IHP[&OT\KGOA_X!T/X7^#=)\+>&K"/3=%TR$06]O&. M@ZEF/\3,Q+,QY+,2>370U\Q7J^VJ.9#"BBBN<1_.C\4_^2G>+_\ L,7G_H]Z MZ/\ 9C_Y.2^$_P#V-ND_^ED5U"6^U/PQHVHWLN/,N;O3 MXI9'P HRS*2< ?0"JG_ J+P+_T)7AW_P %4'_Q%=;163I4V[N*^X[(XW%1 M2C&K))>;"BBBM3C"BBB@ I&8(I9B%4#))Z"EKYK_ ."@WQL_X4O^S?KIL[GR M-=\0_P#$ET_:<.OFJ?.D&.1MB$F&'1BGJ*N$74DHKJ!^5/[9'QK/QZ_:#\3^ M)()O.T:&7^SM*P)T5][?\ !)WX'Q^+OB)KWQ#U6S2X MTSP_!]AL?.0,K7DR_,PSW2+(/_79:^LG*.&I7Z(TV1\$T5_2+_PCND_] NS_ M / =/\*/^$=TG_H%V?\ X#I_A7F?VG_<_'_@"YC^;JBOZ1?^$=TG_H%V?_@. MG^%?D1_P5(^"4?PW^.=MXKTVV%OHWBZV\\K&H5([R$*DR@ < J8G]R[^E=.' MQRK3Y'&P)W/)_P!B?XV?\*)_:(\-:Y6RQDB4!)#Z[XC&Q/\ M>+#M7-F5+:JO0)'J/QR_Y(G\0?\ L7M0_P#2:2OYX*_H?^.7_)$_B#_V+VH? M^DTE?SP4\LVG\@B?5/\ P3)_Y._\+_\ 7G?_ /I-)7[6U_.?\._B1XD^$WBJ MV\2^$M4DT;7+9'2*\CC1RJNI5AAU(Y4D=*]?_P"'@7[0/_12+S_P"M/_ (U6 MF*P?\ M@%:?_&JX_P"S:O=?C_D+E9^Z-*;1[[0=1^V?:;>.9X M6;R[.>5,.A###QJ>#VQ7B=?2W_!.#_D\_P"'G_<1_P#3==5]36;5*379FA^C M7_#LW]G[_H4[S_P<7?\ \^VNPNY[2X7)BF7 MW4]1QE2R]":^NOUV_P"":/[6'_"UO!/_ KGQ/?&7Q=X M>@S93SME[^Q& O/=XLA3W*E#R0Y'Y6_$;X?:U\*O'&L^$O$5J;/6-)N&MYX_ MX3CE74]U92&4]PP-'PY^(.M_"KQQHWBWP[=?8]9TFX6XMY.2I(X9&&>49258 M=PQ'>O>Q%&.)IV7R+>I_1E17G/[/WQNT3]H3X6:/XRT1E1;I/+O+/=N>SN5 M$L+?0]#@;E*MT->C5\G).+LS,****0'\Z/Q3_P"2G>+_ /L,7G_H]ZZ/]F/_ M ).2^$__ &-ND_\ I9%7.?%/_DIWB_\ [#%Y_P"CWKH_V8_^3DOA/_V-ND_^ MED5?9?\ +KY&O0_H+HHHKXTR"BBB@ HHHH **** "ORM_P""E6B_%3XT_&RW MTGP_\._&&J^%?#-J+>UN[+0[J:WN;B4*\\J.L9##_5QY'>(^M?JE1710J^QG MSVN,_GT_X9C^,7_1)_''_A.7G_QNOVA_8Z^"W_"AOV>_"_AJXMQ!K,D/]H:K MP WVN;#.K8ZE!MCSZ1BO:J*VQ&+EB(J+5@;N%%%%<(@KYR_;Y^!TWQR_9TUN MSTVREOO$>BL-7TN&W0O++)&")(E4^+](\*^);0I+=WV MAW4-O;74(9XI'=T"J"ID3W+IZ5^H]%>C5QTJL'"4=RKG'_&2QN=4^$/CFSL[ M>6[O+C0KZ&&W@0O)*[6[A551R6)( Y)-?A)_P ,Q_&+_HD_CC_PG+S_ .-U M_0716&'Q3P][*]Q)V/Y]/^&8_C%_T2?QQ_X3EY_\;H_X9C^,7_1)_''_ (3E MY_\ &Z_H+HKL_M*?\H^8_GT_X9C^,7_1)_''_A.7G_QNC_AF/XQ?]$G\U;]%>?7KNO-3:L)NY_/I_PS'\8O^B3^./_ G+S_XW7T'^P)\"_B3X M-_:U\":QK_P]\5:'I%M]O\^_U+1;FW@BW6%PB[I'0*N695&3R2!WK]B**[)Y MA*<7'EW'S!1117E$GQ!_P4H_9'N?C!X5M_'W@_2Y;[QGHJ"&ZL;*(O-J-IG@ M*JC+R1DD@#DJ6')"BOS3_P"&8_C%_P!$G\?_&Z_H+HKT:.-G1AR6N5 M<_)+]@J\^,W[./Q42TU?X7^._P#A!_$#QVVIH?#MYMM7SB.Z \O^#)#8ZH3U M*J*_6VBBN:O6]M+GM9B84445SB/P7^)/[-WQ;OOB)XIN;;X6^-+BVFU6ZDBF MB\/7;(ZF9B&4B/!!!R"*WOV=_P!G?XJZ)^T!\,M1U'X9>,;#3[/Q/IEQM_:$N7EY2N8****\DD**** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B EBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$! end GRAPHIC 5 alr_1.jpg GRAPHIC begin 644 alr_1.jpg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

222:KE<5IN!]@>#O!VC^ /#=CH.@V,>G:591^7#!&/S)/4L3D MDGDDDFMJODO1?^"C7@K7-9L--B\,Z]'+>7$=NCOY&T,[!03B3IDU]:5DTUN, M*BNKE+.UFN),B.)&=L#)P!DU+2$!@01D>E(#QWX6_M8?#[XP^*E\/>'+N^EU M-H7G"W%FT:E5QGYCWYKV.ORF^('A#Q9^QM\?(M;TRU;^S[>[>?2;R6,FVN[= MP086(_B",489!'WA_":^HO#O_!23X?7VGH^LZ)KNE7V!YD,$<=Q%GOM?>I/X MJ*T,%P#_ MD&O@K M]@W6]0\-?M+66CP2,]MJ4%W9W:H3L98XGE5B/9H@ ?\ :/K7J_QF_P""BUEJ MGAV\TCX?:3?P7UW&8?[6U)43R P(+1QJS9;G@L1@]C6G^P+^S?J_A.\G^(?B M>SDTZ:XMC;:58W"E)0CD;YW4\KD *H/4,QQ]TEZQB[@?;-?FQ_P37_Y+IKO_ M &+D_P#Z56M?I/7Y3?LB_%+2?V??C9J-SXP6XL;62QGTBYD2)I&MI/.C8EE7 MYB 82IP">>E*.S _5FOS8_X*4?\ )=-"_P"Q<@_]*KJOOCX9_%?PO\8-#N=8 M\):D=5TVWNFLWG-O+#^]5$<@+(JMTD7G&.:^!_\ @I1_R730O^Q<@_\ 2JZH MA\0'Z+^'_P#D Z;_ ->T7_H K0K/\/\ _(!TW_KVB_\ 0!6A68S\COV:?AQX ML^)OQ1U+2O#OBZ?P9KT-C-/?&W[7/[2L?_")WNMZ'X2ADA69 M;>[DBC@LXV^:24(P7S)/FPOJ0N3M)K]%KZRAU*QN+2Y02V]Q&T4B'HRL""/R M-3*^EP/RQ_9+^$/C/XJ7'B?_ (0[Q[<^!Y[!;;[1]EN9H6NE]8_\&-]_P#'*\8\#ZUK'["?[0NH66OV5Q=^&;Y&@::- M1FYM"^8KB/H"ZXY7/=U]#7UU?_MQ?!RST1]0C\4M>2!-RV,-C/Y[MC[F&0 ' MW) ]ZJ5[Z >,:3^P+XT_X6)I/BS7?B%;Z[?6M];7<\]XD\L\XB9"%,CL23M0 M*,G@ 5]PU^>W[/.M?$#]H_\ :2N/&(O]7TWP997YOKBU6\E^R1A1^YM@N0K, M<)N&.FXD<@']":B5^HS\V/@O_P I%]0_[&/7_P#T7>5^D]?EK!XVMO@G^W-K MGB3Q!;SI8V?B/4Y)EC7+B*X\Y4D [C;,K^XK]#/A;\=/!7QH;4QX.UAM6&FB M$W1-K- (_,W[!^\1<_ZMNF>E.?<2.^HHHK,84444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M5@^/O^1%\1_]@VY_]%-6]6#X^_Y$7Q'_ -@VY_\ 134 ?B+7ZQ?L.?\ )K?@ MK_M]_P#2ZXK\G:_6+]AS_DUOP5_V^_\ I=<5T5-B4>[4445SE!7Q#_P4T\40 M1Z'X*\.*X:YEN)M0D0=55%$:$_4N^/\ =-?0'Q<_:G^'OP?L;C^T-;@U/5T! M$>CZ9(LUPS>C8.(Q[N1[9/%?EW\8OBSK'QJ\>W_BC6BJ33XC@M8R3';0KG9$ MN>PR23W)8]ZUA%WN)DOP&T>;7OC9X$L802\FMV;$@9VJLRLS?@H)_"OV=K\Z MO^"=/P@N-<\=7GC^]@9=,T6-[6RD8'$EU(NUB/4)&S9]Y%]*_0C6=7M/#^D7 MNJ7\RVUC90/<3S.MJU];"]>:.R,BB=[= \BQY&XJI(!;&< D MGN*ZOXQ?$J]^+GQ(USQ5>[D-].3!"QSY,"_+%'_P% H/J OV6_B?\ M$[PU;^(/#?A9]0TBX9TBN6O;: .58JV%DD5B 01G&,@UM%4?#+_H!>+/\ P#M? M_DBOD[_AASXV_P#0E?\ E5L?_CU'_##GQM_Z$K_RJV/_ ,>J.6'<>IH?M??' M+P'\>]6T37/#.G:UI^M6L36EV=2MX42:'.Z,@I*YW*Q?J.0W7CGSGX#?%*?X M-_%;0?%$9=K6WF\N]B3_ ):VS_+(N.YVG,?\ #M'P-_T-/B'\X/\ MXW1_P[1\#?\ 0T^(?S@_^-U]@45CS,H^/_\ AVCX&_Z&GQ#^<'_QNOISX<>! M[3X:^!]&\+V-Q-=6FEP"".:XQYC@$G+8 &>>PKI**3DWN 4444@"BBB@ HHH MH *^,/\ @II_R(O@O_L)3?\ HH5]GU\8?\%-/^1%\%_]A*;_ -%"KC\2$SYL M_8<_Y.D\%?\ ;[_Z0W%?:'[>7PK_ .%@_!6?6+6#S-5\,N=0B*CYC;D 7"_3 M: Y_ZY"OB_\ 8<_Y.D\%?]OO_I#<5^KEU:PWUK-;7$2S6\R-')$XRKJ1@@CN M"#5S=I7!'XE^ O&-[\/?&FB^)-..+S2[J.Y1%W# M&WM+DM:.W)>W<;XCGN=C 'W!%4]>^*FM^(_ASX9\%WXN[F18XXUY9W8X 'N2:_9CX)_#>#X2 M?"WP[X6BVF6QMA]ID3I)<-\\K?0NS8]L#M7Y[?L#_"K_ (3[XT1ZW=P^9I?A ME!?,6'RFY)(@7Z@AG'O'7ZA5G4?0:/PUU[_D.:C_ -?,G_H1K]8OV-O^39_ MW_7M-_Z42U^3NO?\AS4?^OF3_P!"-?K%^QM_R;/X&_Z]IO\ THEJJFPD>T5Y M)^U%\85^"OP@U;6(90FLW0^PZ8O?[0X.'_X H9_^ @=Z];K\O_V]/C /B)\7 MFT&PG,FC>&5:S&TY5[HG]^_X$+'_ -LSZUG&/,RCYIDD:9V=V+NQW,S'))/4 MDU]K_LY_MB?"WX%_"O3?#3:/XFN-2W-=:CC9)]8_\ #RCX9?\ 0"\6?^ =K_\ )%>2?M.?M<'!Q7E/_##GQM_Z M$K_RJV/_ ,>H_P"&'/C;_P!"5_Y5;'_X]46BNH]3Q#3[ZXTN^MKVTF>WN[:1 M9H9HSAD=2"K ^H(!K]DO@3\4;;XQ?"O0?$\++]HN(1'>Q+_RRN4^65<=AN!( M_P!EE/>OR7^)GPA\7?![5+33O%^CMI%W=0^?"OGQ3*Z;BN0T;,N<@\9STXY% M?17_ 3M^,!\+^/K[P-?W&S3=?7SK0.>$O$'0>F^,$>YC04YKF5T)'Z.T445 MSE'Q_P#\%+O^24^%O^PT/_1$M?"?PC_Y*OX+_P"PW9?^CTK[L_X*7?\ )*?" MW_8:'_HB6OA/X1_\E7\%_P#8;LO_ $>E=$?A%U/VLHHHKG&%%%% 'Y._MQ_\ MG2>-?^W+_P!(;>JG[*OP"T_]H3QCJ^C:AJMSI,5E8?;%EM8U=F/F(FTANWS? MI5O]N/\ Y.D\:_\ ;E_Z0V]>D_\ !-'_ )*OXH_[ A_]'Q5T;1%U/2O^'9?A MG_H=-6_\!HJ/^'9?AG_H=-6_\!HJ^SZ*RYF,^,/^'9?AG_H=-6_\!HJ/^'9? MAG_H=-6_\!HJ^SZ*.9@?A/7ZB?\ !/G_ )-SL_\ L)77_H0K\NZ_43_@GS_R M;G9_]A*Z_P#0A6M38E'TI7Y=?\%!O^3C+S_L&VO_ *":_46ORZ_X*#?\G&7G M_8-M?_0344]QLY3]D_X&Z3\?OB)J/A[6+^\TZVMM*DOUEL=F\NLT,84[E(QB M4]NPKZP_X=H^!O\ H:?$/YP?_&Z\8_X)K_\ )=-=_P"Q\T44F[[@%5M0TVTU M>SFL[ZUAO;29=LMO<1B2-QZ,I&"/K7SE^V)^TAXO^ ,&BKX?T.QN+?54D4:I M>[Y%AE4C*>6N!G:002W.&XXKXY\._MK?$VS^)&E^)M:\076KV-M+^_T9&$%K M-$PVLOEH NX Y5F!((!YYS2BVKB/N/QA^Q#\(?%TSS_\(XVB7#=9-'N'@7\( M^8Q^"UY?KG_!,WPC<;O['\7ZU89^[]MBANOIOX9_%7PQ\7/#L.M> M&-3BO[9@/,BR!-;M_U+3Y!<0+SC+$?,@Z'O _@_4]6\4W5O;:+'"RSK<[2)@5/[H*?OLPR O?.*I38K'X MJ:7JEYHNI6VH:?-U.0RD<@@U^O'[+_P 6IOC1\'-'U^]Q M_:T9:RORJX5IX\ N .FY2K8' +$=J_(2]DAFO)Y+>(P6[2,T<9.2BD\#/? K M]+/^"6DK]LN(G0?^.25\D? 7Q1!X-^-'@K6;MUCM+75;WQ?Z,$A![NI=!_OU^0DD;PR/' M(C1R(2K*PP01U!'K1#6-@/W6HKY,_9!_:^TKQSX?T_PAXOU"/3O%5FBV]O=7 M4@6/44 PI#'@2@ J?O<$9)('UG6#5M"@HHIDDBPQM)(RHBC>";Z/4%N3LU;5;=]T00'F")A]XD@;F'&/EYRO:MX*RNR6?I#_P3FT&32_@/ M>7TJ;?[2UF>>-O[T:QQ1_P#H2/7TQK__ " =2_Z]I/\ T$U@_";X?V_PM^&_ MA[PI;,LB:9:+"\BC DE.6E<#MN=F;\:WM?\ ^0#J7_7M)_Z":R;N[E'X;5^N M'[&W_)L_@;_KVF_]*):_(^OUP_8V_P"39_ W_7M-_P"E$M;5-B4>LZ[H>G^) MM&O=)U6TCOM-O(F@N+:8961&&"#7Y7_M4_LP:A\ _$GVNP6:^\&WTG^A7S#) M@8Y/D2D=& S@_P 0&>H('ZOUC>,/"&D>/O#.H:!KUE'J&DWT?E3V\G0C.00> MH8$ @CD$ BL8RY64?D'\#?C;KOP)\;0Z]HS>? X$5]I\CD17<.>5;T8=5;'R MGU&0?O/]I3XFZ#\7/V*_%'B/P]=K",@@U\ M5_M*?LY:O^S_ .+F@<27OAJ]=FTS4CSO4<^7)@8$BC&>QZCN!YUH_CC6M!\, MZ_X?L[UX]'UQ(DOK0\I)Y4JRQMCLP9!R.Q([UO92LT285?N3H'_(!TW_ *]H M_P#T$5^&U?N3H'_(!TW_ *]H_P#T$5%3H-%^BBBL1A1110 5Q'QOT.7Q)\&_ M'&F0*S7%UHMY'"J_Q2>2VT=.[8KMZ0@,,$9% 'X45^L/[$?BB#Q/^S?X76-P M9]-\[3[A1_ Z2,5'XQM&W_ J_.S]I#X33_!KXN:YH)@,6FO*;O37ZA[5R2F# MWV\H?=#7:?L@?M+#X"^++FRUCS)?".KLHO/+!9K60<+.J]P 2&4?MG?M;:7X;\.:GX#\(W\=_P"(+^-K:_O+5PT= MC$PPZ!AP96&5P/NY).#BFDV[(#Z(_P"%]_#+_HHOA/\ \'EK_P#'*ZGP_P") MM(\6::NH:'JMEK.GLQ1;K3[A)XBPX(#H2,CZU^'D,,ES-'%%&TLLC!$C1269 MB< #J2:_9']GWX MB5\,?\%(/C ([?2/AQI\_P [E=2U38W11D0Q'ZG+M/\!^$] M6\1:K+Y6G:;;/)]5;=?:G%0?[*J%4>RBG35W<&4/#;:4GB'36UT7+:*MS&UZMDH:9H0PWA 64;BN0 M,D=:_0^S_P""COPKT^TAM;;P[XJ@MH46***.RM0J*HP% ^T< "OCOP?^R7\ M5_'WAJP\0:%X3:\TF^0R6\[7]K"74,5SMDE5@,@XR.>HX(K9_P"&'/C;_P!" M5_Y5;'_X]6DN5[L1]8_\/*/AE_T O%G_ (!VO_R17R5^UG\7/!'QN\;6'B?P MGIVK:=?26WV?4EU*"*,2E,")UV2/EMN5.<<(F.]2?\,.?&W_ *$K_P JMC_\ M>H_X8<^-O_0E?^56Q_\ CU)**V8]3#_9=^,#?!7XOZ3K,TK)HUT?L.IKV^SN M1E_^ ,%?_@..]?KW'(LT:R1LKHPW*RG((/0@U^&^M:->^'-8OM*U*W>SU"QG M>VN+>3&Z.1&*LIQZ$&OT^_89^,G_ M#X00:5?3^9KOAO987&XY:2#!\B0_\ M!!0GJ3&3WJ:BZ@CZ-K\G?VX_^3I/&O\ VY?^D-O7ZQ5^3O[X,Y#X*_ 7Q+\>M4U*P\-26,<]A"L\WVZ9HUVLVT8(5LG->M_\.Z?B MK_S\>'O_ .D_P#C5=9_P3+_ .1Z\:?]@V'_ -&U^A55*33L@L?DQ\5OV./B M'\'_ C-XDUB+3[S3()%CG;3;AI6A#WF4,DD; AE8'J""17Y,?M3?L^W?P#^($EM DDOAC42T^E739/ MR9^:%C_?3('N"I[X%1G?1B/3?V:OV*]!^-GA>T\47GC=GT_S/*NM+TZV"W$, MHP6C>1R0IP00=AR&!]J^_P#X>_#GP]\+?#,&@^&=-CTS3826V)DM(YQEW8\L MQP.2>P'0 5^5G[,/Q_O?@'\0(K]C)<>';XK!JMFG.Z//$BC^^A)(]067C=D? MK7HVL67B#2;/4]-N8[W3[R%9[>XA.4DC895@?0@UG.]QHNUXO^V3_P FS^.? M^O:'_P!*(J]HKQ?]LG_DV?QS_P!>T/\ Z415$=T,_(^OH[PK^P7\2O&'A?1] M>L)]"%CJEG#?6XFO'5Q'*@==P\LX.&&>:^<:_9WX"?\ )"_AU_V+FG?^DL== M$Y..Q*/@3_AW3\5?^?CP]_X'2?\ QJO!OB9\-->^$GC"\\->(K86^HVP5LQD MM'*C#*NC8&Y3Z^H(.""*_:^O!?VN?V=8?CIX%,^G0HOB[25:73IN 9UZO;L? M1L97/1L= 6SFJCOJ.Q^8GP[\+V7C;QEIFAWVM0>'H;Z40#4+J,O%&Y^[NP1@ M$X&>@R,X&2/T;^"O[!W@OX7:I;:SK-U)XPUJW8/ UU"(K6%QT98[Q/I<7^B3RM\U];*,=3UD0<'N5P><,:N=[70D?654]9F>WT>^EC8I(D$ MC*PZ@A20:N4R:%+B%XI%#QNI5E/0@\$5SE'Y!?\ #5_Q=_Z'W5O^^U_^)H_X M:O\ B[_T/NK?]]K_ /$U^D__ RA\(O^A"TG_OAO_BJ/^&4/A%_T(6D_]\-_ M\56W/'L(D_9;\3:IXR^ GA'6=:O9=1U2Z@E:>ZF.7D(FD4$_@ /PKU6LOPSX M9TOP;H=IHVBV46G:7:J5@M81A(P6+$#\23^-:E9#/PUU[_D.:C_U\R?^A&OJ M#]F/]C71OCU\-Y?$M_XBOM+G2_EL_(MH4=<(J$-D\Y^<_E7R_KW_ "'-1_Z^ M9/\ T(U^D_\ P3H_Y-_N/^PW<_\ HN&NB3:6A*.3_P"'9?AG_H=-6_\ :*C M_AV7X9_Z'35O_ :*OL^BL>9E'QA_P[+\,_\ 0Z:M_P" T5>>_M ?L+Z%\'/A M'KWC"S\3ZAJ-SIWV?9;3P1JC^9<1Q')'/ D)_"OT1KPG]N/_ )-;\:_]N7_I M=;TU)W0C\G:_:OX1_P#)*/!?_8$LO_1"5^*E?M7\(_\ DE'@O_L"67_HA*NI ML@1UM?CA^TI_RI^SM%%%A?]C'!_Z2 MW5?G-H/_ "'-._Z^8_\ T(5T0V)9^Y5%%%.O"-GX^\&ZUX MX%-:.X'XB5^WO@KQ-;^-/!^B:_:LKV^IV4-VA7IAT#8]L9QCMBOQ;\:>$=3\ M ^*]5\.ZQ ;?4M-N&MYD[9!X93W4C# ]P0:^NOV(_P!K33?!>FQ?#_QI>BRT MP2DZ5JDQQ%;[B2T,K?PH6)(8\#<02!C&\U=71*/T%HJ*WN(KJ".>"1)H9%#I M)&P964C(((X((J6N.M8* 10VMM:!RO)+N[D _]LQD>XKXE):1B22S,?J2: M_63]C?X0S_"'X*Z?;:C ;?6]6D.IWL;##1%P!'&>X*HJY'9BU;STC82/H_P#I5)7[.U^,7Q[_ .2Z?$7_ +&/4?\ TJDJ*>X,^W?^ M":/_ "2GQ3_V&C_Z(BKZ_(##!&17R!_P31_Y)3XI_P"PT?\ T1%7V!42W&?G M3^V=^R&W@6XN?'/@JR9O#DK&34M.A7/V!B>9$'_/(]Q_ ?\ 9^[\L^"?&NL? M#OQ1I_B'0;QK'5+&3S(I5Y'H58=U(R"#U!(K]MKFVAO;>6WN(H[BWF0QR12J M&1U(P5(/!!&>*_-']L7]DN7X1ZE/XM\+VS2>"KJ0>; I+-ILC'&T]S&2?E;L M3M/8MK&5]&(^N_A?^T-HW[0'P5\07MN8[+Q!:Z7.NIZ6&^:%_*8;USR8VQD' MMT/(K\H*WO!?CG6_A]K#:GH5])97+PR6TH7E)H7&UXW7HRD=O4 C! -8-7&/ M*(_7#]C;_DV?P-_U[3?^E$M>T5XO^QM_R;/X&_Z]IO\ THEKVBN:6[*"BBBD M 4444 %%%% 'YS?\%+O^2K^%_P#L"#_T?+7"?L%_\G,>'O\ KVO/_2=Z[O\ MX*7?\E7\+_\ 8$'_ */EKA/V"_\ DYCP]_U[7G_I.]="^ GJ?JI1117.4%%% M% !11575-2M=%TV[U"]F6VLK2%[B>:0X6.-%+,Q]@ 3^% 'R3_P41^,O_",> M";+P'IT^W4==_?WNP_-'9HW"GT\QQCZ1N.]?G99K;M=PBZ>2.V+J)7A0.ZIG MYBJD@$XS@$CZBNR^-7Q.N_C#\3-<\576Y$O)B+:%C_J;=?EB3ZA0,XZDD]ZW M/ '[+_Q.^*'AN'7_ SX7?4=(F=XX[EKVV@#E3AL"2120#D9QC(([&NJ*Y5J M2?8/AK_@H-\)/"7A[3=$TSP[XL@T_3K:.UMX_LEKPB*%7/\ I')P.36G_P / M*/AE_P! +Q9_X!VO_P D5\G?\,.?&W_H2O\ RJV/_P >H_X8<^-O_0E?^56Q M_P#CU1RP[CU-7]K[X[> OC]?:%K/AO3M:T_7+.-K2Y;4K>%(YH,EDP4E<[E8 MMVY#GG@9\N^!_P 3KCX/_%'0?%,&]X;.<+=0QGF:W;Y94^NTG&>X![5WG_## MGQM_Z$K_ ,JMC_\ 'J\?\6>$]6\"^([_ $'7;-]/U:QD\JXMF96*-@'JI((( M((()!!!JU:UD(_;C3-2M=:TVTU"QG2YLKN%)X)XSE9(V4,K#V((-6J^2O^"> M?Q@'B[X'6W6P<_,]FYRN/78^Y?8,@KZUKF:L[%'Y=?\%!O^3C M+S_L&VO_ *":Y;]DCX/Z%\;OBI+X>\0O>)8+ITUT#92B-]ZO&!R5/&&/:NI_ MX*#?\G&7G_8-M?\ T$U?_P""=/\ RI])_\.Z/A5_S M\>(?_ Z/_P"-4?\ #NCX5?\ /QXA_P# Z/\ ^-5]1T5AS/N4?+4G_!.7X5R1 MLJWGB.,D8#K?19'N,Q$?F*^?OVD/V%+GX2^%KSQ7X7UB;7-%L\-=VEW&! _@3XJBU*XB%YK%A-IEC:,09)I)4 M*95?1 QY-/GD"#6-*GM(@<$_V=?&UQ))L>[LCI\:[L%VG(BP/7Y68GV!K\ MB*^EOVS/VGH/C?KEKH7AUY/^$1TF4R),ZE3>SX*^;M/10"0N1GYF)Z@#S#]G MWX2W7QH^*FB^'88G:Q,@N-1E7_EE:H09&SV)&%'^TZUT17*M23]2_P!G/0Y? M#OP)\!V$ZE)TT>WD=&ZJSH'*GCL6Q^'>OA[_ (*4?\ETT+_L7(/_ $JNJ_22 M.-((TCC18XT 5448"@= !Z5^;?\ P4H_Y+IH7_8N0?\ I5=5G#XALH?\$Z?^ M3@+C_L"W/_HR*OTVK\R?^"=/_)P%Q_V!;G_T9%7Z;45-P1\L?MB_LE1?%K3Y MO%OA2U2+QI;(#- I"KJ4:C&T]O- "MW VG^$C\TI8I[&Z>.1)+>YAG0KC[>H&3(@'_+4 '(_ MC'^T/F<)=&!H?L9_M<)\2K.W\%^,+Q4\66Z[;*\D^4:C&HZ$_P#/50#G^\!G MJ#7QI^U?_P G&>/?^PDW_H*UY=97MSI=]!=VD\MI=V\BRQ30L4>-U.0RD<@@ MCK6AXN\5ZEXX\1WVNZQ.+G5+UA)<3!0OF.% +8' )QDXK11Y7<1]Q_\ !,7_ M ) ?Q _Z^;/_ -!FK[>KXA_X)B_\@/X@?]?-G_Z#-7V]6,MR@HHHJ /)OVK_ M /DW/Q[_ -@UO_0EK\@*_7_]J_\ Y-S\>_\ 8-;_ -"6OR K>GL)G[._ 3_D MA?PZ_P"QUY_Z%%7RM\%_ ]I\2OBGX;\+WUQ-:VFJ78MY)K?'F(""A?]C'!_Z2W5?)W[#G_)TG@K_M]_](;BOK'_ M (*4?\D+T+_L8X/_ $ENJ^3OV'/^3I/!7_;[_P"D-Q6\?@8NI^L5%%%8#,'Q M]_R(OB/_ +!MS_Z*:OQ%K]NO'W_(B^(_^P;<_P#HIJ_$6MZ?43/VZ\ _\B+X M<_[!MM_Z*6MZL'P#_P B+X<_[!MM_P"BEK>K 85^/_[5_P#R<9X]_P"PDW_H M*U^P%?C_ /M7_P#)QGCW_L)-_P"@K6M/<3.R^!G[:6O_ -\$Q^&+'P]INJ6 M,3! M =RS,68 L!R ,GCO7O?[)?[)?P_^,'P?M_$7B*WOY=2DO)X"UO=F-=J$ < 5 M] ^&_P!A_P"#WARY2X_X1AM4F0Y4ZE=RS)^*;@A_%35WC$<<:CHJJ!@#V%6:RE+F8PHHHJ0"BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** *NIZ79ZUI]Q8:A:07]C<(8IK6YC62*5#P596!!!]#7'?\*%^&7_1.O"?_ M (([7_XW7=T4 <)_PH7X9?\ 1.O"?_@CM?\ XW5O2?@YX!T'4K?4-,\#^&]. MO[=M\-U::3;Q2QMZJZH"#]#7844[L K!\8>!?#WQ TK^S?$FBV6MV6=RPWD( MD"-_>4GE3[C!K>HI >.:+^Q_\'= U,7]KX&LGN V\"[FFN8PL=;2+/E/< MQ R1YZ['&&7/L17544@/)O"'[*?PG\"ZE'?Z1X*L4O(VWQRWFX^M;U%% !7F/C3]F?X7_$*^EO=<\&:?<7LQS+X\#6D;DDX ML[FXMDY_V8I%'Z5[113NUL!Q?@/X,^!_AB[R>%_#&GZ1.XVM<0Q;IB/0R-EL M>V<5VE%%("KJ6EV>M6,]CJ%I!?64Z[);:YC62.1?1E8$$?6O(=7_ &-?@UK= MR9[CP-:1N23BSN;BV3G_ &8I%'Z5[113NUL!Q?@/X,^!_AB[R>%_#&GZ1.XV MM<0Q;IB/0R-EL>V<5VE%%( HHHH *QO$W@W0/&EK%:^(=#TW7K:)_,CAU.TC MN$1\$;@K@@'!(S[ULT4 4-#T#3/"^EP:9HVG6FDZ;!N\JSL8%AACW,6;:B@ M98DG ZDFK]%% &9XB\-:3XNTJ;3-;TRTU;3IOOVM["LL;>AVL",CL>U>3-^Q M?\&&U#[8? ]OYV<[1>7(C_[]^;M_2O;**=V@,GPSX3T;P7I,6EZ#I5II&G1_ M=MK.%8TSW. .2?4\FM.2-)HVCD57C8%65AD$'J"*?12 X3_A0OPR_P"B=>$_ M_!':_P#QNC_A0OPR_P"B=>$__!':_P#QNN[HIW8'#V_P-^&]G<13P?#[PM#/ M$P>.2/1;961@<@@A."#WKN***0!1110!0UO0=,\3:;+I^KZ=:ZI82C$EK>PK M-$_U5@0:\CU3]C#X,:MC444@"O+/''[+_PN^(VL3:K MK_A"TNM1F;?-U2>)?AGX/\:7R7WB#PIH>NWL<8A2XU+3H;B18 MP20@9U)"@LQQTR3ZUTU% #(XTAC6.-52-0%55& .@ I]%% &;X@\-Z3XLTN M73-;TRTU?3Y?OVM["LL;8Z':P(R/6O))_P!BWX,7%Z;IO \ ESG;'>W21_\ M? E"_I7MM%.[0&)X3\%:!X#TM=-\.Z/9:+8@[O(LH%C5C_>; ^8^YYK;HHI M87B[P+X>\?:;_9_B31;'6[,'=_$3]GOX=_%>^%]XI\+6FIWVT1F[5Y()BHZ O&RL0/<^U7/AC\$_! M7P;BOX_!^B+HZW_E_:2+B68R[-VS)D=CQO?\Z[BBG=@%%%%( HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ K!\??\ (B^(_P#L&W/_ **:MZJVHV$.K:?=65RI>VN8FAE4 M$@E6!!&1TX- 'X85UFA_%SQUX7TN#3-&\:>(=)TV#=Y5G8ZK/##'N8LVU%< M98DG ZDFOTG_ .&"_@U_T+]W_P"#.X_^+H_X8+^#7_0OW?\ X,[C_P"+KHYX MBL?G/_POOXF_]%%\6?\ @\NO_CE8NM_$;Q9XFC>/6/$^LZJCYW+?:A+,&SUR M&8^@_*OTR_X8+^#7_0OW?_@SN/\ XNK%E^PK\%[23>_A26Z.00)M3NL#'L)! MG\:7/$-3\I "3@ZPQL, M\C^-AMYR-W2OT2\'?!#P#\/Y(Y?#_A#2--N8_N726JM.,?\ 35LO^M=Q2=3L M%C%\'^#]'\ ^&K#0-!L8].TJQC\N&WCZ =22>I8DDECR2237RS_P41^,O_", M>";+P'IT^W4==_?WNP_-'9HW"GT\QQCZ1N.]?8%>/?$/]D_X(O$F MF7E_JMPJ(\@U"9%"JH55558!1@=AU)/>LXM7NQGY2^!?!M_\0O&6C>&],3?? M:G!?">D>'M+C,>GZ9;1VL(;J550,D]R> MI/N MU4I;?-AWLARK!E(92"""HY!JHNSN!^2?[ M.OQ8E^#/QP%5)I["/S0_X*#?\G&7G_8-M?\ T$U\^:'X MBU;PS=O=:/J=YI5RZ&)IK&X>%RA()4LI!QD X]A7ZV?$K]E?X=?%KQ0_B#Q+ MI-Q>:H\20M+'>RQ#:HPHVJP%.O^AT\0_P#@UG_^+H_X6YXZ_P"AT\0_^#6?_P"+K])_^&"_@U_T+]W_ .#. MX_\ BZ/^&"_@U_T+]W_X,[C_ .+I\\0U/S8_X6YXZ_Z'3Q#_ .#6?_XNC_A; MGCK_ *'3Q#_X-9__ (NOTG_X8+^#7_0OW?\ X,[C_P"+H_X8+^#7_0OW?_@S MN/\ XNCGB&IQ'_!.?Q1K/BCP7XOEUG5[[5Y8M0B6-[ZY>=D!CR0"Q.!7N7[2 MO_)O_P 0?^P+=?\ HLU?^%'P4\)_!73[^R\)V,MC;WTJS3K+*O#.G^-/#>I:%JL33Z;J,#VUQ&KE"T;#! 8)-.L+==D-K::O<111KZ*JN !]!7Z1_\,%_!K_H7[O_ ,&=Q_\ M%T?\,%_!K_H7[O\ \&=Q_P#%UMSQ%8_.?_A??Q-_Z*+XL_\ !Y=?_'*/^%]_ M$W_HHOBS_P 'EU_\ MVV@W27%M*LT;'4IR RD$'&_GD"ES1#4]]HHHK 84444 %%%% !7QA_P4T_Y$ M7P7_ -A*;_T4*^SZX3XK_!3PG\:M/L++Q98RWUO8RM- L5P\)5B,$Y0C/%5% MV=P/S8_8<_Y.D\%?]OO_ *0W%?K%7C?P_P#V2/AG\,?%UAXF\/Z/<6NKV/F> M1-)?32!=\;1M\K,0?E=A^->R4Y2YG<1\3?\ !23X4_;]"T/X@6<69K!AIM^5 M'_+%R6B<^@5RR_\ ;5?2O@"OV^\8^$-*\?>&-1\/ZY:B\TK4(O)GAW%=RY!! M!!R"" 01T(%>+0_L'_!N&9)!X=N7*L&VOJ,Y4X/0C?R*N,[*S L?L4_"L?#' MX&Z5)4GX1A3CLS-7O=-50BA5 "@8 '2G5D]7<9^& MNO?\AS4?^OF3_P!"-?K%^QM_R;/X&_Z]IO\ THEK&N/V$_@[=7$L\F@79DD8 MNQ_M*XY).3_'7L?@?P3I/PY\*Z?XGF0V\<5W+"JE]NXD(PR M?E')Z<^IKA=,_8;^#^DZE:7T/AV=YK:9)D6:_G="RL" REL,,CD'@T1DHH#0 M_9!^$?\ PJ+X*Z3:W4/E:UJ@_M+4,]5DD VQGTV($4C^\&/>O;***S;OJ,** M**0'S?\ MV_"/_A8_P &;C5[2'S-8\,EM0B*CYFM\?Z0GTV@/_VS [U^86CZ MM=Z#JUEJ>GSM:WUG,EQ;S)]Z.1&#*P]P0*_*5%DB=2KHX!5@1@@C MN*^?G_8-^#3LS?\ "/70RG?!GXE6OQ<^&>@>*K;8K M7UN#<0H'!QGJ,'O7;5Q7PK^#_AGX,Z+=:3X5MKBST^XG^TO#-= M23#S"H4L-Y.,A1T]!7:UGZ#/C_\ X*7?\DI\+?\ 8:'_ *(EKX3^$?\ R5?P M7_V&[+_T>E?KK\5?@YX6^-&CVFE^*[*2^L[6?[3$D5P\)$FTKG*$$\,:\]T7 M]B+X1^']9L-4LM"NH[RQGCN8';49V"R(P93@M@\@5I&22L(]YHHHK(84444 M?D[^W'_R=)XU_P"W+_TAMZ])_P"":/\ R5?Q1_V!#_Z/BKZU^('[)'PS^)WB MZ_\ $WB#1[BZU>^\OSYH[Z:,-LC6-?E5@!\J*/PK4^%7[-_@/X+ZQ=ZIX4TR M>QO+JW^S2O+=RS Q[@V,.Q Y4*'\0>)=)N+S5'B2%I8[V6(;5&%&U6 J8RY7=C/R9\->+M=\%WTE[X? MUK4-"O9(S"]QIMU);R-&2"4+(02N54XZ94>E=+_POOXF_P#11?%G_@\NO_CE M?HQ_PP7\&O\ H7[O_P &=Q_\71_PP7\&O^A?N_\ P9W'_P 76O/$1^<__"^_ MB;_T47Q9_P"#RZ_^.4?\+[^)O_11?%G_ (/+K_XY7Z,?\,%_!K_H7[O_ ,&= MQ_\ %T?\,%_!K_H7[O\ \&=Q_P#%T<\0U/SG_P"%]_$W_HHOBS_P>77_ ,&-=C8VMQ\\4\>/,MYAG9*A_O#)^H)!X)K\K? MC=^S=XQ^!.JRQZO8O=Z*S[;;6K5";:49X#'_ )9O_LMSUQDH(/!'M4QDX@?B!X=\3:QX1U./4=#U2\T>_CX6YL9V MAD ]-RD''M7L.C_MN?&71X!"OBXW<8&!]LLK>5A_P(Q[C^)-?=WC3]B?X1^- M)WN&\-_V)=.EP()3CZA%K M3FB]P/F>\_;J^,]Y;M$OBB&WW<%X=-M@V/8F,X^HYKR/QE\0_$WQ$OQ>>)M> MO];N%^XUY.SK'GLBDX4>R@5]W6O_ 3-\(I)FY\7ZU+'C[L44*'\R&]^U>@^ M$/V#?A'X4F2:?2KWQ%*G*MK%V77/ND813]""*.:*V#4_/KX'_ 'Q3\=O$D5A MHMH\.F1R 7NKS(?L]JO?)_B?'1!R?89(_6WP#X)TWX<>#-'\,Z/&8].TVW6" M/=]Y\C^"OVG/BC\/K> M.VT7QGJ,=I&-J6UV5NXD7^ZJRA@H^F*_57X@_!GP3\5(=GBGPU8ZO(%V+(H[F.6(?0/&6]/XJVYT]Q6 M/E=OV\_C,RD#Q%:J2.HTRWR/_'*\Z\=_'WXA_$R%X/$GBW4M1M'.7M!((;=O MK%&%0_E7V8O_ 3+\+AAN\9ZN1GD"VB'%=7X;_X)U_"W1Y5DU"?7->(^]%=7 MBQ1GGTB1&''^U1S1#4_-[PSX6UCQEK$&DZ%IMUJVI3G$=M:1&1S[X'0#N3P. M]?I#^R-^Q^GP7QXI\4F&[\8S1%(H(R'BTY&'S!6_BD(X+#@ D#(R3[]X(^&_ MA;X;Z>UEX8T&QT2!\>9]DA"M)CH7;[SGW8FNEJ)3OH@L%4-?_P"0#J7_ %[2 M?^@FK]17%NEU;RP2#,QDS\+*_7#]C;_ )-G\#?]>TW_ *42UA?\ M,%_!K_H7[O\ \&=Q_P#%U[/X'\$Z3\.?"NG^'-"@:VTFQ5D@B>1I"H+%C\S$ MD\L>M:SDI+01O4445D,YOXA_#S0OBEX3O?#OB*R6]TVZ7D='BGEUE52Q1XW'1D=2&4]1P>02.AJXRY1'XHU^Y.@ M?\@'3?\ KVC_ /017A/_ P7\&O^A?N__!GP M&!3G)2V EHHHK,84444 %%%% 'D7[2'[.^D_M!>#Q93NMAKUENDTW4MN?*+/ MAK=M<>%_$.H:)(YS(MK,5CD_WT^ZWX@UZS;?MW?&>W@2-O$UO.5&/,DTRVW' MZXC _2OL'Q=_P3Z^%'B29YK/#X:GR1XX_:D^*7Q$M);36?&-\;*0;7M;(): MQLO]UA$J[A_O9KS"TLY]0NHK:UADN;B5@D<,*%W=CT Y)K](M#_ .";OPXT M^1)-1UCQ!JI4#,9GBAC;UX6/=_X]7NOPY^!?@/X3J&\+^&;'3;G;M-YM,MR0 M>H,KDO@^F<>U'.EL%CY>_8[_ &,;[PSJUGXZ\?6@M[ZWQ+IFBRC+POP5FF[! MA_"G4'DX( K[=HHK%MO<9\/?\%'_ (P"VT_2/ASI]Q^\N2NHZH$/_+,']S&? MJP+D?["'O7QQ\(?AS=_%GXD:#X5L]R-J%RJ33*,F&$?-+)_P% Q^H K]/_&W M['_PR^(GBG4/$6OZ5>7VK7SAYYCJ,ZYPH4 -@ #H!6K\+?V9/A[\'-?F MUKPOHTEIJ4L#6QGFNI9B(RP)"AV(!)4I1S7EG[)7QB'P:^,FF7]W+Y>B:C_P 2[4MQ^58G88D/ M^XX5B?0,.]?J/\2OACX=^+GAA] \46/V_36E2<(LC1LLBYPRLI!!P2/H2*\E M_P"&"_@U_P!"_=_^#.X_^+K525K,1]" AAD_;C_ .3I/&O_ &Y?^D-O M7ZJ:)I,&@:-8:9:F0VME!';1>=(9'V(H5=S'EC@#D\GO7E/Q _9(^&?Q.\77 M_B;Q!H]Q=:O?>7Y\T=]-&&V1K&ORJP ^5%'X5,7RNXSY9_X)E_\ (]>-/^P; M#_Z-K]"J\T^%'[.W@;X*:A?WOA/39K&XOHEAG:6[DF#*#D##L<;:787+VMPH.R0?F01W4D=Z[VBI _$7QUX)U; MX<^+M3\-ZY;&UU/3YC%*O9NZNI[JP(8'N"*^J_V#_P!IH>$]4A^'/B6ZQHU] M+_Q*;J5N+6=CS"2>B.3QZ.?]HD?8'Q4_9M^'_P 9M6M-3\4Z,UWJ%M#Y"7$- MQ) [1YR%8H1N ).,]-QKB?\ A@OX-@Y'A^\!_P"PG0R2,% +,3EF..2>2 M:RO''@G2?B-X5U#PYKL#7.DWRJD\22-&6 8,/F4@CE1TK);C/Q%K]G?@)_R0 MOX=?]BYIW_I+'7FO_#!?P:_Z%^[_ /!GZ>'=!LO"OA_2]$TV-H=/T MVUBL[:-F+%8HT"("3R!= #UX#_@W=C7Q7X7\3:EX-\0Z?KFCW3V6IV$RSV]Q&>58?S!Z$=""0 M:_;Z\LX-1LY[2[ACN;6>-HI895#)(C##*P/!!!((]Z\"?]@WX-,S$>';I6_"W]FOP+\&=:N-4\)V-YI]U<0^1,K7\TLO=J MYWX@> =&^)WA&_\ #/B"W>ZTB^\OSX8Y6C+;)%D7YE((^9%/X4UH[@?B37[5 M_"/_ ))1X+_[ EE_Z(2O)_\ A@OX-?\ 0OW?_@SN/_BZ]XT72+;P_H]AI=DA MCL[&WCMH$9BQ6-%"J,GD\ 5I.2EL(NU^.'[2G_)P'Q!_[#=U_P"C#7['UX=X MJ_8Q^%7C/Q)J6NZKHEU/J6HSO(?_!K/_P#%U^D__#!?P:_Z%^[_ /!G.O\ H=/$/_@UG_\ BZ/^%N>.O^AT\0_^#6?_ .+K])_^ M&"_@U_T+]W_X,[C_ .+H_P"&"_@U_P!"_=_^#.X_^+HYXAJ?+W["7C_Q1XB^ M/UI9ZKXDU?4[0Z?\OI98R0HP=K,1D5^DU>1_#7]E?X=?"7Q0GB#PUI-Q M9ZHD3PK+)>RRC:PPPVLQ%>N5C)IO0#Y._P""E'_)"]"_[&.#_P!);JOSFT'_ M )#FG?\ 7S'_ .A"OV7^*GPD\,_&;P_;Z)XJLY+[3[>Z6\CCBG>$B54= DC<>]>8V_["?P=M;B*>/0+L21L'4_VE<<$'(_CJXR25@/H&BBBLAA1110!\ MX?M9_LF6WQVL4US0WAT_QG9Q>6DDGRQ7L8R1'(1T8<[7]\'C!7\S_%W@S7/ M.N3Z/XBTJZT?4H3\UO=1E3CLRGHRGLP)![&OV_KG_&7@'PY\0M+.G^)-$L=; ML^JQWD(?8?53U4^ZD&M(SMH(_(#P#\,_E5\T6&I\E>,?V MJ/BMXZMY;?5/&FH+:R AK>QV6B%3_"1$J[A]V<4H_^E4E?L[7A7B+]BGX3^*O$&J:UJ6AW4VHZE=2WES(NH3J&EDFW.GZA;17MC=1M#/;SH'21&&" MK ]015JBI _+#]K;]E>[^!FNMK.C))=>"M0F(MY.6:Q<\B"0]QUVL>H&#R,G MYVK]QO$7AW3?%FAWNCZQ9Q:AIE[$89[:9=RNI_KW!Z@@$5X9_P ,%_!K_H7[ MO_P9W'_Q=;1J=Q6-W]C;_DV?P-_U[3?^E$M>T5@^!_!.D_#GPKI_AS0H&MM) ML59((GD:0J"Q8_,Q)/+'K6]63W&%%%%( HHHH **** /SF_X*7?\E7\+_P#8 M$'_H^6ODS2-:U#P_?)>Z7?W.FWB A;BSF:*101@@,I!&17Z^?%7]F_P'\:-8 MM-4\5Z9/?7EK;_9HGBNY80(]Q;&$8 \L>:XK_A@OX-?]"_=_^#.X_P#BZVC- M)6$?FQ_PMSQU_P!#IXA_\&L__P 71_PMSQU_T.GB'_P:S_\ Q=?I/_PP7\&O M^A?N_P#P9W'_ ,71_P ,%_!K_H7[O_P9W'_Q=5SQ#4_-C_A;GCK_ *'3Q#_X M-9__ (NC_A;GCK_H=/$/_@UG_P#BZ_2?_A@OX-?]"_=_^#.X_P#BZ/\ A@OX M-?\ 0OW?_@SN/_BZ.>(:GD'_ 3C\8Z_XIUKQRFM:YJ6KK#;VAB6_NY)PA+2 MY*[B<9P.GI75_P#!0SXR?\(EX!M/ VGS[-4\0?O+O:?FCLT;D>WF.-ON$<=Z M]R^$_P"S[X)^"=QJ4_A+3IK&34%1+@RW4DVX(6*XWDX^\>E8_P 1OV4_AU\5 M_%4_B+Q+IEW?:I,B1F1=0FC5510JJJJP"COP.I)[UG=$=0\>^+= M(\.Z5'YNH:G'M$D@U:W1TBFGNY9O+W+M8@,Q M."1GT)KU^B4N;8 HHHK,85\#_P#!2+X2?9=0T7XB6,/[NYQIFI%?^>@!,,A^ MJAE)_P!A!WK[XK \=>!M&^)/A6_\.>(+07VDWJJLT.XJ3M8,I##D$%001Z54 M7RNX'Y%?L_\ Q4G^#?Q8T+Q*KL+**80W\:#/F6KD+*,=R!\P']Y5K]CK2\@U M"U@NK:5)[>9%EBEC.5=6&0P/<$&O /\ A@OX-?\ 0OW?_@SN/_BZ]M\(>%=/ M\#^&=-T#2EF33=/A%O;I-,TK)&/NKN8DD <#T JI-/81^:7_!0;_DXR\_[! MMK_Z":\%\)^--=\"ZH=2\/:M>:+?F,PFYLI3&^PD$KD=B0/RK]8_B5^RO\.O MBUXH?Q!XETFXO-4>)(6ECO98AM484;58"N6_X8+^#7_0OW?_ (,[C_XNK4U: MS _/7_AI3XJ_]%!\0_\ @PD_QH_X:4^*O_10?$/_ (,)/\:_0K_A@OX-?]"_ M=_\ @SN/_BZ/^&"_@U_T+]W_ .#.X_\ BZ.>(:GYZ-^TG\5&4@_$+Q%@C'&H M2 _SKA]=\1:MXHU!K[6=3O-7OF&&N;ZX>>0_5F)-?J(G[!OP95E)\.73 ')5 MM3N,'VX>NO\ "O[+/PH\&7"3Z9X'TSSHSE)+T/>,I]09F?!]Z.>(6/SY_9E_ M91U_XV^(++4=1LYM-\$PR![J_E4H;E1SY4/=BW0L.%&3G( /ZJVMK#8VL-M; MQ+#;PHL<<2#"HH& .P %2(BQJJ(H55& JC ]*=64I9&CDBD4,KJ1@J0>H()XK\W_ -J+]B35_ .HW?B/P)93:OX5D)EDT^$&2YT_ MN1MZO$.S#) X;IN/Z3441DX@?A9:W4^GW4<]O+);7$3!DEB8JZ,.A!'(->P> M%_VQ/B_X2MDMK7QI=W<"C 34HHKMO^^Y59_UK](OB)^S)\-/BE/)=:[X6M&U M"3EK^S+6T[-_>9HR-Y_W\UXKK'_!-7P#=2,^G>(O$&GYZ)*\,RCZ?NU/YFM> M>+W$?,-U^W;\9KB%HU\3P0%O^6D6F6VX?3,9KRCQO\4?%WQ)N5F\3^(M0UMD M.42ZG9HXS_L)]U?P K[E@_X)F>%%F4S>,=9DC[K'!$I/XD'^5=YX3_8!^$OA MF9);JQU+Q%(O(_M6].W.?[L0C!^A!%'-%;!J?G/\,?A'XJ^,&O)I/A?29M0F MR/.GQM@MU/\ %)(>%'7W., $\5^I/[-_[.NC_L^^$6L[=UU#7KT*^I:GMP96 M'1$'41KDX'4Y)/7 ]-T'P[I7A738].T;3;32;"/[EK90+#&OT50!6C65_%3]F?P!\9O$%OK?BK2Y[W4+>U6S22.\ MEA B5W<#"L!UD;GWHB^5W&?#O_!.G_DX"X_[ MS_ .C(J_3:O)_AC^R_\/?@ M_P")&UWPOI4]EJ30-;&22\EE&QBI(VLQ'517K%$GS.X@HHHJ!GPW^VQ^R*+M M;_XB^"K,"=09M8TFWC_UG/S7,:C^+NZ]\%NN<_!=?NQ7A.O?L2_"'Q%K5[JE MUX;DBN;R5IY5M;V:&/+_P#!,7_D!_$#_KYL_P#T M&:OMZN ^$_P-\(?!.WU*#PE82V,>H-&]P);F2;<4#!<;R/2N_J).[N,** M**D#R;]J_P#Y-S\>_P#8-;_T):_("OV^\8^$=,\>>&-1\/ZS"UQI>H1&&XB2 M1D+*2#@,"".G:O%/^&"_@U_T+]W_ .#.X_\ BZUA)1W$>E? 3_DA?PZ_[%S3 MO_26.N[K.\.Z#9>%?#^EZ)IL;0Z?IMK%9VT;,6*Q1H$0$GDX"CDUHUD,**** M /@3_@IU_P A[P!_U[7G_H45?%NDZO?:#J5OJ&F7MQIU_;MOANK25HI8V]59 M2"#]#7[#?%C]GWP3\;+C39_%NG37TFGJZ6YBNI(=H M(:GYS_\ "^_B;_T47Q9_X/+K_P".4?\ "^_B;_T47Q9_X/+K_P".5^C'_#!? MP:_Z%^[_ /!G/Q%\5^-O&7 MBV#Q#XGUG7H8+")XH]3U"6Y6-C)@E0['!QZ5]TUYI\*/V=O WP4U"_O?">FS M6-Q?1+#.TMW),&4'(&'8XYKTNL9.[T&%%%%2!\G?\%*/^2%Z%_V,<'_I+=5\ M$?"/XF7_ ,'OB%I7B[3+6WO;W3O-\N"[W>6WF0O$<[2#P)">O4"OUU^*GPD\ M,_&;P_;Z)XJLY+[3[>Z6\CCBG>$B54= DC<>]>6_\,%_!K_H7[O_ ,&= MQ_\ %UK&22LQ'S7_ ,/+O'7_ $*_A[\I_P#XY5G3?^"DGCB]U&UMV\,>'U6: M58R5$^0"0/\ GI7T7_PP7\&O^A?N_P#P9W'_ ,74EO\ L)_!VUN(IX] NQ)& MP=3_ &E<<$'(_CHO#L&I['X^_P"1%\1_]@VY_P#135^(M?N?J-A#JVGW5E M-M%T>QT^+PSH#QVD$=NC.)]Q"*%!/[SKQ5S_ (>7>.O^A7\/?E/_ /'*^E/^ M&"_@U_T+]W_X,[C_ .+H_P"&"_@U_P!"_=_^#.X_^+JKP#4[7]F_XJZA\:/A M+IGBO5+2UL;RZEGC:&SW>6 DK(,;B3T'K7YG_M7_ /)QGCW_ +"3?^@K7ZM? M#KX=:'\*_"MMX<\.6SVFDV[N\<4DK2D%V+-\S$D\DUYQXQ_8Y^%OCSQ1J/B# M6=%N;C5-0E,UQ*E_,@9L 9"AL#IVJ8R47<#F/^"?/_)N=G_V$KK_ -"%?2E< MK\-?AGX?^$OA=/#_ (:M9+/2TE>98I)FE.YCECN8DUU50]6,****0!1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 445\I?M%_MV:5\*=9N_#7A73XO$7B&U8QW-Q< M.1:6L@ZH=OS2,#U *@=-V00&DWL!]6T5^>D/QD_:U\;6PU'1M$OM/LG^9/L^ MAPHC _W?/1F8>X)^M0:=^W)\8?A;X@AL/B+X:2ZC/,EO?6+:?=%<_>C8 *?^ M^"#ZU?(P/T2HKD?A7\4-#^,'@JQ\3>'YVELKD%7BD&)()1]Z)QV89^A!!&00 M:ZZLP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHKS7]H[XE:G\(/@SXA\7:-!:7.I:=]G\J*^1GA/F7,43;@K*3\KG&".0/I0! MZ517YU:7_P % OC+KD+RZ;X-T'4(D;8TEKI=[*JMC."5G/-6IOV\OC=8Q-<7 M?@+2(;:/YI'DTB^0!>^6,V!]:OD8C]"Z*^2/@'^WYI7Q)\26GASQ;I,7AO4K MQEBM;Z"8O:S2G@(P89C)/ Y8$G&1QGZWJ6FMQA17/^//'FB?#7PM?>(?$-\E MAI=FNYY&Y+$]$4=68G@ 5\1:S^W)\4?BQXFETGX4>$C% IRG^B&\N]G3?)_R MSC7Z@@=-QIJ+8'W[17Y\ZO\ &3]K/X>V'->LHM \5,I:!8G)MKW )81[N58 $[23D X) MZ4 MRMYXI%9U"E]AY!^4GD=:^W*;30!117R]^V!^UEJ_P!UC0-&\-66EW M^IWD#W=V-3CDD6*+=MCVA)$.699.I_AH2N[(#ZAHKEOA?J^N^(/AYX>U3Q-! M:6NNWUG'=75O8HR11,XW! &9B"%(!Y/(/:NII %%>??'+XR:3\"_A_>>)=40 M74BD0V=@)!&]W.?NQAL'' ))P'/^$0_L#[+I MLFH?:?[3^T[MLL4>S;Y*8SYNS;Y*8SYN\=?"#XS>(?".C:5X>N=-T[[/Y4M];3O,WF6\4K;BLRC[SG& M. /K7MG[*/[1R_M!>#+J?4(K6R\3:;+LOK2T#+&48DQR(&9B%(!4Y)^93ZBG MRNUP/7MZ_J,.EZ5:+NFN9SA5YP!@7JV>\?W@H20X^N#].E=7\*?^"@W M@?QYJUMI>O6%SX/O+AE2.:YE6>TWGC:TH"E><"O$&HV2E[RST^XN(549)=(V91C'J!7YK?L M':'I'C+]H@3^(O+OKFWL;C4+1;L[_-NP\?S$'[S!7D?ZKGM7ZA2Q)/&\/AO<^'R]O::FDL<]AJ$R%OLT@8;CQSA MDW*1[CT%?$'AW]O#XO?#NX73?$]G;:P\0P\6LV36UT!VY39S[LIZ5[IX"_X* M1>#-HV?]\U[1KFOZ9X7TN?4]9U&TTG38-OFWE]. ML,,>Y@J[G8@#+$ 9/4@4SP[XBTOQ9HMKJ^BW]OJ>F72;X;JUD#HXZ<$=P<@C MJ""#7C?[U?5.A?\$U_"LFG^;XF M\7:]J.M2_/-<6+10Q%SRW$B2,W)ZE@3UXJG%+=B/L*21(8VDD94C4%F9C@ # MJ2:YSPU\3/!_C2^>R\/^*]#UV]CC,SV^FZC#<2+&" 7*HQ(4%E&>F2/6NE(# M @C(]*_'7]GJP\6>)/'DGA7P=>-IVH^);1M,N+Y25-O:^9'-*^X* MZBOE?X??\$]_!G@;7- UY_$>O7^M:1>P7Z,IABMY)(I%< Q^6S!25Y^?//6N MU_;#^--U\%?A#<7>E2^3K^JS#3["48)A+*6>7!_NJIQ_M,M*RO9 ==\0/VA? MAS\+KQK/Q-XLL=/O5 +V:;YYTSTW1Q*S#/N*H>#/VH_A7\0-1CL-$\9V,U[( MVR."Z62T>1CT"B94W'V&:^9_V2_V/?#_ (_\&P>/OB''<:Y<:N\DUK8S3R(N MP,1YTC*0SLQ!(R<8()SGC9_:K_8O\%Z/\,=6\5>"=-;0M3T:+[5/;1SR20W, M"_ZS(=FVLJY8$<':01SD5:-["/M.N4U#XL>"-(UI]&O_ !EX?LM7218FT^XU M2".X#MC:IC+[LG(P,(_L%_&*_P#B;\*[K2M8N7O-6\.S):FXE?=)+;NI M,18GDD;77/<(.^:\7_X*0?"PZ7XAT+X@V,12._']GW\B#&)D&87)]60,O_;( M4E'6S&?H#17F7[-_Q0'Q>^#?AWQ#)('U!H?LU^!VN8_E<_\ L!Q[.*S?VKO MBE_PJ7X(Z_JD$_D:K>)_9VGD'#>?*"-R^ZH'?_@%3;6P';:+\5/!7B75ETK2 M/%^@ZKJC;L65EJ<$TQV@EOD5BW !SQQBNIKXB_X)O_"/['I.L_$2^AQ+>%M- MTTNO_+)2#-(/JX"?]LV'>OMVG)6=@"BBBI *\)_;C_Y-;\:_]N7_ *76]>[5 MX3^W'_R:WXU_[7>H^"] N[\$7\^GV\MQDY/F-&I;GZDU^;O[.W MA?0_VC_C$-?^)GCBWN-9EN5E71)U9)M19,;8]Q41B/ \M"6(!&%ZU^G@ 4 M 8'I2GT0'YS_ /!0KXF7OB[XIZ=X T]VDL]'2-I+>,_ZV\F (SZX1D ]"[5] MJ? ?X.:5\$?AWIV@6$$?VWRUDU&\51ONK@CYV)ZD Y"CLH K\\[]AXL_;R=+ MKE/^$X$+*P!W+#=! I]B(P/QK]4:):)(!" P((R/2OA/XA?L0^-K/XY7/B_X M>-HUAI,>H1:G8P37+P-#(-KNH54("^8&P!V(&*^[:*E-H84445(!1110!^;/ M_!0SX>OX-^,.F^+K!3;PZ];B1I(^"MW!M5B,=#L,1]SN-?>GP<\>1_$[X6^& M?%"$%]1LDDF"XPLP^65>/217'X5YA^W'\-Q\0/@)JUS#$)-0T!AJT)"Y;8@( MF'T\MF;ZH/2O,_\ @FO\0_[3\%>(O!MQ)F;2[E;ZV4]?)E&' ]E=,_\ ;3\M M-X^@C[-K\QI8_P#AJC]MED)^UZ"NHX/=/L%K_(2!/SEK[E_:?^(W_"K?@?XH MUJ*3R[][?[%9$=?/F^16'NH)?_@%?.__ 36^&OV31/$GCJYCQ+>2#2[,D<^ M6F'E8>Q8H/\ MF:(Z)L#[S7FJZE)&FJ"V.7)[$JS>VT=V%0E=V&<1 M=7&H?MX?M();1F:'X<>'3DD90_9]W+>TL[+@=U4?[!SC?\$U_P#DNFN_]BY/ M_P"E5K7VE^S;\#[/X$?#6ST50DNL7&+G5+I>?-G(&5!_N(/E7Z9ZDU\6_P#! M-?\ Y+IKO_8N3_\ I5:UK>Z:0C])Z**\9_:X^*W_ J7X(ZY?V\OE:MJ"_V; M88(#"64$%Q_NH';ZJ/6LEKH,^/\ 5[C_ (:V_;6@MHS]K\,:?%O#_CF MUBS-ILIT^\91R89#NC)]E<,/K+6M_>Y1'V?'(DT:R1LKQL RLIR"#T(-/KP3 M]B?XI'XF? O2H[F8RZKH1_LJZ+,2S! /*]UD]-!A1112 @O+ MR#3K.>[NIH[:U@C:66:5@J1HHRS,3P "2?:OSXNKC4/V\/VD$MHS-#\./#I MR2,H?L^[EO:6=EP.ZJ/]@Y[?]NKXZ7FJ7EK\'O![->:KJ4D::H+8YI-:+ MW5<1\6_\$U_^2Z:[_P!BY/\ ^E5K7Z3U^;'_ 37_P"2Z:[_ -BY/_Z56M?I M/1/<$?F5^T)HUGXC_;]&DZA"+C3[_6]$M;B%NCQO#:*ZGZ@D5B6TNN_L0_M+ MLK^;<:5&^UNWV_3)&X/^\-OT#QXZ5U/QH_Y2+Z?_ -C'H'_HNSKZ>_;4^ ?_ M N+X:OJ>EV_F>*-!5[FT" ;[B'&98??(&Y1_>7'\1J[VLF![YHNL67B'2++ M5-.N$N["]A2XMYXSE9(V 96!]""*^6_^"E'_ "0O0O\ L8X/_26ZKCO^">/Q MY%U:3_#+6+C]] 'NMⅅ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end GRAPHIC 6 alr_3.jpg GRAPHIC begin 644 alr_3.jpg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�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end EX-101.INS 7 alrt-20161231.xml XBRL INSTANCE FILE 0001087022 2016-12-31 0001087022 2015-12-31 0001087022 2016-01-01 2016-12-31 0001087022 2015-01-01 2015-12-31 0001087022 us-gaap:CommonStockMember 2014-12-31 0001087022 us-gaap:AdditionalPaidInCapitalMember 2015-12-31 0001087022 us-gaap:AdditionalPaidInCapitalMember 2015-01-01 2015-12-31 0001087022 us-gaap:RetainedEarningsMember 2015-01-01 2015-12-31 0001087022 us-gaap:CommonStockMember 2015-12-31 0001087022 us-gaap:RetainedEarningsMember 2015-12-31 0001087022 us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0001087022 us-gaap:AdditionalPaidInCapitalMember 2016-01-01 2016-12-31 0001087022 us-gaap:RetainedEarningsMember 2016-01-01 2016-12-31 0001087022 us-gaap:CommonStockMember 2016-12-31 0001087022 us-gaap:RetainedEarningsMember 2016-12-31 0001087022 2014-12-31 0001087022 2018-02-02 0001087022 2036-12-31 0001087022 2021-12-31 0001087022 2022-12-31 0001087022 2023-12-31 0001087022 2024-12-31 0001087022 2025-12-31 0001087022 2026-12-31 0001087022 2027-12-31 0001087022 2028-12-31 0001087022 2029-12-31 0001087022 2030-12-31 0001087022 2031-12-31 0001087022 2032-12-31 0001087022 2033-12-31 0001087022 2034-12-31 0001087022 2035-12-31 0001087022 2020-12-31 0001087022 2017-06-30 0001087022 us-gaap:AdditionalPaidInCapitalMember 2014-12-31 0001087022 us-gaap:RetainedEarningsMember 2014-12-31 0001087022 alrt:ChairmanAndCEOMember 2016-12-31 0001087022 alrt:ChairmanAndCEOMember 2015-12-31 0001087022 alrt:WifeOfChairmanMember 2016-12-31 0001087022 alrt:WifeOfChairmanMember 2015-12-31 0001087022 alrt:ChairmanAndCEOMember 2016-01-01 2016-12-31 0001087022 alrt:WifeOfChairmanMember 2016-01-01 2016-12-31 0001087022 alrt:ChairmanAndCEOMember 2015-01-01 2015-12-31 0001087022 alrt:WifeOfChairmanMember 2015-01-01 2015-12-31 0001087022 2019-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure ALR Technologies Inc. 10-K --12-31 false 0001087022 No No Smaller Reporting Company No 2016-12-31 2016 FY <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0"><b>1.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b>Basis of presentation, nature of operations and going concern </b></p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">ALR Technologies Inc. (the &#8220;Company&#8221;) was incorporated under the laws of the state of Nevada on March 24, 1987. The Company has developed a compliance monitoring system that will allow for health care professionals to remotely monitor patient health conditions and provide patient health management. On October 17, 2011 the Company announced that it had received Section 510(k) clearance from the United States Food and Drug Administration for its Health-e-Connect System. The Company is currently seeking pilot programs to deploy its product.</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">These consolidated financial statements have been prepared in accordance with Generally Accepted Accounting Principles in the United States of America (&#8220;U.S. GAAP&#8221;) in U.S dollars and on a going-concern basis, which presumes the realization of assets and the discharge of liabilities and commitments in the normal course of operations for the foreseeable future. Several adverse conditions cast substantial doubt on the validity of this assumption. The Company has incurred significant losses over the past several fiscal years (2016 - $10,093,733; 2015 - $6,298,813), is currently unable to self-finance its operations, has a working capital deficit of $23,230,725 (2015 - $20,621,972), accumulated deficit of $71,686,050 (2015 - $61,592,317), limited resources, no source of operating cash flow, and no assurance that sufficient funding will be available to conduct continued product development activities. If the Company is able to finance its required product development activities, there is no assurance the Company&#8217;s current projects will be commercially viable or profitable. The Company has debts comprised of accounts payable, interest, lines of credit and promissory notes payable totaling $23,234,762 currently due, due on demand or considered delinquent. There is no assurance that the Company will not face additional legal action from creditors regarding delinquent accounts payable, payroll payable, promissory notes and interest payable. Any one or a combination of these above conditions could result in the failure of the business and cause the Company to cease operations.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">The Company&#8217;s ability to continue as a going-concern is dependent upon the continued financial support of its creditors and its ability to obtain financing to fund working capital and overhead requirements, fund the development of the Company&#8217;s product line and ultimately, the Company&#8217;s ability to achieve profitable operations and repay overdue obligations. Management has obtained short-term financing from related parties through lines of credit facilities with available borrowing in principal amount up to $10,500,000. As of December 31, 2016 the total principal balance outstanding was $9,628,210. The resolution of whether the Company is able to continue as a going concern is dependent upon the realization of management&#8217;s plans. If additional financing is required, the Company plans to raise needed capital through the exercise of share options and by future common share private placements. There can be no assurance that the Company will be able to raise any additional debt or equity capital from the sources described above, or that the lenders in the line of credit arrangements will maintain the availability of borrowing from the line. If management is unsuccessful in obtaining short-term financing or achieving long-term profitable operations, the Company will be required to cease operations.</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">All of the Company&#8217;s debt is either due on demand or is in default, while continuing to accrue interest at its stated rate. The Company will seek to obtain creditors&#8217; consents to delay repayment of the outstanding promissory notes payable and related interest thereto, until it is able to replace this financing with funds generated by operations, recapitalization with replacement debt or from equity financings through private placements. While some of the Company&#8217;s creditors have agreed to extend repayment deadlines in the past, there is no assurance that they will continue to do so in the future. In the past, creditors have successfully commenced legal action against the Company to recover debts outstanding. In those instances, the Company was able to obtain financing from related parties to cover the verdict or settlement; however, there is no assurance that the Company would be able to obtain the same financing in the future. If the Company is unsuccessful in obtaining financing to cover any potential verdicts or settlements, the Company will be required to cease operations.</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">The Company&#8217;s activities will necessitate significant uses of working capital beyond 2016. Additionally, the Company&#8217;s capital requirements will depend on many factors, including the success of the Company&#8217;s continued product development and distribution efforts. The Company plans to continue financing its operations with the lines of credit it has available.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">While the Company strongly believes that&#160;its capital resources will be sufficient&#160;in the near term, there is no assurance that the Company&#8217;s activities will generate sufficient revenues to sustain its operations without additional capital or if additional capital is needed, that such funds, if available, will be obtainable on terms satisfactory to the Company.</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>2.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b>Significant accounting policies</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">a)</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Principles of consolidation</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">These consolidated financial statements include the accounts of the Company and its integrated wholly-owned subsidiary, Canada ALRTech Health Systems Inc., which was incorporated on April 15, 2008 in Canada. All significant inter-company balances and transactions have been eliminated.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 238.5pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 23px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">b)</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Stock-based compensation</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify">The Company follows the fair value method of accounting for stock-based compensation. The Company estimates the fair value of share-based payment awards on the date of grant using an option pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service period in the Company&#8217;s consolidated financial statements. The Company estimates the fair value of the stock options using the Black-Scholes Option Pricing Model. The Black-Scholes Option Pricing Model requires the input of highly subjective assumptions, including the option&#8217;s expected life and the price volatility of the underlying stock.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">c)</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Income taxes</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Income taxes are accounted for under the asset and liability method. Deferred income tax assets and liabilities are recognized for the differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis, and operating loss carry-forwards that are available to be carried forward to future years for tax purposes.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred income tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. When it is not considered to be more likely than not that a deferred income tax asset will be realized, a valuation allowance is provided for the excess.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">The Company follows the accounting requirements associated with uncertainty in income taxes using the provisions of Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC 740, Income Taxes. Using that guidance, tax positions initially need to be recognized in the financial statements when it is more-likely-than-not the positions will be sustained upon examination by the tax authorities. It also provides guidance for derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. As of December 31, 2016, the Company has no uncertain tax positions that qualify for either recognition or disclosure in the financial statements.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 25px">&#160;</td> <td style="width: 22px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">d)</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Use of estimates</font></td></tr> </table> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, the measurement of stock-based compensation, the fair value of financial instruments and the reported amounts of revenues and expenses during the reporting period. Management believes the estimates are reasonable; however, actual results could differ from those estimates.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">e)</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Loss per share</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Basic loss per common share is calculated by dividing net loss by the weighted average number of common shares outstanding during the year. Diluted loss per common share is calculated by dividing the net loss by the sum of the weighted average number of common shares outstanding and the dilutive common equivalent shares outstanding during the year. Common equivalent shares consist of the shares issuable upon exercise of stock options and warrants calculated using the treasury stock method. Common equivalent shares are not included in the calculation of the weighted average number of shares outstanding for diluted loss per common shares when the effect would be anti-dilutive.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">f)</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Comprehensive income</font></td></tr> </table> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Comprehensive income is the overall change in the net assets of the Company for a period, other than changes attributable to transactions with stockholders. It is made up of net income and other comprehensive income. Other comprehensive income consists of net income and other gains and losses affecting stockholders' equity that under generally accepted accounting principles are excluded from net income. The Company has no items of other comprehensive income (loss) in any period presented. Therefore, as presented in the Company's consolidated statements of loss, net loss equals comprehensive loss.</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">g)</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Fair value of financial instruments</font></td></tr> </table> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 37.1pt; text-align: justify">The Company&#8217;s financial instruments include cash, accounts payable, promissory notes payable and lines of credit. The fair values of these financial instruments approximate their carrying values due to the relatively short periods to maturity of these instruments. For fair value measurement, U.S. GAAP establishes a three-tier hierarchy which prioritizes the inputs used in the valuation methodologies in measuring fair value:</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Level 1 &#8212; observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Level 2 &#8212; include other inputs that are directly or indirectly observable in the marketplace.</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Level 3 &#8212; unobservable inputs which are supported by little or no market activity.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.2pt">h)&#160;&#160;&#160;&#160;&#160; Recently adopted and issued accounting pronouncements</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Adopted</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 49.5pt; text-align: justify">In August 2014, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2014-15, &#8220;Presentation of Financial Statements &#8211; Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entitiy&#8217;s Ability to Continue as a Going Concern&#8221; (&#8220;ASU 2014-15&#8221;). ASU 2014-15 requires management to evaluate whether there is substantial doubt about an entity&#8217;s ability to continue as a going concern for each annual and interim reporting period. If substantial doubt exists, additional disclosure is required. This new standard was effective for the Company for annual and interim periods beginning after December 15, 2016. Adoption of this pronouncement did not have a material impact on the Company&#8217;s consolidated financial statements.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 49.5pt; text-align: justify">In March 2016, the FASB issued ASU No. 2016-09,&#160;<i>Compensation&#160;&#8212;&#160;Stock Compensation: Improvements to Employee Share-Based Payment Accounting</i>&#160;(&#8220;ASU 2016-09&#8221;). The new guidance will change how companies account for certain aspects of share-based payments to employees. Under existing accounting guidance, tax benefits and certain tax deficiencies arising from the vesting of share-based payments are recorded in additional paid-in-capital. The new guidance will require such benefits or deficiencies to be recognized as income tax benefits or expenses in the statement of operations. Companies are required to apply the new guidance prospectively. This new standard was effective for the Company for annual and interim periods beginning after December 15, 2016. Adoption of this pronouncement did not have a material impact on the Company&#8217;s consolidated financial statements.</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">ii.</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Issued</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In January 2016, the FASB issued ASU 2016-01, Financial Instruments - Overall: Recognition and Measurement of Financial Assets and Financial Liabilities. This new standard provides guidance on how entities measure certain equity investments and present changes in the fair value. This standard requires that entities measure certain equity investments that do not result in consolidation and are not accounted for under the equity method at fair value and recognize any changes in fair value in net income. ASU 2016-01 is effective for fiscal years beginning after December 31, 2017.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In June 2016, the FASB issued Accounting Standards Update (&#34;ASU&#34;) No. 2016-13, Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The new standard requires financial assets measured at amortized cost be presented at the net amount expected to be collected, through an allowance for credit losses that is deducted from the amortized cost basis. The standard will be effective for the Company beginning January 1, 2020, with early application permitted. This standard is not expected to have a material impact on the Company&#8217;s financial position, results of operations or statement of cash flows upon adoption.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In August 2016, the FASB issued Accounting Standards Update (&#34;ASU&#34;) No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. The new standard will make eight targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. The standard will be effective for the Company beginning January 1, 2018, with early application permitted. The standard will require adoption on a retrospective basis unless it is impracticable to apply, in which case we would be required to apply the amendments prospectively as of the earliest date practicable.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">The Company has implemented all new accounting pronouncements that are in effect and may impact its financial statements. The Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or statement of operations.</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><b>3.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b>Promissory notes and interest payable</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Promissory notes payable to related parties:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: 0.25in">A summary of the promissory notes payable to related parties is as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: 0.25in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="3" style="border-top: black 4.5pt double"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><b>Promissory Notes Payable to Related Parties</b></p></td> <td style="border-top: black 4.5pt double; text-align: center; line-height: 107%">&#160;</td> <td rowspan="2" style="border-top: black 4.5pt double; border-bottom: black 1pt solid"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">December 31,</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">2016</p></td> <td style="border-top: black 4.5pt double; text-align: center; line-height: 107%">&#160;</td> <td rowspan="2" style="border-top: black 4.5pt double; border-bottom: black 1pt solid"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">December 31,</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">2015</p></td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td colspan="3" style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Promissory notes payable to relatives of directors collateralized by a general security agreement on all the assets of the Company, due on demand:</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 65%; line-height: 107%">&#160;</td> <td style="width: 1%; text-align: center; line-height: 107%">&#160;</td> <td style="width: 16%; text-align: right; line-height: 107%">&#160;</td> <td style="width: 1%; text-align: center; line-height: 107%">&#160;</td> <td style="width: 13%; text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">i.</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest at 1% per month</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">580,619</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">580,619</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">ii.</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest at 1.25% per month</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">51,347</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">51,347</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">iii.</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest at the U.S. bank prime rate plus 1%</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">100,000</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">100,000</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">iv.</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest at 0.5% per month</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">695,000</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">695,00</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td colspan="3" style="line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td colspan="3" style="border-bottom: black 1pt solid; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Promissory notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, due on demand</font></td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,465,000</font></td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,465,000</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td colspan="3" style="border-bottom: black 4.5pt double; padding-top: 12pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Total Promissory Notes Payable to Related Parties</b></font></td> <td style="border-bottom: black 4.5pt double; padding-top: 12pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 4.5pt double; padding-top: 12pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,891,966</font></td> <td style="border-bottom: black 4.5pt double; padding-top: 12pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 4.5pt double; padding-top: 12pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,891,966</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Promissory notes payable to unrelated parties</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: 0.25in">A summary of the promissory notes payable to unrelated parties is as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="3" style="border-top: black 4.5pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Promissory Notes Payable to Unrelated Parties</b></font></td> <td style="border-top: black 4.5pt double; text-align: center; line-height: 107%">&#160;</td> <td style="border-top: black 4.5pt double"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right">December 31,</p></td> <td style="border-top: black 4.5pt double; text-align: right; line-height: 107%">&#160;</td> <td style="border-top: black 4.5pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">December 31,</font></td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td colspan="3" style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Unsecured promissory notes payable to unrelated lenders:</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; width: 2%; line-height: 107%">&#160;</td> <td style="vertical-align: top; width: 2%; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; width: 68%; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; width: 1%; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; width: 13%; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; width: 1%; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; width: 13%; text-align: right; line-height: 107%">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: top; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">i.</font></td> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest at 1% per month, repayable on March 31, 2009, due on demand</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">450,000</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">450,000</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: top; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: top; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">ii.</font></td> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest at 1% per month, with $50,000 repayable on December 31, 2004, $75,000 repayable on August 18, 2007, $75,000 repayable on November 19, 2007 and the balance due on demand. All are due on demand, accruing interest at the same rate.</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">887,455</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">887,455</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: top; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: top; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">iii.</font></td> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest at 0.625% per month, with $50,000 repayable on October 5, 2004, $40,000 repayable on December 31, 2004, and $60,000 repayable on July 28, 2006, all due on demand</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">150,000</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">150,000</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: top; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: top; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">iv.</font></td> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Non-interest-bearing, repayable on July 17, 2005, due on demand</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">270,912</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">270,912</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: top; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: top; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">v.</font></td> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Non-interest-bearing loan repayable at $25,000 per month beginning October 2009, none repaid to date</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">310,986</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">310,986</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: top; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: top; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">vi.</font></td> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest at 0.667% per month, with $125,000 due January 15, 2011</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">125,000</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">125,000</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td colspan="3" style="border-bottom: black 1pt solid; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Promissory notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month</font></td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">200,000</font></td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">230,000</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td colspan="3" style="border-bottom: black 4.5pt double; padding-top: 12pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Total Promissory Notes Payable to Unrelated Parties</b></font></td> <td style="border-bottom: black 4.5pt double; padding-top: 12pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 4.5pt double; padding-top: 12pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,394,353</font></td> <td style="border-bottom: black 4.5pt double; padding-top: 12pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 4.5pt double; padding-top: 12pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,394,353</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interest payable</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in">A summary of the interest payable activity is as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 71%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Balance, December 31, 2014</font></td> <td style="width: 10%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 17%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,620,172</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-indent: 0.25in; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest incurred on promissory notes payable</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">515,571</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-indent: 0.25in; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Balance, December 31, 2015</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3,135,743</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-indent: 0.25in; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest incurred on promissory notes payable</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">494,171</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-indent: 0.25in; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Balance, December 31, 2016</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3,629,913</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: center; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">December 31,</font></td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">December 31,</font></td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Related parties (relatives of the Chairman)</font></td> <td style="width: 8%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,956,403</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 8%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,667,977</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Non-related parties</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,673,511</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,467,766</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3,629,913</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3,135,743</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">The payment terms, security and any interest payable are based on the underlying promissory notes payable that the Company has outstanding.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interest expense</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">During the year ended December 31, 2016, the Company incurred interest expense of $9,064,906 (2015: $4,795,168) substantially as follows:</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px">&#160;</td> <td style="width: 24px; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$494,170 (2015: $515,571), including interest incurred on promissory notes (note 3(a)) and other payables;</font></td></tr> </table> <p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px">&#160;</td> <td style="width: 24px; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$1,102,242 (2015: $944,010) incurred on lines of credit payable as shown in note 4;</font></td></tr> </table> <p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px">&#160;</td> <td style="width: 24px; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$148,426 (2015: $148,620) incurred from the calculation of imputed interest on accounts payable outstanding for longer than one year, advances payable and promissory notes payable, which had no stated interest rate; and</font></td></tr> </table> <p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px">&#160;</td> <td style="width: 24px; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$7,318,539 (2015: $3,184,459) incurred on stock options granted to creditors (note 6(a)).</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><b>4. &#160;&#160;&#160;&#160;&#160;&#160;&#160;Lines of credit</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">As of December 31, 2016, the Company has two lines of credit as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Creditor</font></td> <td style="width: 8%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest Rate</font></td> <td style="width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Borrowing Limit</font></td> <td style="width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Repayment Terms</font></td> <td style="width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Principal Borrowed</font></td> <td style="vertical-align: top; width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Accrued Interest</font></td> <td style="vertical-align: top; width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Total</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Outstanding</p></td> <td style="width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Security</font></td> <td style="width: 22%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Purpose</font></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Chairman and CEO</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1% per Month</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$8,500,000</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Due on Demand</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;7,628,219</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$ &#160;2,490,958</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$10,119,177</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">General Security over Assets</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">General Corporate Requirements</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Wife of Chairman</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1% per Month</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$2,000,000</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Due on Demand</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;2,000,000</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$ &#160;1,256,385</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$ 3,256,385</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">General Security over Assets</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">General Corporate Requirements</font></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$10,500,000</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$ &#160;&#160;9,628,219</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$ &#160;3,747,343</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$13,375,562</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">On July 1, 2016, the Company and the Chief Executive Officer of the Company agreed to amend the existing credit agreement to increase the borrowing limit on the line of credit provided to the Company from $7,000,000 to $8,500,000.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">As of December 31, 2015, the Company has two lines of credit as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Creditor</font></td> <td style="width: 8%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest Rate</font></td> <td style="width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Borrowing Limit</font></td> <td style="width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Repayment Terms</font></td> <td style="width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Principal Borrowed</font></td> <td style="vertical-align: top; width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Accrued Interest</font></td> <td style="vertical-align: top; width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Total</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Outstanding</p></td> <td style="width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Security</font></td> <td style="width: 22%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Purpose</font></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Chairman and CEO</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1% per Month</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$7,000,000</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Due on Demand</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;6,626,993</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;1,628,716</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$ 8,255,708</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">General Security over Assets</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">General Corporate Requirements</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Wife of Chairman</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1% per Month</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$2,000,000</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Due on Demand</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;2,000,000</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$ &#160;1,016,385</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$ 3,016,385</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">General Security over Assets</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">General Corporate Requirements</font></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$9,000,000</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$ &#160;&#160;8,626,993</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$ &#160;2,645,101</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$11,272,093</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">On May 29, 2015, the Company and the Chief Executive Officer of the Company agreed to amend the existing credit agreement to increase the borrowing limit on the line of credit provided to the Company from $5,500,000 to $7,000,000.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><b>5.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b>Capital stock</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 23px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">a)</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">Authorized share capital</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">i.</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">Common Stock</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 1in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 53.45pt; text-indent: 18.55pt; background-color: white"><b>During the year ended December 31, 2016:</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 1in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">On December 21, 2016, the Company&#8217;s shareholders holding a majority of the issued capital stock consented in writing to increase the authorized shares of common stock of the Company from two billion shares (2,000,000,000) to ten billion shares (10,000,000,000) shares. The increase in the authorized shares of common stock of the Company is pending approval from the Securities and Exchange Commission (&#8220;SEC&#8221;).</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 71.45pt; text-indent: 0.55pt; background-color: white"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 71.45pt; text-indent: 0.55pt; background-color: white"><b>During the year ended December 31, 2015:</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 1in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><font style="background-color: white">On June 25, 2015, the Company&#8217;s articles of incorporation were amended to increase the authorized shares of common stock from 500,000,000 to 2,000,000,000 shares with a par value of $0.001 per share. </font></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">ii.</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">Preferred Stock</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 1in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 1in">500,000,000 shares of preferred stock with a par value of $0.001 per share.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 1in">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 23px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">b)</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">Issued share capital</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; background-color: white"><b>During the years ended December 31, 2016 and December 31, 2015:</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; background-color: white"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; background-color: white">There was no activity during the period.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; background-color: white"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><b>6. &#160;&#160;&#160;&#160;&#160;&#160;&#160;Additional paid-in capital </b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 23px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">a)</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">Stock options</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">A summary of stock option activity is as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-top: black 2.25pt double; line-height: 107%">&#160;</td> <td colspan="3" style="border-top: black 2.25pt double; text-align: center; line-height: 107%">&#160;</td> <td colspan="3" style="border-top: black 2.25pt double; text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Year Ended</font></td> <td colspan="3" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Year Ended</font></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2016</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2015</font></td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Weighted Average</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Weighted Average</font></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Number of Options</font></td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Exercise</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Price</p></td> <td style="border-bottom: black 1pt solid"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Number of</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Options</p></td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Exercise</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Price</p></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 42%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, beginning of period</font></td> <td style="width: 16%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">579,000,200</font></td> <td style="width: 5%; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; padding-right: 3.75pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.015</font></td> <td style="width: 16%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">245,700,100</font></td> <td style="width: 3%; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; padding-right: 3.75pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4,390,001,300</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="padding-right: 3.75pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.002</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">334,500,100</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="padding-right: 3.75pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.015</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Cancelled</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(6,700,000)</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="padding-right: 1.15pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(0.030)</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="padding-right: 3.75pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Expired</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(1,200,000)</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(0.250)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="border-bottom: black 1pt solid; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; padding-right: 3.75pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; padding-right: 3.75pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 4.5pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, end of period</font></td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4,962,301,500</font></td> <td style="border-bottom: black 4.5pt double; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 3.75pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.004</font></td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">579,000,200</font></td> <td style="border-bottom: black 4.5pt double; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 3.75pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.015</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 4.5pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Exercisable, end of period</font></td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4,960,101,500</font></td> <td style="border-bottom: black 4.5pt double; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 2.85pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.004</font></td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">575,650,200</font></td> <td style="border-bottom: black 4.5pt double; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 2.85pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.015</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: 17.45pt"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: 17.45pt"><b>During the year ended December 31, 2016:</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify">On July 1, 2016, the Company and the Chief Executive Officer of the Company agreed to amend the existing credit agreement to increase the borrowing limit on the line of credit provided to the Company from $7,000,000 to $8,500,000 (Note 4). In exchange for Mr. Chan making available the additional loan of $1,500,000 to the Company, the Company:</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 95px">&#160;</td> <td style="width: 24px; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">reduced the exercise price of the 560,000,200 shares of common stock under option to Mr. Chan and his spouse from $0.015 to $0.002;</font></td></tr> </table> <p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 95px">&#160;</td> <td style="width: 24px; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">granted Mr. Chan and his spouse the right and option to purchase, an additional 4,390,001,300 shares of common stock at a price of $0.002 per share for a term of five years</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 1.35pt; text-align: center">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 89.45pt">The interest expense recognized related to the option grant was $7,318,539.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 1.35pt; text-align: center">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 35.1pt; text-align: justify">The Company recorded a further $18,014 in compensation expense related to vesting of stock options granted in previous years.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 1.35pt; text-align: center">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: 17.45pt"><b>During the year ended December 31, 2015:</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; background-color: white"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify">On January 30, 2015, the Company granted options to acquire 4,500,000 shares of common stock at a price of $0.03 per share to 14 individuals. The fair value of the options granted was $42,858. During the year the Company recognized fair value of $10,964 and will recognize the balance over the vesting period for the unvested options.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; background-color: white"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; background-color: white">On April 22, 2015, our Board of Directors approved the modification of the exercise price to acquire 12,400,000 shares of common stock of the Company from $0.03 per share to $0.015 per share held by 20 individuals. There was no increase in the fair value of the options from this modification. None of these option agreements have been executed.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify">On May 29, 2015, the Company and the Chief Executive Officer of the Company agreed to amend the existing credit agreement to increase the borrowing limit on the line of credit provided to the Company from $5,500,000 to $7,000,000 (Note 4). In exchange for Mr. Chan making available the additional loan of $1,500,000 to the Company, the Company:</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 95px">&#160;</td> <td style="width: 24px; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">reduced the exercise price of the 230,000,100 shares of common stock under option to Mr. Chan and his spouse from $0.03 to $0.015;</font></td></tr> </table> <p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 95px">&#160;</td> <td style="width: 24px; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">extended the expiry date of the 230,000,100 shares of common stock under option to Mr. Chan to be five years from the date of execution of the amended credit agreement;</font></td></tr> </table> <p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 95px">&#160;</td> <td style="width: 24px; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">granted Mr. Chan the right and option to purchase, an additional 329,999,967 shares of common stock at a price of $0.015 per share for a term of five years from the date of execution of the amended credit agreement.</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -0.35pt">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 89.8pt; text-align: justify; text-indent: -0.35pt">The interest expense recognized related to the option grant was $3,184,459.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 35.1pt">The Company recorded a further $27,569 in compensation expense related to vesting of stock options granted in previous years.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.25in">The options outstanding at December 31, 2016 and 2015 were as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: bottom; border-top: black 2.25pt double; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; border-top: black 2.25pt double; text-align: center; line-height: 107%">&#160;</td> <td colspan="5" style="vertical-align: bottom; border-top: black 2.25pt double; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; border-top: black 2.25pt double; text-align: center; line-height: 107%">&#160;</td> <td colspan="3" style="vertical-align: bottom; border-top: black 2.25pt double; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; border-top: black 2.25pt double; text-align: center; line-height: 107%">&#160;</td></tr> <tr> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td colspan="5" style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2016</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%">&#160;</td> <td colspan="4" style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2015</font></td></tr> <tr> <td style="vertical-align: bottom; width: 32%; border-bottom: black 1pt solid; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Expiry Date</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; width: 14%; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Options</font></td> <td style="vertical-align: bottom; width: 1%; border-top: black 1pt solid; border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Exercise Price</font></td> <td style="vertical-align: bottom; width: 1%; border-top: black 1pt solid; border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; width: 8%; border-top: black 1pt solid; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Intrinsic Value</font></td> <td style="vertical-align: top; width: 1%; border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; width: 11%; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Options</font></td> <td style="vertical-align: bottom; width: 1%; border-top: black 1pt solid; border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Exercise Price</font></td> <td style="vertical-align: top; width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Intrinsic Value</font></td></tr> <tr> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">May 4, 2016</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.050</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">May 23, 2016</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">100,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">May 27, 2017</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">400,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">400,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">May 31, 2017</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">500,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.050</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">500,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.050</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">August 16, 2017</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">250,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">250,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">December 28, 2017</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">January 28, 2018</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,500,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,300,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">March 26, 2018</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">500,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">500,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">April 9, 2018</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">October 1, 2018</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">500,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">February 7, 2019</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">700,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">April 18,2019</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,000,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">May 21, 2019</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">500,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">500,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">July 25, 2019</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">August 1, 2019</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,250,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,250,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">August 26, 2019</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,500,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,500,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">January 30, 2020</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,900,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4,500,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">May 29, 2020</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">560,000,200</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.002</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">560,000,200</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.015</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; border-bottom: black 1pt solid; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">July 21, 2021</font></td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4,390,001,300</font></td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.002</font></td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: right; line-height: 107%">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4,962,301,500</font></td> <td style="vertical-align: top; border-bottom: black 2.25pt double; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.002</font></td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; border-bottom: black 2.25pt double; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">579,000,200</font></td> <td style="vertical-align: top; border-bottom: black 2.25pt double; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.015</font></td> <td style="vertical-align: top; border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td colspan="3" style="border-bottom: black 4.5pt double"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Weighted Average Remaining</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Contractual Life</p></td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4.81</font></td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4.37</font></td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">The Company uses the fair value method for determining stock-based compensation for all options granted during the fiscal periods. The fair value was determined using the Black-Scholes Option Pricing Model based on the following weighted average assumptions:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right">December 31,</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right">2016</p></td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right">December 31,</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right">2015</p></td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Risk-free interest rate</font></td> <td style="width: 8%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 11%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1.68</font></td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td style="width: 8%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 11%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1.68</font></td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Expected life</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Expected dividends</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Expected volatility</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">210</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">194</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Forfeiture rate</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in">The weighted average fair value for the options granted during 2016 was $0.002 (2015: $0.010).</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.55pt">The fair value of the stock options granted was allocated as follows:</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: center; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2016</font></td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right">December 31,</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right">2015</p></td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest expense</font></td> <td style="width: 8%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">7,318,539</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 8%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3,184,459</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Product development expense</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">14,267</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">14,374</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Professional expense</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">577</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3,806</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Selling, general and administration expenses:</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3,170</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">20,355</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">7,336,553</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3,222,992</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><b>7.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b>Related party transactions and balances</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">a)</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">Related party transactions</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; background-color: white"> <td style="width: 69%; border-top: black 4.5pt double; padding-left: 35.45pt; text-indent: -35.45pt; line-height: 107%">&#160;</td> <td style="width: 1%; border-top: black 4.5pt double; text-align: center; line-height: 107%">&#160;</td> <td style="width: 1%; border-top: black 4.5pt double; text-align: center; line-height: 107%">&#160;</td> <td style="width: 15%; border-top: black 4.5pt double; text-align: center; line-height: 107%">&#160;</td> <td style="width: 1%; border-top: black 4.5pt double; text-align: center; line-height: 107%">&#160;</td> <td style="width: 13%; border-top: black 4.5pt double; text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="border-bottom: black 1pt solid; padding-left: 35.45pt; text-indent: -35.45pt; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Year End December 31, 2016</font></td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Year End December 31, 2015</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="padding-left: 35.45pt; text-indent: -35.45pt; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Related party transaction included within interest expense:</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="padding-left: 14.2pt; text-indent: -7.1pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest expenses on promissory notes issued to relatives of the Chairman &#38; Chief Executive Officer of the Company</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">288,426</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">309,826</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; padding-left: 14.05pt; text-indent: -6.95pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest expense on lines of credit payable to the Chairman &#38; Chief Executive Officer of the Company and his spouse</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,102,242</font></td> <td style="vertical-align: top"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">$</p></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">944,010</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; border-bottom: black 1pt solid; padding-left: 14.05pt; text-indent: -6.95pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Stock based compensation related to stock options granted to the Chairman &#38; Chief Executive Officer for increasing the borrowing limit on the line of credit available to the Company</font></td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">7,318,539</font></td> <td style="vertical-align: top; border-bottom: black 1pt solid"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">$</p></td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3,184,459</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; padding-left: 14.05pt; text-indent: -6.95pt; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Related party transactions including within selling, general and administration expenses</b>:</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="padding-left: 14.05pt; text-indent: -6.95pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Consulting fees to the Chairman &#38; Chief Executive Officer of the Company accrued on the line of credit available to the Company</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">189,600</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">189,600</font></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="border-bottom: black 4.5pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Consulting fees paid to the President of the Company</font></td> <td style="border-bottom: black 4.5pt double; text-align: center; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">15,500</font></td> <td style="border-bottom: black 4.5pt double; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">186,000</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Interest on promissory notes payable to related parties, management compensation and compensation paid to a relative of a director have been recorded at the exchange amount, which is the amount agreed to by the parties. Options granted to related parties have been recorded at their estimated fair value.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">b)</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Related party balances</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Included in accounts payable is $nil (2015: $15,529) due to a Director of the Company.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><b>8.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b>Commitments and contingencies</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 25px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">a)</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">Contingencies</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 36.45pt"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 37.8pt; text-align: justify">The Company has had three judgments against it relating to overdue promissory notes and accrued interest and a fourth creditor has demanded repayment of an overdue promissory note and accrued interest. To date, the Company has not repaid any of these promissory notes and related accrued interest and could be subject to further action. The legal liability, totaling $1,076,168, of these promissory notes and related accrued interest have been fully recognized and recorded by the Company.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in">b) Commitments</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">The Company has a consulting arrangement with Mr. Sidney Chan, Chief Executive Officer and Chairman of the Board of Directors of the Company. Under the terms of the contract, Mr. Chan will be paid $180,000 per annum for services as Chief Executive Officer. The contract can be terminated at any time with thirty days&#8217; notice and the payment of two years annual salary. Should the contract be terminated, all debts owed to Mr. Chan and his spouse must be immediately repaid. The initial term of the contract is for one year and automatically renews for continuous one year terms. Also under the terms of the contract are the following:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 58.5pt; text-align: justify; text-indent: 0.9pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 86px">&#160;</td> <td style="width: 58px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">i.</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Incentive Revenue Bonus</u></font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">Mr. Chan will be entitled to a 1% net sales commission from the sales of any of the Company&#8217;s products at any time during his life, regardless if Mr. Chan is still under contract with the Company.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 1in">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 86px">&#160;</td> <td style="width: 58px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">ii.</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Sale of Business</u></font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">If more than 50% of the Company&#8217;s stock or assets are sold, Mr. Chan will be compensated for entering into non-compete agreements based on the selling price of the Company or its assets as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 96px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">2% of sales price up to $24,999,999 plus</font></td></tr> </table> <p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 96px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">3% of sales price between $25,000,000 and $49,999,999 plus</font></td></tr> </table> <p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 96px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">4% of sales price between $50,000,000 and $199,999,999 plus</font></td></tr> </table> <p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 96px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">5% of sales price in excess of $200,000,000</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><b>9.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b>Financial instruments</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 54.55pt">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 37.1pt; text-align: justify">The Company&#8217;s financial instruments consist of cash, accounts payable, interest payable, promissory notes payable to unrelated parties and promissory notes payable to related parties.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 37.1pt; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">a)</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Fair value </u></font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 37.1pt; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 55.1pt; text-align: justify">The fair values of cash and certain accounts payable and accrued liabilities approximate their carrying values due to the relatively short periods to maturity of these instruments.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 55.1pt; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 55.1pt; text-align: justify">Certain accounts payable have been outstanding longer than one year. The Company has recorded imputed interest at a rate of 1% per month over the period the payables have been outstanding for longer than one year, with a corresponding amount recognized in additional paid-in capital. The calculated amount represents the implicit compensation for the use of funds beyond a reasonable term for regular trade payables.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 1in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">For the purposes of fair value analysis, promissory notes payable to related parties and promissory notes payable to unrelated parties can be separated into two classes of financial liabilities.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interest-bearing promissory notes, lines of credit and related interest payable</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">ii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Non-interest-bearing promissory notes past due</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The interest-bearing promissory notes payable are all delinquent and have continued to accrue interest at their stated rates. The Company currently does not have the funds to extinguish these debts and will continue to incur interest until such time as the liabilities are extinguished. There is not an active market for delinquent loans for a Company with a similar financial position. Management asserts the carrying values of the promissory notes and related interest payable are a reasonable estimate of fair value as they represent the Company&#8217;s best estimate of their legal obligation for these debts. As there is no observable market for interest rates on similar promissory notes, the fair value was estimated using level 2 inputs in the fair value hierarchy.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: center">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Company has three non-interest-bearing promissory notes payable past due. The first is several years delinquent and there have been no renegotiated repayment terms. There is not an active market for default loans not bearing interest nor is there an observable market for lending to companies with a financial position similar to the Company. The Company has recorded imputed interest at a rate of 1% per month over the life of the promissory notes, with a corresponding amount recognized in additional paid-in capital representing the implicit compensation for the use of funds.&#160;&#160;Management asserts the payment date for these amounts cannot be reasonably determined. Management further asserts there is not a determinable interest rate for arm&#8217;s-length borrowings based on the current financial position of the Company and asserts the carrying value is the best estimate of the Company&#8217;s legal liability and represents the fair value for the promissory note. This would be considered a level 2 input in the fair value hierarchy.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 37.1pt; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">b)</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Credit risk</u></font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 55.1pt; text-align: justify">Financial instruments that potentially subject the Company to credit risk consist of cash. The Company only has an immaterial cash balance and is not exposed to significant credit risk.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">c)</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Market risk</u></font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 55.1pt; text-align: justify">Market risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices.&#160;&#160;Market risk comprises two types of risk: interest rate risk and foreign currency risk.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: center">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 13.5pt">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interest rate risk</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 94.5pt; text-align: justify; text-indent: 13.5pt">Interest rate risk consists of two components:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 94.5pt; text-align: justify; text-indent: 13.5pt">a) &#160;&#160;&#160;&#160;&#160;&#160;&#160;Cash flow risk</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 130.5pt; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 2in; text-align: justify">To the extent that payments made or received on the Company&#8217;s monetary assets and liabilities are affected by changes in the prevailing market interest rates, the Company is exposed to interest rate cash flow risk.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 94.5pt; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 2in; text-align: justify">The Company is exposed to interest rate cash flow risk on promissory notes payable of $500,000, which incur a variable interest rate of prime plus 1%. A hypothetical change of 1% on interest rates would increase or decrease net loss and comprehensive loss by $5,000.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 58.5pt">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 94.5pt; text-align: justify; text-indent: 13.5pt">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Price risk</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 130.5pt; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 2in; text-align: justify">To the extent that changes in prevailing market interest rates differ from the interest rate on the Company&#8217;s monetary assets and liabilities, the Company is exposed to price risk.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 37.1pt; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 2in; text-align: justify">The Company&#8217;s promissory notes payable consist of $500,000 of variable interest rate notes and $4,786,319 of fixed interest rate notes. All of these notes are past due and are currently due on demand while interest continues to accrue. Due to the delinquency of the fixed interest rate promissory notes payable, there is no active market for these instruments and fluctuations in market interest rates do not have a significant impact on their estimated fair values as of December 31, 2016.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 2in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 2in; text-align: justify">At December 31, 2016, the effect on the net loss and comprehensive loss of a hypothetical change of 1% in market interest rate cannot be reasonably determined.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">c) <u>Foreign currency risk</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Company incurs certain accounts payable and expenses in Canadian dollars and is exposed to fluctuations in changes in exchange rates between the US and Canadian dollars. As at December 31, 2016, the effect on net loss and comprehensive loss of a hypothetical change of 10% between the US and Canadian dollar would not be material. The Company has not entered into any foreign currency contracts to mitigate risk.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><b>10.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b>Income taxes </b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">The provision for income taxes differs from the result that would be obtained by applying the statutory tax rate of 34% (2015 - 34%) to income before income taxes. The difference results from the following items:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: center; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right"><b>December 31, </b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right"><b>2016</b></p></td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right"><b>December 31, </b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right"><b>2015</b></p></td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Computed expected benefit of income taxes</font></td> <td style="width: 8%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(3,431,869</font></td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="width: 8%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(2,141,596</font></td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Stock-based compensation</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,494,428</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,095,817</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Non-deductible interest expense</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">50,465</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">50,531</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Increase in valuation allowance</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">886,976</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">995,248</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Income tax provision</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;&#160;&#160;</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;&#160;&#160;</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in">The components of the net deferred income tax asset, the statutory tax rate and the amount of the valuation allowance are as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: center; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right"><b>December 31, </b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right"><b>2016</b></p></td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right"><b>December 31, </b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right"><b>2015</b></p></td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Net operating loss carried forward</font></td> <td style="width: 8%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">37,532,822</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 8%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">34,924,072</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Tax rate</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">34</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">34</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Deferred income tax assets</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">12,761,159</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">11,874,184</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Valuation allowance</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(12,761,159</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(11,874,184</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Net deferred income tax asset</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;&#160;&#160;</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;&#160;&#160;</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">The potential benefit of the deferred income tax asset has not been recognized in these financial statements since it cannot be assured that it is more likely than not that such benefit will be utilized in future years. The Company believes that the available objective evidence creates sufficient uncertainty regarding the realizability of the deferred income tax assets such that a full valuation allowance has been recorded.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">The operating losses amounting to $37,532,822 for utilization in the United States of America, the jurisdiction where they were incurred, will expire between 2019 and 2036 if they are not used. The following table lists the fiscal year in which the loss was incurred and the expiration date of the operating loss carry-forwards:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="width: 33%; border-top: black 2.25pt double; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Fiscal Year</b></font></td> <td style="width: 5%; border-top: black 2.25pt double; border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="width: 25%; border-top: black 2.25pt double; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Amount</b></font></td> <td style="width: 37%; border-top: black 2.25pt double; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Expiry Date</b></font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1999</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">88,022</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2019</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2000</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4,425,866</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2020</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2001</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3,681,189</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2021</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2002</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,503,951</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2022</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2003</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,775,900</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2023</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2004</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,250,783</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2024</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2005</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,304,283</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2025</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2006</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,532,322</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2026</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2007</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,479,818</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2027</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2008</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,599,919</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2028</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2009</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,723,146</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2029</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2010</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">822,678</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2030</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2011</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,746,615</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2031</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2012</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,638,421</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2032</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2013</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,568,328</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2033</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2014</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,855,631</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2034</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,927,200</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2035</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,608,750</font></td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2036</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="border-bottom: black 2.25pt double; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Total</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">37,532,822</font></td> <td style="border-bottom: black 2.25pt double; line-height: 107%">&#160;</td></tr> </table> <p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&#160;</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>11.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b>Subsequent events</b></font></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 35.45pt"></td><td style="width: 18pt"><font style="font: 10pt Times New Roman, Times, Serif">a)</font></td><td><font style="font: 10pt Times New Roman, Times, Serif">On January 27, 2017, the Company&#8217;s Board of Directors approved a 100:1 reverse share split of the Company&#8217;s common stock. The reverse share split is pending approval from the SEC and other regulatory bodies.</font></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 35.45pt"></td><td style="width: 18pt"><font style="font: 10pt Times New Roman, Times, Serif">b)</font></td><td><font style="font: 10pt Times New Roman, Times, Serif">On November 27, 2017, the Company&#8217;s Board of Directors approved the grant of the option to 8,700,000 shares of common stock of the Company at a price of $0.015 per share for a term of five years. 2,200,000 of the approved options were to a director of the Company and 6,500,000 were to consultants of the Company.</font></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif"></font></p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 35.45pt"></td><td style="width: 18pt"><font style="font: 10pt Times New Roman, Times, Serif">c)</font></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On January 31, 2018, the Company&#8217;s Board of Directors approved the following grants: </font></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.75in"></td><td style="width: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">the option to acquire 47,000,000 shares of common stock of the Company at a price of $0.015 per share for a term of five years to 9 consultants of the Company, and </font></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.75in"></td><td style="width: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">the option to acquire 200,000 shares of common stock of the Company at a price of $0.015 per share until April 19, 2019 to 1 consultant of the Company. </font></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Of the options granted with a term of five years, options to acquire a total of 11,000,000 shares of common stock were granted to three relatives of the Chairman of the Board.</font></p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">a)</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Principles of consolidation</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">These consolidated financial statements include the accounts of the Company and its integrated wholly-owned subsidiary, Canada ALRTech Health Systems Inc., which was incorporated on April 15, 2008 in Canada. All significant inter-company balances and transactions have been eliminated.</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 23px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">b)</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Stock-based compensation</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify">The Company follows the fair value method of accounting for stock-based compensation. The Company estimates the fair value of share-based payment awards on the date of grant using an option pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service period in the Company&#8217;s consolidated financial statements. The Company estimates the fair value of the stock options using the Black-Scholes Option Pricing Model. The Black-Scholes Option Pricing Model requires the input of highly subjective assumptions, including the option&#8217;s expected life and the price volatility of the underlying stock.</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">c)</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Income taxes</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Income taxes are accounted for under the asset and liability method. Deferred income tax assets and liabilities are recognized for the differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis, and operating loss carry-forwards that are available to be carried forward to future years for tax purposes.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred income tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. When it is not considered to be more likely than not that a deferred income tax asset will be realized, a valuation allowance is provided for the excess.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">The Company follows the accounting requirements associated with uncertainty in income taxes using the provisions of Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC 740, Income Taxes. Using that guidance, tax positions initially need to be recognized in the financial statements when it is more-likely-than-not the positions will be sustained upon examination by the tax authorities. It also provides guidance for derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. As of December 31, 2016, the Company has no uncertain tax positions that qualify for either recognition or disclosure in the financial statements.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 25px">&#160;</td> <td style="width: 22px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">d)</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Use of estimates</font></td></tr> </table> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, the measurement of stock-based compensation, the fair value of financial instruments and the reported amounts of revenues and expenses during the reporting period. Management believes the estimates are reasonable; however, actual results could differ from those estimates.</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">e)</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Loss per share</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Basic loss per common share is calculated by dividing net loss by the weighted average number of common shares outstanding during the year. Diluted loss per common share is calculated by dividing the net loss by the sum of the weighted average number of common shares outstanding and the dilutive common equivalent shares outstanding during the year. Common equivalent shares consist of the shares issuable upon exercise of stock options and warrants calculated using the treasury stock method. Common equivalent shares are not included in the calculation of the weighted average number of shares outstanding for diluted loss per common shares when the effect would be anti-dilutive.</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">f)</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Comprehensive income</font></td></tr> </table> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Comprehensive income is the overall change in the net assets of the Company for a period, other than changes attributable to transactions with stockholders. It is made up of net income and other comprehensive income. Other comprehensive income consists of net income and other gains and losses affecting stockholders' equity that under generally accepted accounting principles are excluded from net income. The Company has no items of other comprehensive income (loss) in any period presented. Therefore, as presented in the Company's consolidated statements of loss, net loss equals comprehensive loss.</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">g)</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Fair value of financial instruments</font></td></tr> </table> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 37.1pt; text-align: justify">The Company&#8217;s financial instruments include cash, accounts payable, promissory notes payable and lines of credit. The fair values of these financial instruments approximate their carrying values due to the relatively short periods to maturity of these instruments. For fair value measurement, U.S. GAAP establishes a three-tier hierarchy which prioritizes the inputs used in the valuation methodologies in measuring fair value:</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Level 1 &#8212; observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Level 2 &#8212; include other inputs that are directly or indirectly observable in the marketplace.</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Level 3 &#8212; unobservable inputs which are supported by little or no market activity.</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.2pt">h)&#160;&#160;&#160;&#160;&#160; Recently adopted and issued accounting pronouncements</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Adopted</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 49.5pt; text-align: justify">In August 2014, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2014-15, &#8220;Presentation of Financial Statements &#8211; Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entitiy&#8217;s Ability to Continue as a Going Concern&#8221; (&#8220;ASU 2014-15&#8221;). ASU 2014-15 requires management to evaluate whether there is substantial doubt about an entity&#8217;s ability to continue as a going concern for each annual and interim reporting period. If substantial doubt exists, additional disclosure is required. This new standard was effective for the Company for annual and interim periods beginning after December 15, 2016. Adoption of this pronouncement did not have a material impact on the Company&#8217;s consolidated financial statements.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 49.5pt; text-align: justify">In March 2016, the FASB issued ASU No. 2016-09,&#160;<i>Compensation&#160;&#8212;&#160;Stock Compensation: Improvements to Employee Share-Based Payment Accounting</i>&#160;(&#8220;ASU 2016-09&#8221;). The new guidance will change how companies account for certain aspects of share-based payments to employees. Under existing accounting guidance, tax benefits and certain tax deficiencies arising from the vesting of share-based payments are recorded in additional paid-in-capital. The new guidance will require such benefits or deficiencies to be recognized as income tax benefits or expenses in the statement of operations. Companies are required to apply the new guidance prospectively. This new standard was effective for the Company for annual and interim periods beginning after December 15, 2016. Adoption of this pronouncement did not have a material impact on the Company&#8217;s consolidated financial statements.</p> <p style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">ii.</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Issued</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In January 2016, the FASB issued ASU 2016-01, Financial Instruments - Overall: Recognition and Measurement of Financial Assets and Financial Liabilities. This new standard provides guidance on how entities measure certain equity investments and present changes in the fair value. This standard requires that entities measure certain equity investments that do not result in consolidation and are not accounted for under the equity method at fair value and recognize any changes in fair value in net income. ASU 2016-01 is effective for fiscal years beginning after December 31, 2017.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In June 2016, the FASB issued Accounting Standards Update (&#34;ASU&#34;) No. 2016-13, Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The new standard requires financial assets measured at amortized cost be presented at the net amount expected to be collected, through an allowance for credit losses that is deducted from the amortized cost basis. The standard will be effective for the Company beginning January 1, 2020, with early application permitted. This standard is not expected to have a material impact on the Company&#8217;s financial position, results of operations or statement of cash flows upon adoption.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In August 2016, the FASB issued Accounting Standards Update (&#34;ASU&#34;) No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. The new standard will make eight targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. The standard will be effective for the Company beginning January 1, 2018, with early application permitted. The standard will require adoption on a retrospective basis unless it is impracticable to apply, in which case we would be required to apply the amendments prospectively as of the earliest date practicable.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">The Company has implemented all new accounting pronouncements that are in effect and may impact its financial statements. The Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or statement of operations.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 34%; line-height: 107%">&#160;</td> <td style="width: 3%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 60%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,620,172</font></td> <td style="width: 3%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">515,571</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3,135,743</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">494,171</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3,629,913</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: center; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">December 31,</font></td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">December 31,</font></td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Related parties (relatives of the Chairman)</font></td> <td style="width: 8%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,956,403</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 8%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,667,977</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Non-related parties</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,673,511</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,467,766</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3,629,913</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3,135,743</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="3" style="border-top: black 4.5pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Promissory Notes Payable to Unrelated Parties</b></font></td> <td style="border-top: black 4.5pt double; text-align: center; line-height: 107%">&#160;</td> <td style="border-top: black 4.5pt double"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right">December 31,</p></td> <td style="border-top: black 4.5pt double; text-align: right; line-height: 107%">&#160;</td> <td style="border-top: black 4.5pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">December 31,</font></td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td colspan="3" style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Unsecured promissory notes payable to unrelated lenders:</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; width: 2%; line-height: 107%">&#160;</td> <td style="vertical-align: top; width: 2%; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; width: 68%; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; width: 1%; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; width: 13%; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; width: 1%; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; width: 13%; text-align: right; line-height: 107%">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: top; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">i.</font></td> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest at 1% per month, repayable on March 31, 2009, due on demand</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">450,000</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">450,000</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: top; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: top; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">ii.</font></td> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest at 1% per month, with $50,000 repayable on December 31, 2004, $75,000 repayable on August 18, 2007, $75,000 repayable on November 19, 2007 and the balance due on demand. All are due on demand, accruing interest at the same rate.</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">887,455</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">887,455</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: top; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: top; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">iii.</font></td> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest at 0.625% per month, with $50,000 repayable on October 5, 2004, $40,000 repayable on December 31, 2004, and $60,000 repayable on July 28, 2006, all due on demand</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">150,000</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">150,000</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: top; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: top; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">iv.</font></td> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Non-interest-bearing, repayable on July 17, 2005, due on demand</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">270,912</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">270,912</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: top; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: top; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">v.</font></td> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Non-interest-bearing loan repayable at $25,000 per month beginning October 2009, none repaid to date</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">310,986</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">310,986</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: top; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: top; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">vi.</font></td> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest at 0.667% per month, with $125,000 due January 15, 2011</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">125,000</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">125,000</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td colspan="3" style="border-bottom: black 1pt solid; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Promissory notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month</font></td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">200,000</font></td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">230,000</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td colspan="3" style="border-bottom: black 4.5pt double; padding-top: 12pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Total Promissory Notes Payable to Unrelated Parties</b></font></td> <td style="border-bottom: black 4.5pt double; padding-top: 12pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 4.5pt double; padding-top: 12pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,394,353</font></td> <td style="border-bottom: black 4.5pt double; padding-top: 12pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 4.5pt double; padding-top: 12pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,394,353</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="3" style="border-top: black 4.5pt double"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><b>Promissory Notes Payable to Related Parties</b></p></td> <td style="border-top: black 4.5pt double; text-align: center; line-height: 107%">&#160;</td> <td rowspan="2" style="border-top: black 4.5pt double; border-bottom: black 1pt solid"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">December 31,</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">2016</p></td> <td style="border-top: black 4.5pt double; text-align: center; line-height: 107%">&#160;</td> <td rowspan="2" style="border-top: black 4.5pt double; border-bottom: black 1pt solid"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">December 31,</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">2015</p></td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td colspan="3" style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Promissory notes payable to relatives of directors collateralized by a general security agreement on all the assets of the Company, due on demand:</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 65%; line-height: 107%">&#160;</td> <td style="width: 1%; text-align: center; line-height: 107%">&#160;</td> <td style="width: 16%; text-align: right; line-height: 107%">&#160;</td> <td style="width: 1%; text-align: center; line-height: 107%">&#160;</td> <td style="width: 13%; text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">i.</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest at 1% per month</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">580,619</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">580,619</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">ii.</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest at 1.25% per month</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">51,347</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">51,347</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">iii.</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest at the U.S. bank prime rate plus 1%</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">100,000</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">100,000</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">iv.</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest at 0.5% per month</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">695,000</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">695,00</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td colspan="3" style="line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td colspan="3" style="border-bottom: black 1pt solid; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Promissory notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, due on demand</font></td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,465,000</font></td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,465,000</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td colspan="3" style="border-bottom: black 4.5pt double; padding-top: 12pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Total Promissory Notes Payable to Related Parties</b></font></td> <td style="border-bottom: black 4.5pt double; padding-top: 12pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 4.5pt double; padding-top: 12pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,891,966</font></td> <td style="border-bottom: black 4.5pt double; padding-top: 12pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 4.5pt double; padding-top: 12pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,891,966</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">As of December 31, 2016, the Company has two lines of credit as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Creditor</font></td> <td style="width: 8%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest Rate</font></td> <td style="width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Borrowing Limit</font></td> <td style="width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Repayment Terms</font></td> <td style="width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Principal Borrowed</font></td> <td style="vertical-align: top; width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Accrued Interest</font></td> <td style="vertical-align: top; width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Total</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Outstanding</p></td> <td style="width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Security</font></td> <td style="width: 22%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Purpose</font></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Chairman and CEO</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1% per Month</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$8,500,000</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Due on Demand</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;7,628,219</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$ &#160;2,490,958</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$10,119,177</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">General Security over Assets</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">General Corporate Requirements</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Wife of Chairman</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1% per Month</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$2,000,000</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Due on Demand</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;2,000,000</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$ &#160;1,256,385</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$ 3,256,385</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">General Security over Assets</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">General Corporate Requirements</font></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$10,500,000</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$ &#160;&#160;9,628,219</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$ &#160;3,747,343</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$13,375,562</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">As of December 31, 2015, the Company has two lines of credit as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Creditor</font></td> <td style="width: 8%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest Rate</font></td> <td style="width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Borrowing Limit</font></td> <td style="width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Repayment Terms</font></td> <td style="width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Principal Borrowed</font></td> <td style="vertical-align: top; width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Accrued Interest</font></td> <td style="vertical-align: top; width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Total</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Outstanding</p></td> <td style="width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Security</font></td> <td style="width: 22%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Purpose</font></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Chairman and CEO</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1% per Month</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$7,000,000</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Due on Demand</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;6,626,993</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;1,628,716</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$ 8,255,708</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">General Security over Assets</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">General Corporate Requirements</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Wife of Chairman</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1% per Month</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$2,000,000</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Due on Demand</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;2,000,000</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$ &#160;1,016,385</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$ 3,016,385</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">General Security over Assets</font></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">General Corporate Requirements</font></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$9,000,000</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$ &#160;&#160;8,626,993</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$ &#160;2,645,101</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$11,272,093</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&#160;</p> <p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-top: black 2.25pt double; line-height: 107%">&#160;</td> <td colspan="3" style="border-top: black 2.25pt double; text-align: center; line-height: 107%">&#160;</td> <td colspan="3" style="border-top: black 2.25pt double; text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Year Ended</font></td> <td colspan="3" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Year Ended</font></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2016</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2015</font></td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Weighted Average</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Weighted Average</font></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Number of Options</font></td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Exercise</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Price</p></td> <td style="border-bottom: black 1pt solid"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Number of</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Options</p></td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Exercise</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Price</p></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 42%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, beginning of period</font></td> <td style="width: 16%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">579,000,200</font></td> <td style="width: 5%; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; padding-right: 3.75pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.015</font></td> <td style="width: 16%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">245,700,100</font></td> <td style="width: 3%; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; padding-right: 3.75pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4,390,001,300</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="padding-right: 3.75pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.002</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">334,500,100</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="padding-right: 3.75pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.015</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Cancelled</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(6,700,000)</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="padding-right: 1.15pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(0.030)</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="padding-right: 3.75pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Expired</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(1,200,000)</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(0.250)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="border-bottom: black 1pt solid; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; padding-right: 3.75pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; padding-right: 3.75pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 4.5pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, end of period</font></td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4,962,301,500</font></td> <td style="border-bottom: black 4.5pt double; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 3.75pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.004</font></td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">579,000,200</font></td> <td style="border-bottom: black 4.5pt double; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 3.75pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.015</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 4.5pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Exercisable, end of period</font></td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4,960,101,500</font></td> <td style="border-bottom: black 4.5pt double; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 2.85pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.004</font></td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">575,650,200</font></td> <td style="border-bottom: black 4.5pt double; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 4.5pt double; padding-right: 2.85pt; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.015</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: bottom; border-top: black 2.25pt double; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; border-top: black 2.25pt double; text-align: center; line-height: 107%">&#160;</td> <td colspan="5" style="vertical-align: bottom; border-top: black 2.25pt double; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; border-top: black 2.25pt double; text-align: center; line-height: 107%">&#160;</td> <td colspan="3" style="vertical-align: bottom; border-top: black 2.25pt double; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; border-top: black 2.25pt double; text-align: center; line-height: 107%">&#160;</td></tr> <tr> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td colspan="5" style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2016</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%">&#160;</td> <td colspan="4" style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2015</font></td></tr> <tr> <td style="vertical-align: bottom; width: 32%; border-bottom: black 1pt solid; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Expiry Date</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; width: 14%; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Options</font></td> <td style="vertical-align: bottom; width: 1%; border-top: black 1pt solid; border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Exercise Price</font></td> <td style="vertical-align: bottom; width: 1%; border-top: black 1pt solid; border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; width: 8%; border-top: black 1pt solid; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Intrinsic Value</font></td> <td style="vertical-align: top; width: 1%; border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; width: 11%; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Options</font></td> <td style="vertical-align: bottom; width: 1%; border-top: black 1pt solid; border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Exercise Price</font></td> <td style="vertical-align: top; width: 10%; border-top: black 1pt solid; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Intrinsic Value</font></td></tr> <tr> <td style="vertical-align: bottom; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">May 4, 2016</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.050</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">May 23, 2016</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">100,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">May 27, 2017</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">400,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">400,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">May 31, 2017</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">500,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.050</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">500,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.050</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">August 16, 2017</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">250,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">250,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">December 28, 2017</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">January 28, 2018</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,500,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,300,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">March 26, 2018</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">500,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">500,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">April 9, 2018</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">October 1, 2018</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">500,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">February 7, 2019</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">700,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">April 18,2019</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,000,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">May 21, 2019</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">500,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">500,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">July 25, 2019</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">August 1, 2019</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,250,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,250,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">August 26, 2019</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,500,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,500,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">January 30, 2020</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,900,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4,500,000</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.030</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">May 29, 2020</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">560,000,200</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.002</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">560,000,200</font></td> <td style="vertical-align: top; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.015</font></td> <td style="vertical-align: top; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; border-bottom: black 1pt solid; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">July 21, 2021</font></td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4,390,001,300</font></td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.002</font></td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: right; line-height: 107%">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4,962,301,500</font></td> <td style="vertical-align: top; border-bottom: black 2.25pt double; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.002</font></td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: top; border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="vertical-align: top; border-bottom: black 2.25pt double; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">579,000,200</font></td> <td style="vertical-align: top; border-bottom: black 2.25pt double; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.015</font></td> <td style="vertical-align: top; border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td colspan="3" style="border-bottom: black 4.5pt double"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Weighted Average Remaining</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Contractual Life</p></td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4.81</font></td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4.37</font></td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="margin: 0pt"></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td>&#160;</td> <td colspan="3">&#160;</td><td>&#160;</td> <td colspan="3" style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="text-align: right; border-bottom: Black 1pt solid">December 31, <br />2016</td><td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="text-align: right; border-bottom: Black 1pt solid">December 31, <br />2015</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td>&#160;</td> <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td> <td colspan="3" style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Risk-free interest rate</td><td style="width: 8%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">1.68</td><td style="width: 1%; text-align: left">%</td><td style="width: 8%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">1.68</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected life</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected dividends</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected volatility</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">210</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">194</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Forfeiture rate</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="margin: 0pt"></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2016</font></td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right">December 31,</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right">2015</p></td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest expense</font></td> <td style="width: 8%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">7,318,539</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 8%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3,184,459</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Product development expense</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">14,267</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">14,374</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Professional expense</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">577</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3,806</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Selling, general and administration expenses:</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3,170</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">20,355</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">7,336,553</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3,222,992</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; background-color: white"> <td style="width: 69%; border-top: black 4.5pt double; padding-left: 35.45pt; text-indent: -35.45pt; line-height: 107%">&#160;</td> <td style="width: 1%; border-top: black 4.5pt double; text-align: center; line-height: 107%">&#160;</td> <td style="width: 1%; border-top: black 4.5pt double; text-align: center; line-height: 107%">&#160;</td> <td style="width: 15%; border-top: black 4.5pt double; text-align: center; line-height: 107%">&#160;</td> <td style="width: 1%; border-top: black 4.5pt double; text-align: center; line-height: 107%">&#160;</td> <td style="width: 13%; border-top: black 4.5pt double; text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="border-bottom: black 1pt solid; padding-left: 35.45pt; text-indent: -35.45pt; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Year End December 31, 2016</font></td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Year End December 31, 2015</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="padding-left: 35.45pt; text-indent: -35.45pt; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Related party transaction included within interest expense:</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="padding-left: 14.2pt; text-indent: -7.1pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest expenses on promissory notes issued to relatives of the Chairman &#38; Chief Executive Officer of the Company</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">288,426</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">309,826</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; padding-left: 14.05pt; text-indent: -6.95pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Interest expense on lines of credit payable to the Chairman &#38; Chief Executive Officer of the Company and his spouse</font></td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,102,242</font></td> <td style="vertical-align: top"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">$</p></td> <td style="vertical-align: bottom; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">944,010</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; border-bottom: black 1pt solid; padding-left: 14.05pt; text-indent: -6.95pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Stock based compensation related to stock options granted to the Chairman &#38; Chief Executive Officer for increasing the borrowing limit on the line of credit available to the Company</font></td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">7,318,539</font></td> <td style="vertical-align: top; border-bottom: black 1pt solid"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">$</p></td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3,184,459</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; padding-left: 14.05pt; text-indent: -6.95pt; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td> <td style="vertical-align: top; text-align: center; line-height: 107%">&#160;</td> <td style="vertical-align: bottom; text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Related party transactions including within selling, general and administration expenses</b>:</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="padding-left: 14.05pt; text-indent: -6.95pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Consulting fees to the Chairman &#38; Chief Executive Officer of the Company accrued on the line of credit available to the Company</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">189,600</font></td> <td style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">189,600</font></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="border-bottom: black 4.5pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Consulting fees paid to the President of the Company</font></td> <td style="border-bottom: black 4.5pt double; text-align: center; line-height: 107%">&#160;</td> <td style="border-bottom: black 4.5pt double; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">15,500</font></td> <td style="border-bottom: black 4.5pt double; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 4.5pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">186,000</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: center; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right"><b>December 31, </b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right"><b>2016</b></p></td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right"><b>December 31, </b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right"><b>2015</b></p></td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="3" style="text-align: right; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Computed expected benefit of income taxes</font></td> <td style="width: 8%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(3,431,869</font></td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="width: 8%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(2,141,596</font></td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Stock-based compensation</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,494,428</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,095,817</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Non-deductible interest expense</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">50,465</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">50,531</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Increase in valuation allowance</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">886,976</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">995,248</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Income tax provision</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;&#160;&#160;</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;&#160;&#160;</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"></font></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td>&#160;</td> <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td> <td colspan="3" style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td> <td colspan="3" style="font-size: 12pt; text-align: right; border-bottom: Black 1pt solid"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, </b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>2016</b></font></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td> <td colspan="3" style="font-size: 12pt; text-align: right; border-bottom: Black 1pt solid"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, </b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>2015</b></font></p></td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td>&#160;</td> <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td> <td colspan="3" style="text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Net operating loss carried forward</td><td style="width: 8%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">37,532,822</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">34,924,072</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Tax rate</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">34</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">34</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred income tax assets</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">12,761,159</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">11,874,184</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(12,761,159</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(11,874,184</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Net deferred income tax asset</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><b>&#160;</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="width: 34%; border-top: Black 3pt double; border-bottom: Black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Fiscal Year</b></font></td> <td style="width: 5%; border-top: Black 3pt double; border-bottom: Black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 25%; border-top: Black 3pt double; border-bottom: Black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Amount</b></font></td> <td style="width: 36%; border-top: Black 3pt double; border-bottom: Black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Expiry Date</b></font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">1999</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">88,022</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2019</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2000</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,425,866</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2020</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2001</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,681,189</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2021</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2002</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,503,951</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2022</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2003</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,775,900</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2023</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2004</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,250,783</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2024</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2005</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,304,283</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2025</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2006</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,532,322</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2026</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2007</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,479,818</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2027</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2008</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,599,919</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2028</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2009</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,723,146</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2029</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2010</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">822,678</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2030</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2011</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,746,615</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2031</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2012</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,638,421</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2032</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2013</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,568,328</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2033</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2014</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,855,631</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2034</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,927,200</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2035</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td> <td style="border-bottom: Black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,608,750</font></td> <td style="border-bottom: Black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2036</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 3pt double; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Total</b></font></td> <td style="border-bottom: Black 3pt double; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: Black 3pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">37,532,822</font></td> <td style="border-bottom: Black 3pt double">&#160;</td></tr> </table> 242777909 0 4036 54253 1429 1565 2607 52688 23234761 20676225 13375562 11272094 3629913 3135743 2394353 2394353 2891966 2891966 942967 982069 4036 54253 -23230725 -20621972 242777 40727569 242777 -61592317 48212548 242777 -71686050 -17694771 37355956 -55293504 -71686050 -61592317 48212548 40727568 242777 242777 0.001 0.001 500000000 500000000 0 0 0 0 0.001 0.001 2000000000 500000000 242777909 242777909 242777909 242777909 242777909 242777909 242777909 -1029027 -1577128 354948 836756 108275 217454 565804 522918 9064706 4795168 70000 3483 -10093733 -6298813 -6298813 -10093733 -0.04 -0.03 242777909 242777909 148426 148621 148621 148426 7336554 3222992 3222992 7336554 494170 515571 -39102 -3399 136 5145 -70000 148426 148620 1102243 944010 577 3804 3170 20355 7318539 3184459 14268 14374 -1051307 -1535874 1001226 1529720 1001226 1529720 2607 52688 58842 -50081 -6154 23230725 20621972 2891966 2891966 1465000 1465000 695000 69500 100000 100000 51347 51347 580619 580619 2394353 2394353 200000 230000 125000 125000 310986 310986 270912 270912 150000 150000 887455 887455 450000 450000 3629913 3135743 2620172 494171 515571 1673511 1467766 1956403 1667977 0.01 0.01 0.01 0.01 8500000 7000000 2000000 2000000 9628219 8626993 7628219 6626993 2000000 2000000 3747343 2645101 2490958 1628716 1256385 1016385 13375562 11272093 10119177 8255708 3256385 3016385 Due on Demand Due on Demand Due on Demand Due on Demand General Security over Assets General Security over Assets General Security over Assets General Security over Assets General Corporate Requirements General Corporate Requirements General Corporate Requirements General Corporate Requirements 4962301500 579000200 245700100 0.004 0.015 0.030 4390001300 334500100 0.002 0.015 -1200000 -0.250 -6700000 -0.030 0.0168 0.0168 P5Y P5Y 0 0 2.10 1.94 0 0 7318539 3184459 14267 14374 577 3806 -3170 -20355 7336553 3222992 288426 309826 1102242 944010 7318539 3184459 189600 189600 15500 186000 -3431869 -2141596 2494428 1095817 -50465 -50531 -886976 -995248 0 0 37532822 34924072 12761150 11874184 -12761150 -11874184 0 0 .34 .34 2608750 3681189 2503951 2775900 1250783 1304283 1532322 1479818 1599919 1723146 822678 1746615 1638421 2568328 2855631 2927200 4425866 88022 0.002 0.015 P4Y9M22D P4Y4M13D EX-101.SCH 8 alrt-20161231.xsd XBRL SCHEMA FILE 00000001 - Disclosure - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Change in Shareholders Deficit link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - 1. Basis of Presentation, Nature of Operations and Going Concern link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - 2. Significant accounting policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - 3. Promissory notes interest payable link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - 4. Lines of Credit link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - 5. Capital Stock link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - 6. Additional paid in capital link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - 7. Related party transactions and balances link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - 8. Commitments and contingencies link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - 9. Financial instruments link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - 10. Income taxes link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - 11. Subsequent event link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - 2. Significant accounting policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - 3. Interest, advances and promissory notes payable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - 4. Lines of Credit (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - 6. Additional paid in capital (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - 7. Related party transactions and balances (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - 10. Income taxes: (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - 1. Basis of Presentation, Nature of Operations and Going Concern (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - 3. Interest, advances and promissory notes payable (Details) - Promissory Notes Payable - Relatives of Board of Directors link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - 3. Interest, advances and promissory notes payable (Details) - Unsecured Promissory Notes Payable to Unrelated Leaders link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - 3. Interest, advances and promissory notes payable (Details) - Summary of Interest Payable Activity link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - 3. Interest, advances and promissory notes payable (Details) - Interest Payable link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - 4. Lines of Credit (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - 6. Additional paid in capital - Summary of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - 6. Additional paid in capital - Options Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - 6. Additional paid in capital - Fair Value Method Stock-Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - 6. Additional paid in capital - Fair Value of Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - 7. Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - 10. Income taxes: (Details) - Provision for Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - 10. Income taxes: (Details) - Net Deferred Income Tax Asset link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - 10. Income taxes: (Details) - Summary of Operating Loss Carryforwards link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 alrt-20161231_cal.xml XBRL CALCULATION FILE EX-101.DEF 10 alrt-20161231_def.xml XBRL DEFINITION FILE EX-101.LAB 11 alrt-20161231_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock Additional Paid-in Capital Retained Earnings Lender Name [Axis] Chairman and CEO Wife of Chairman Document and Entity Information [Abstract] Entity Registrant Name Document Type Current Fiscal Year End Date Entity Common Stock, Shares Outstanding Entity Public Float Amendment Flag Amendment Description Entity Central Index Key Entity Current Reporting Status Entity Voluntary Filers Entity Filer Category Entity Well-known Seasoned Issuer Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Statement of Financial Position [Abstract] Assets Current assets: Cash Prepaid expenses and other Total assets Liabilities and Stockholders' Deficit Current liabilities: Accounts payable and accrued liabilities Promissory notes payable due to related parties Promissory notes payable due to unrelated parties Interest payable Lines of credit from related parties Total liabilities Stockholders' Deficit Preferred stock Authorized: 500,000,000 shares of preferred stock (2015 - 500,000,000) with a par value of $0.001 per share Shares issued and outstanding: No shares of preferred stock (2015: No) were issued and outstanding Common stock Authorized: 2,000,000,000 shares of common stock (2015 - 500,000,000) with a par value of $0.001 per share Shares issued and outstanding: 242,777,909 shares of common stock (2015 - 242,777,909 shares of common stock). Additional paid-in capital Accumulated deficit Stockholders' deficit Total liabilities and stockholders' deficit Preferred stock: par value (in Dollars per share) Preferred stock: Authorized Preferred stock: issued Preferred stock: outstanding Common stock, par value (in Dollars per share) Common stock Authorized Common stock Shares, issued Common stock Shares, outstanding Income Statement [Abstract] Operating Expenses Product development Professional fees Selling, general and administration Operating Loss Foreign exchange gain Recovery of expense Interest expense Net loss Weighted average number of shares of common stock outstanding, basic and diluted Loss per share, basic and diluted Statement [Table] Statement [Line Items] Balance at year end (in Shares) Balance at year end Imputed interest Stock options granted as compensation Shares issued for stock options exercised (in Shares) Shares issued for stock options exercised Net loss for the year Balance at year end (in Shares) Balance at year end Statement of Cash Flows [Abstract] OPERATING ACTIVITIES Stock-based compensation-product development Stock-based compensation-interest expenses Stock-based compensation-selling, general and admin Stock-based compensation-professional fees Unpaid interest expense on line of credit Non-cash imputed interest expense Non-cash gain on reversal of accrual Changes in assets and liabilities: Decrease in prepaid expenses Increase in accounts payable and accrued liabilities Increase in interest payable Net cash used in operating activities FINANCING ACTIVITIES Proceeds from lines of credit Net cash provided by financing activities Decrease in cash Cash, beginning of year Cash, end of year Basisof Presentation Natureof Operationsand Going Concern [Abstract] Basisof Presentation Nature of Operations and Going Concern Accounting Policies [Abstract] Significant Accounting Policies Interest Advancesand Promissory Notes Payable [Abstract] Promissory notes interest payable Linesof Credit Related Party [Abstract] Lines of Credit Stockholders' Equity Note [Abstract] Capital Stock Additional Paid in Capital [Abstract] Additional paid in capital Related Party Transactions [Abstract] Related party transactions and balances Compensation Related Costs [Abstract] Commitments and contingencies Disclosure Text Block Supplement [Abstract] Financial Instruments Income Tax Disclosure [Abstract] Income Taxes Subsequent Events [Abstract] Subsequent Events Significant Accounting Policies Policies a) Principles of consolidation b) Stock-based compensation c) Income taxes d) Use of estimates e) Loss per share f) Comprehensive income g) Fair value of financial instruments h) Recently adopted and issued accounting pronouncements Schedule of Promissory Notes Payable - Relatives of Board of Directors Schedule of Activity of Promissory Notes Payable to Unrelated Lenders Schedule of Interest Payable Schedule Line of Credit Related Party Schedule of Share-based Compensation, Stock Options, Activity Schedule of Options Outstanding Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions Schedule of Recognized Compensation Cost, Vested Awards Related Party Transactions And Balances Tables Schedule of related party transactions Schedule of Components of Income Tax Expense (Benefit) Schedule of Deferred Tax Assets and Liabilities Summary of Operating Loss Carryforwards Working Capital Deficit Net Income (Loss) Attributable to Parent Promissory Notes Payable - Relatives of Board of Directors [Abstract] Promissory notes payable to relatives of directors collateralized by a general security agreement on all the assets of the Company, due on demand: i.Interest at 1% per month ii.Interest at 1.25% per month iii.Interest at the U.S. bank prime rate plus 1% iv. Interest at 0.5% per month Promissory notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, due on demand Total Related Promissory Notes Unsecured Promissory Notes Payable to Unrelated Leaders [Abstract] Unsecured promissory notes payable to unrelated lenders: i. Interest at 1% per month, repayable on March 31, 2009, due on demand ii. Interest at 1% per month, with $50,000 repayable on December 31, 2004, $75,000 repayable on August 18, 2007, $75,000 repayable on November 19, 2007 and the balance due on demand. All are due on demand, accruing interest at the same rate. iii. Interest at 0.625% per month, with $50,000 repayable on October 5, 2004, $40,000 repayable on December 31, 2004, and $60,000 repayable on July 28, 2006, all due on demand iv. Non-interest-bearing, repayable on July 17, 2005, due on demand v. Non-interest-bearing loan repayable at $25,000 per month beginning October 2009, none repaid to date vi. Interest at 0.667% per month, with $125,000 due January 15, 2011 Promissory notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month Total Promissory Notes Payable to Unrelated Parties Summary of Interest Payable Activity [Abstract] Beginning Balance Interest incurred on promissory notes payable Ending Balance Interest Payable [Abstract] Relatives of directors Non-related parties Total Interest Rate Borrowing Limit Repayment Terms Principal Borrowed Accrued Interest Total Outstanding Security Purpose Summary of Stock Option Activity [Abstract] Outstanding, beginning of period Average Exercise Price, beginning Exercisable, end of period Exercisable, end of period Granted Granted, per share Cancelled Cancelled per share Expired Expired pe share Exercised Exercised per share Outstanding, end of period Average Exercise price, ending Options Outstanding [Abstract] Options Outstanding Exercise Price Weighted Average Remaining Contractual Life Fair Value Method Stock-Based Compensation [Abstract] Risk-free interest rate Expected life Expected dividends Expected volatility Forfeiture rate Fair Value of Stock Options [Abstract] Interest expense Product development expense Professional expense Selling, general and administration expenses: Total Related party transaction included within interest expense: Interest expenses on promissory notes issued to relatives of the Chairman & Chief Executive Officer of the Company Interest expense on lines of credit payable to the Chairman & Chief Executive Officer of the Company and his spouse Stock based compensation related to stock options granted to the Chairman & Chief Executive Officer for increasing the borrowing limit on the line of credit available to the Company Related party transactions including within selling, general and administration expenses: Consulting fees to the Chairman & Chief Executive Officer of the Company accrued on the line of credit available to the Company Consulting fees paid to the President of the Company Provision for Income Taxes [Abstract] Computed expected benefit of income taxes Stock-based compensation Non-deductible interest expense Increase in valuation allowance Income tax provision Net Deferred Income Tax Asset [Abstract] Net operating loss carried forward Tax rate Deferred income tax assets Valuation allowance Net deferred income tax asset Summary of Operating Loss Carryforwards [Abstract] Opearting Loss Carryforward The entire disclosure for the basis of presentation. The entire disclosure for the nature of an entity's business, the major products or services it sells or provides and its principal markets, including the locations of those markets. If the entity operates in more than one business, the disclosure also indicates the relative importance of its operations in each business and the basis for the determination (for example, assets, revenues, or earnings). If there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date), disclose: (a) pertinent conditions and events giving rise to the assessment of substantial doubt about the entity's ability to continue as a going concern for a reasonable period of time, (b) the possible effects of such conditions and events, (c) management's evaluation of the significance of those conditions and events and any mitigating factors, (d) possible discontinuance of operations, (e) The cost of borrowed funds accounted for as interest that was charged against earnings during the period. Carrying value as of the balance sheet date of [accrued] interest payable to relatives of directors on all forms of debt, including trade payables, that has been incurred and is unpaid. Carrying value as of the balance sheet date of [accrued] interest payable to non-related parties on all forms of debt, including trade payables, that has been incurred and is unpaid. Number of shares issued during the period as a result of the conversion of equity derivative security. The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit from a related party, which is a commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire wi The increase (decrease) during the reporting period in imputed interest payable. Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable due to unrelated lenders, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer Tabular disclosure of short-term or long-term contractual arrangements with lenders, who are related parties, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. The entire disclosure for activity in the reporting period of notes payable to unrelated lenders. Tabular disclosure interest expense. Schedule of options outstanding. Monies owed by promissory notes payable to relatives of members of the board of directors. The number of shares under options that were cancelled during the reporting period. The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and ad The aggregate amount of noncash, equity-based remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method. The cost of borrowed funds accounted for as interest that was charged against earnings during the period. The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. These cost are then translated into this noncash element which is an add back when calculating net cash generated by operating activities using the indirect method. The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. These cost are then translated into this noncash element which is an add back when calculating net cash generated by operating activities using the indirect method. The increase (decrease) during the reporting period in interest payable on line of credit to related party, which represents the amount owed to holders of line of credit for interest earned on credit extended to the reporting entity. An entity's working capital is the difference between current assets minus current liabilities. If current liabilities exceed current assets there is a deficit in working capital. Assets [Default Label] Liabilities, Current Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Income (Loss) Foreign Currency Transaction Gain (Loss), before Tax Recovery of Direct Costs Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Cash and Cash Equivalents, at Carrying Value PromissoryNotesRelatedParty TotalPromissoryNotesPayableToUnrelatedParties Interest Payable Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Interest Expense, Other SellingGeneralAndAdministrationExpenses NondeductibleInterestExpense Valuation Allowances and Reserves, Period Increase (Decrease) Income Tax Expense (Benefit) EX-101.PRE 12 alrt-20161231_pre.xml XBRL PRESENTATION FILE XML 13 R1.htm IDEA: XBRL DOCUMENT v3.8.0.1
Document And Entity Information - USD ($)
12 Months Ended
Dec. 31, 2016
Feb. 02, 2018
Jun. 30, 2017
Document and Entity Information [Abstract]      
Entity Registrant Name ALR Technologies Inc.    
Document Type 10-K    
Current Fiscal Year End Date --12-31    
Entity Common Stock, Shares Outstanding   242,777,909  
Entity Public Float     $ 0
Amendment Flag false    
Entity Central Index Key 0001087022    
Entity Current Reporting Status No    
Entity Voluntary Filers No    
Entity Filer Category Smaller Reporting Company    
Entity Well-known Seasoned Issuer No    
Document Period End Date Dec. 31, 2016    
Document Fiscal Year Focus 2016    
Document Fiscal Period Focus FY    

XML 14 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2016
Dec. 31, 2015
Current assets:    
Cash $ 2,607 $ 52,688
Prepaid expenses and other 1,429 1,565
Total assets 4,036 54,253
Current liabilities:    
Accounts payable and accrued liabilities 942,967 982,069
Promissory notes payable due to related parties 2,891,966 2,891,966
Promissory notes payable due to unrelated parties 2,394,353 2,394,353
Interest payable 3,629,913 3,135,743
Lines of credit from related parties 13,375,562 11,272,094
Total liabilities 23,234,761 20,676,225
Stockholders' Deficit    
Preferred stock Authorized: 500,000,000 shares of preferred stock (2015 - 500,000,000) with a par value of $0.001 per share Shares issued and outstanding: No shares of preferred stock (2015: No) were issued and outstanding
Common stock Authorized: 2,000,000,000 shares of common stock (2015 - 500,000,000) with a par value of $0.001 per share Shares issued and outstanding: 242,777,909 shares of common stock (2015 - 242,777,909 shares of common stock). 242,777 242,777
Additional paid-in capital 48,212,548 40,727,568
Accumulated deficit (71,686,050) (61,592,317)
Stockholders' deficit (23,230,725) (20,621,972)
Total liabilities and stockholders' deficit $ 4,036 $ 54,253
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Balance Sheets (Parentheticals) - $ / shares
Dec. 31, 2016
Dec. 31, 2015
Statement of Financial Position [Abstract]    
Preferred stock: par value (in Dollars per share) $ 0.001 $ 0.001
Preferred stock: Authorized 500,000,000 500,000,000
Preferred stock: issued 0 0
Preferred stock: outstanding 0 0
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock Authorized 2,000,000,000 500,000,000
Common stock Shares, issued 242,777,909 242,777,909
Common stock Shares, outstanding 242,777,909 242,777,909
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Operating Expenses    
Product development $ 565,804 $ 522,918
Professional fees 108,275 217,454
Selling, general and administration 354,948 836,756
Operating Loss 1,029,027 1,577,128
Foreign exchange gain (3,483)
Recovery of expense (70,000)
Interest expense 9,064,706 4,795,168
Net loss $ (10,093,733) $ (6,298,813)
Weighted average number of shares of common stock outstanding, basic and diluted 242,777,909 242,777,909
Loss per share, basic and diluted $ (0.04) $ (0.03)
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Change in Shareholders Deficit - USD ($)
Common Stock
Additional Paid-in Capital
Retained Earnings
Total
Balance at year end (in Shares) at Dec. 31, 2014 242,777,909      
Balance at year end at Dec. 31, 2014 $ 242,777 $ 37,355,956 $ (55,293,504) $ (17,694,771)
Imputed interest   148,621   148,621
Stock options granted as compensation   3,222,992   3,222,992
Net loss for the year     (6,298,813) $ (6,298,813)
Balance at year end (in Shares) at Dec. 31, 2015 242,777,909     242,777,909
Balance at year end at Dec. 31, 2015 $ 242,777 40,727,569 (61,592,317) $ (20,621,972)
Imputed interest   148,426   148,426
Stock options granted as compensation   7,336,554   7,336,554
Net loss for the year     (10,093,733) $ (10,093,733)
Balance at year end (in Shares) at Dec. 31, 2016 242,777,909     242,777,909
Balance at year end at Dec. 31, 2016 $ 242,777 $ 48,212,548 $ (71,686,050) $ (23,230,725)
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
OPERATING ACTIVITIES    
Net loss $ (10,093,733) $ (6,298,813)
Stock-based compensation-product development 14,268 14,374
Stock-based compensation-interest expenses 7,318,539 3,184,459
Stock-based compensation-selling, general and admin 3,170 20,355
Stock-based compensation-professional fees 577 3,804
Unpaid interest expense on line of credit 1,102,243 944,010
Non-cash imputed interest expense 148,426 148,620
Non-cash gain on reversal of accrual (70,000)
Changes in assets and liabilities:    
Decrease in prepaid expenses 136 5,145
Increase in accounts payable and accrued liabilities (39,102) (3,399)
Increase in interest payable 494,170 515,571
Net cash used in operating activities (1,051,307) (1,535,874)
FINANCING ACTIVITIES    
Proceeds from lines of credit 1,001,226 1,529,720
Net cash provided by financing activities 1,001,226 1,529,720
Decrease in cash (50,081) (6,154)
Cash, beginning of year 52,688 58,842
Cash, end of year $ 2,607 $ 52,688
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
1. Basis of Presentation, Nature of Operations and Going Concern
12 Months Ended
Dec. 31, 2016
Basisof Presentation Natureof Operationsand Going Concern [Abstract]  
Basisof Presentation Nature of Operations and Going Concern

1.       Basis of presentation, nature of operations and going concern

 

ALR Technologies Inc. (the “Company”) was incorporated under the laws of the state of Nevada on March 24, 1987. The Company has developed a compliance monitoring system that will allow for health care professionals to remotely monitor patient health conditions and provide patient health management. On October 17, 2011 the Company announced that it had received Section 510(k) clearance from the United States Food and Drug Administration for its Health-e-Connect System. The Company is currently seeking pilot programs to deploy its product.

 

These consolidated financial statements have been prepared in accordance with Generally Accepted Accounting Principles in the United States of America (“U.S. GAAP”) in U.S dollars and on a going-concern basis, which presumes the realization of assets and the discharge of liabilities and commitments in the normal course of operations for the foreseeable future. Several adverse conditions cast substantial doubt on the validity of this assumption. The Company has incurred significant losses over the past several fiscal years (2016 - $10,093,733; 2015 - $6,298,813), is currently unable to self-finance its operations, has a working capital deficit of $23,230,725 (2015 - $20,621,972), accumulated deficit of $71,686,050 (2015 - $61,592,317), limited resources, no source of operating cash flow, and no assurance that sufficient funding will be available to conduct continued product development activities. If the Company is able to finance its required product development activities, there is no assurance the Company’s current projects will be commercially viable or profitable. The Company has debts comprised of accounts payable, interest, lines of credit and promissory notes payable totaling $23,234,762 currently due, due on demand or considered delinquent. There is no assurance that the Company will not face additional legal action from creditors regarding delinquent accounts payable, payroll payable, promissory notes and interest payable. Any one or a combination of these above conditions could result in the failure of the business and cause the Company to cease operations.

 

The Company’s ability to continue as a going-concern is dependent upon the continued financial support of its creditors and its ability to obtain financing to fund working capital and overhead requirements, fund the development of the Company’s product line and ultimately, the Company’s ability to achieve profitable operations and repay overdue obligations. Management has obtained short-term financing from related parties through lines of credit facilities with available borrowing in principal amount up to $10,500,000. As of December 31, 2016 the total principal balance outstanding was $9,628,210. The resolution of whether the Company is able to continue as a going concern is dependent upon the realization of management’s plans. If additional financing is required, the Company plans to raise needed capital through the exercise of share options and by future common share private placements. There can be no assurance that the Company will be able to raise any additional debt or equity capital from the sources described above, or that the lenders in the line of credit arrangements will maintain the availability of borrowing from the line. If management is unsuccessful in obtaining short-term financing or achieving long-term profitable operations, the Company will be required to cease operations.

 

All of the Company’s debt is either due on demand or is in default, while continuing to accrue interest at its stated rate. The Company will seek to obtain creditors’ consents to delay repayment of the outstanding promissory notes payable and related interest thereto, until it is able to replace this financing with funds generated by operations, recapitalization with replacement debt or from equity financings through private placements. While some of the Company’s creditors have agreed to extend repayment deadlines in the past, there is no assurance that they will continue to do so in the future. In the past, creditors have successfully commenced legal action against the Company to recover debts outstanding. In those instances, the Company was able to obtain financing from related parties to cover the verdict or settlement; however, there is no assurance that the Company would be able to obtain the same financing in the future. If the Company is unsuccessful in obtaining financing to cover any potential verdicts or settlements, the Company will be required to cease operations.

 

The Company’s activities will necessitate significant uses of working capital beyond 2016. Additionally, the Company’s capital requirements will depend on many factors, including the success of the Company’s continued product development and distribution efforts. The Company plans to continue financing its operations with the lines of credit it has available.

 

While the Company strongly believes that its capital resources will be sufficient in the near term, there is no assurance that the Company’s activities will generate sufficient revenues to sustain its operations without additional capital or if additional capital is needed, that such funds, if available, will be obtainable on terms satisfactory to the Company.

 

XML 20 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
2. Significant accounting policies
12 Months Ended
Dec. 31, 2016
Accounting Policies [Abstract]  
Significant Accounting Policies

2.       Significant accounting policies

 

  a) Principles of consolidation

 

These consolidated financial statements include the accounts of the Company and its integrated wholly-owned subsidiary, Canada ALRTech Health Systems Inc., which was incorporated on April 15, 2008 in Canada. All significant inter-company balances and transactions have been eliminated.

 

  b) Stock-based compensation

 

The Company follows the fair value method of accounting for stock-based compensation. The Company estimates the fair value of share-based payment awards on the date of grant using an option pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service period in the Company’s consolidated financial statements. The Company estimates the fair value of the stock options using the Black-Scholes Option Pricing Model. The Black-Scholes Option Pricing Model requires the input of highly subjective assumptions, including the option’s expected life and the price volatility of the underlying stock.

 

  c) Income taxes

 

Income taxes are accounted for under the asset and liability method. Deferred income tax assets and liabilities are recognized for the differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis, and operating loss carry-forwards that are available to be carried forward to future years for tax purposes.

 

Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred income tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. When it is not considered to be more likely than not that a deferred income tax asset will be realized, a valuation allowance is provided for the excess.

 

The Company follows the accounting requirements associated with uncertainty in income taxes using the provisions of Financial Accounting Standards Board (“FASB”) ASC 740, Income Taxes. Using that guidance, tax positions initially need to be recognized in the financial statements when it is more-likely-than-not the positions will be sustained upon examination by the tax authorities. It also provides guidance for derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. As of December 31, 2016, the Company has no uncertain tax positions that qualify for either recognition or disclosure in the financial statements.

 

  d) Use of estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, the measurement of stock-based compensation, the fair value of financial instruments and the reported amounts of revenues and expenses during the reporting period. Management believes the estimates are reasonable; however, actual results could differ from those estimates.

 

  e) Loss per share

 

Basic loss per common share is calculated by dividing net loss by the weighted average number of common shares outstanding during the year. Diluted loss per common share is calculated by dividing the net loss by the sum of the weighted average number of common shares outstanding and the dilutive common equivalent shares outstanding during the year. Common equivalent shares consist of the shares issuable upon exercise of stock options and warrants calculated using the treasury stock method. Common equivalent shares are not included in the calculation of the weighted average number of shares outstanding for diluted loss per common shares when the effect would be anti-dilutive.

 

  f) Comprehensive income

 

Comprehensive income is the overall change in the net assets of the Company for a period, other than changes attributable to transactions with stockholders. It is made up of net income and other comprehensive income. Other comprehensive income consists of net income and other gains and losses affecting stockholders' equity that under generally accepted accounting principles are excluded from net income. The Company has no items of other comprehensive income (loss) in any period presented. Therefore, as presented in the Company's consolidated statements of loss, net loss equals comprehensive loss.

 

  g) Fair value of financial instruments

 

The Company’s financial instruments include cash, accounts payable, promissory notes payable and lines of credit. The fair values of these financial instruments approximate their carrying values due to the relatively short periods to maturity of these instruments. For fair value measurement, U.S. GAAP establishes a three-tier hierarchy which prioritizes the inputs used in the valuation methodologies in measuring fair value:

 

Level 1 — observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.

 

Level 2 — include other inputs that are directly or indirectly observable in the marketplace.

 

Level 3 — unobservable inputs which are supported by little or no market activity.

 

h)      Recently adopted and issued accounting pronouncements

 

i.       Adopted

 

In August 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-15, “Presentation of Financial Statements – Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entitiy’s Ability to Continue as a Going Concern” (“ASU 2014-15”). ASU 2014-15 requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern for each annual and interim reporting period. If substantial doubt exists, additional disclosure is required. This new standard was effective for the Company for annual and interim periods beginning after December 15, 2016. Adoption of this pronouncement did not have a material impact on the Company’s consolidated financial statements.

 

In March 2016, the FASB issued ASU No. 2016-09, Compensation — Stock Compensation: Improvements to Employee Share-Based Payment Accounting (“ASU 2016-09”). The new guidance will change how companies account for certain aspects of share-based payments to employees. Under existing accounting guidance, tax benefits and certain tax deficiencies arising from the vesting of share-based payments are recorded in additional paid-in-capital. The new guidance will require such benefits or deficiencies to be recognized as income tax benefits or expenses in the statement of operations. Companies are required to apply the new guidance prospectively. This new standard was effective for the Company for annual and interim periods beginning after December 15, 2016. Adoption of this pronouncement did not have a material impact on the Company’s consolidated financial statements.

  

  ii. Issued

 

In January 2016, the FASB issued ASU 2016-01, Financial Instruments - Overall: Recognition and Measurement of Financial Assets and Financial Liabilities. This new standard provides guidance on how entities measure certain equity investments and present changes in the fair value. This standard requires that entities measure certain equity investments that do not result in consolidation and are not accounted for under the equity method at fair value and recognize any changes in fair value in net income. ASU 2016-01 is effective for fiscal years beginning after December 31, 2017.

 

In June 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The new standard requires financial assets measured at amortized cost be presented at the net amount expected to be collected, through an allowance for credit losses that is deducted from the amortized cost basis. The standard will be effective for the Company beginning January 1, 2020, with early application permitted. This standard is not expected to have a material impact on the Company’s financial position, results of operations or statement of cash flows upon adoption.

 

In August 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. The new standard will make eight targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. The standard will be effective for the Company beginning January 1, 2018, with early application permitted. The standard will require adoption on a retrospective basis unless it is impracticable to apply, in which case we would be required to apply the amendments prospectively as of the earliest date practicable.

 

The Company has implemented all new accounting pronouncements that are in effect and may impact its financial statements. The Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or statement of operations.

 

XML 21 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1
3. Promissory notes interest payable
12 Months Ended
Dec. 31, 2016
Interest Advancesand Promissory Notes Payable [Abstract]  
Promissory notes interest payable

3.       Promissory notes and interest payable

 

a)       Promissory notes payable to related parties:

 

A summary of the promissory notes payable to related parties is as follows:

 

 

Promissory Notes Payable to Related Parties

 

December 31,

2016

 

December 31,

2015

     
         
Promissory notes payable to relatives of directors collateralized by a general security agreement on all the assets of the Company, due on demand:        
             
  i. Interest at 1% per month $ 580,619 $ 580,619
             
  ii. Interest at 1.25% per month   51,347   51,347
             
  iii. Interest at the U.S. bank prime rate plus 1%   100,000   100,000
             
  iv. Interest at 0.5% per month   695,000   695,00
         
Promissory notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, due on demand   1,465,000   1,465,000
Total Promissory Notes Payable to Related Parties $ 2,891,966 $ 2,891,966

 

 

b)       Promissory notes payable to unrelated parties

 

A summary of the promissory notes payable to unrelated parties is as follows:

 

Promissory Notes Payable to Unrelated Parties  

 

December 31,

  December 31,
    2016   2015
         
Unsecured promissory notes payable to unrelated lenders:        
             
  i. Interest at 1% per month, repayable on March 31, 2009, due on demand $ 450,000 $ 450,000
             
  ii. Interest at 1% per month, with $50,000 repayable on December 31, 2004, $75,000 repayable on August 18, 2007, $75,000 repayable on November 19, 2007 and the balance due on demand. All are due on demand, accruing interest at the same rate.   887,455   887,455
             
  iii. Interest at 0.625% per month, with $50,000 repayable on October 5, 2004, $40,000 repayable on December 31, 2004, and $60,000 repayable on July 28, 2006, all due on demand   150,000   150,000
             
  iv. Non-interest-bearing, repayable on July 17, 2005, due on demand   270,912   270,912
             
  v. Non-interest-bearing loan repayable at $25,000 per month beginning October 2009, none repaid to date   310,986   310,986
             
  vi. Interest at 0.667% per month, with $125,000 due January 15, 2011   125,000   125,000
           
Promissory notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month   200,000   230,000
Total Promissory Notes Payable to Unrelated Parties $ 2,394,353 $ 2,394,353

 

 

c)       Interest payable

 

A summary of the interest payable activity is as follows:

 

     
Balance, December 31, 2014   $ 2,620,172  
Interest incurred on promissory notes payable     515,571  
         
Balance, December 31, 2015     3,135,743  
Interest incurred on promissory notes payable     494,171  
         
Balance, December 31, 2016   $ 3,629,913  

 

 

         
    December 31,   December 31,
    2016   2015
         
Related parties (relatives of the Chairman)   $ 1,956,403     $ 1,667,977  
Non-related parties     1,673,511       1,467,766  
                 
    $ 3,629,913     $ 3,135,743  

 

The payment terms, security and any interest payable are based on the underlying promissory notes payable that the Company has outstanding.

 

d)       Interest expense

 

During the year ended December 31, 2016, the Company incurred interest expense of $9,064,906 (2015: $4,795,168) substantially as follows:

  - $494,170 (2015: $515,571), including interest incurred on promissory notes (note 3(a)) and other payables;

 

  - $1,102,242 (2015: $944,010) incurred on lines of credit payable as shown in note 4;

 

  - $148,426 (2015: $148,620) incurred from the calculation of imputed interest on accounts payable outstanding for longer than one year, advances payable and promissory notes payable, which had no stated interest rate; and

 

  - $7,318,539 (2015: $3,184,459) incurred on stock options granted to creditors (note 6(a)).

 

 

XML 22 R10.htm IDEA: XBRL DOCUMENT v3.8.0.1
4. Lines of Credit
12 Months Ended
Dec. 31, 2016
Linesof Credit Related Party [Abstract]  
Lines of Credit

4.        Lines of credit

 

As of December 31, 2016, the Company has two lines of credit as follows:

 

Creditor Interest Rate Borrowing Limit Repayment Terms Principal Borrowed Accrued Interest

Total

Outstanding

Security Purpose
Chairman and CEO 1% per Month $8,500,000 Due on Demand $   7,628,219 $  2,490,958 $10,119,177 General Security over Assets General Corporate Requirements
Wife of Chairman 1% per Month $2,000,000 Due on Demand $   2,000,000 $  1,256,385 $ 3,256,385 General Security over Assets General Corporate Requirements
Total   $10,500,000   $   9,628,219 $  3,747,343 $13,375,562    

 

 

On July 1, 2016, the Company and the Chief Executive Officer of the Company agreed to amend the existing credit agreement to increase the borrowing limit on the line of credit provided to the Company from $7,000,000 to $8,500,000.

 

As of December 31, 2015, the Company has two lines of credit as follows:

 

Creditor Interest Rate Borrowing Limit Repayment Terms Principal Borrowed Accrued Interest

Total

Outstanding

Security Purpose
Chairman and CEO 1% per Month $7,000,000 Due on Demand $   6,626,993 $  1,628,716 $ 8,255,708 General Security over Assets General Corporate Requirements
Wife of Chairman 1% per Month $2,000,000 Due on Demand $   2,000,000 $  1,016,385 $ 3,016,385 General Security over Assets General Corporate Requirements
Total   $9,000,000   $   8,626,993 $  2,645,101 $11,272,093    

 

On May 29, 2015, the Company and the Chief Executive Officer of the Company agreed to amend the existing credit agreement to increase the borrowing limit on the line of credit provided to the Company from $5,500,000 to $7,000,000.

 

XML 23 R11.htm IDEA: XBRL DOCUMENT v3.8.0.1
5. Capital Stock
12 Months Ended
Dec. 31, 2016
Stockholders' Equity Note [Abstract]  
Capital Stock

5.       Capital stock

 

  a) Authorized share capital

 

  i. Common Stock

 

During the year ended December 31, 2016:

 

On December 21, 2016, the Company’s shareholders holding a majority of the issued capital stock consented in writing to increase the authorized shares of common stock of the Company from two billion shares (2,000,000,000) to ten billion shares (10,000,000,000) shares. The increase in the authorized shares of common stock of the Company is pending approval from the Securities and Exchange Commission (“SEC”).

 

During the year ended December 31, 2015:

 

On June 25, 2015, the Company’s articles of incorporation were amended to increase the authorized shares of common stock from 500,000,000 to 2,000,000,000 shares with a par value of $0.001 per share.

 

  ii. Preferred Stock

 

500,000,000 shares of preferred stock with a par value of $0.001 per share.

 

  b) Issued share capital

 

During the years ended December 31, 2016 and December 31, 2015:

 

There was no activity during the period.

 

XML 24 R12.htm IDEA: XBRL DOCUMENT v3.8.0.1
6. Additional paid in capital
12 Months Ended
Dec. 31, 2016
Additional Paid in Capital [Abstract]  
Additional paid in capital

6.        Additional paid-in capital

 

  a) Stock options

 

A summary of stock option activity is as follows:

 

     
  Year Ended Year Ended
  December 31, 2016 December 31, 2015
    Weighted Average   Weighted Average
  Number of Options

Exercise

Price

Number of

Options

Exercise

Price

Outstanding, beginning of period 579,000,200 $ 0.015 245,700,100 $ 0.030
Granted 4,390,001,300   0.002 334,500,100   0.015
Cancelled (6,700,000)   (0.030) -   -
Expired -   - (1,200,000)   (0.250)
Exercised -   - -   -
Outstanding, end of period 4,962,301,500 $ 0.004 579,000,200 $ 0.015
             
Exercisable, end of period 4,960,101,500 $ 0.004 575,650,200 $ 0.015

 

During the year ended December 31, 2016:

 

On July 1, 2016, the Company and the Chief Executive Officer of the Company agreed to amend the existing credit agreement to increase the borrowing limit on the line of credit provided to the Company from $7,000,000 to $8,500,000 (Note 4). In exchange for Mr. Chan making available the additional loan of $1,500,000 to the Company, the Company:

  · reduced the exercise price of the 560,000,200 shares of common stock under option to Mr. Chan and his spouse from $0.015 to $0.002;

 

  · granted Mr. Chan and his spouse the right and option to purchase, an additional 4,390,001,300 shares of common stock at a price of $0.002 per share for a term of five years

 

The interest expense recognized related to the option grant was $7,318,539.

 

The Company recorded a further $18,014 in compensation expense related to vesting of stock options granted in previous years.

 

During the year ended December 31, 2015:

 

On January 30, 2015, the Company granted options to acquire 4,500,000 shares of common stock at a price of $0.03 per share to 14 individuals. The fair value of the options granted was $42,858. During the year the Company recognized fair value of $10,964 and will recognize the balance over the vesting period for the unvested options.

 

On April 22, 2015, our Board of Directors approved the modification of the exercise price to acquire 12,400,000 shares of common stock of the Company from $0.03 per share to $0.015 per share held by 20 individuals. There was no increase in the fair value of the options from this modification. None of these option agreements have been executed.

 

On May 29, 2015, the Company and the Chief Executive Officer of the Company agreed to amend the existing credit agreement to increase the borrowing limit on the line of credit provided to the Company from $5,500,000 to $7,000,000 (Note 4). In exchange for Mr. Chan making available the additional loan of $1,500,000 to the Company, the Company:

  · reduced the exercise price of the 230,000,100 shares of common stock under option to Mr. Chan and his spouse from $0.03 to $0.015;

 

  · extended the expiry date of the 230,000,100 shares of common stock under option to Mr. Chan to be five years from the date of execution of the amended credit agreement;

 

  · granted Mr. Chan the right and option to purchase, an additional 329,999,967 shares of common stock at a price of $0.015 per share for a term of five years from the date of execution of the amended credit agreement.

 

The interest expense recognized related to the option grant was $3,184,459.

 

The Company recorded a further $27,569 in compensation expense related to vesting of stock options granted in previous years.

 

The options outstanding at December 31, 2016 and 2015 were as follows:

 

           
    December 31, 2016   December 31, 2015
Expiry Date   Options   Exercise Price   Intrinsic Value   Options   Exercise Price Intrinsic Value
                       
May 4, 2016   - $ -   -   1,000,000 $ 0.050 -
May 23, 2016   - $ -   -   100,000 $ 0.030 -
May 27, 2017   400,000 $ 0.030   -   400,000 $ 0.030 -
May 31, 2017   500,000 $ 0.050   -   500,000 $ 0.050 -
August 16, 2017   250,000 $ 0.030   -   250,000 $ 0.030 -
December 28, 2017   1,000,000 $ 0.030   -   1,000,000 $ 0.030 -
January 28, 2018   1,500,000 $ 0.030   -   2,300,000 $ 0.030 -
March 26, 2018   500,000 $ 0.030   -   500,000 $ 0.030 -
April 9, 2018   1,000,000 $ 0.030   -   1,000,000 $ 0.030 -
October 1, 2018   - $ -   -   500,000 $ 0.030 -
February 7, 2019   - $ -   -   700,000 $ 0.030 -
April 18,2019   - $ -   -   2,000,000 $ 0.030 -
May 21, 2019   500,000 $ 0.030   -   500,000 $ 0.030 -
July 25, 2019   1,000,000 $ 0.030   -   1,000,000 $ 0.030 -
August 1, 2019   1,250,000 $ 0.030   -   1,250,000 $ 0.030 -
August 26, 2019   1,500,000 $ 0.030   -   1,500,000 $ 0.030 -
January 30, 2020   2,900,000 $ 0.030   -   4,500,000 $ 0.030 -
May 29, 2020   560,000,200 $ 0.002   -   560,000,200 $ 0.015 -
July 21, 2021   4,390,001,300 $ 0.002       - $ -  
Total   4,962,301,500 $ 0.002   -   579,000,200 $ 0.015 -

Weighted Average Remaining

Contractual Life

  4.81           4.37  

 

 

The Company uses the fair value method for determining stock-based compensation for all options granted during the fiscal periods. The fair value was determined using the Black-Scholes Option Pricing Model based on the following weighted average assumptions:

 

 

         
   

December 31,

2016

 

December 31,

2015

         
Risk-free interest rate     1.68 %     1.68 %
Expected life     5 years       5 years  
Expected dividends     0 %     0 %
Expected volatility     210 %     194 %
Forfeiture rate     0 %     0 %

 

The weighted average fair value for the options granted during 2016 was $0.002 (2015: $0.010).

 

The fair value of the stock options granted was allocated as follows:

         
    December 31, 2016  

December 31,

2015

         
Interest expense   $ 7,318,539     $ 3,184,459  
Product development expense     14,267       14,374  
Professional expense     577       3,806  
Selling, general and administration expenses:     3,170       20,355  
                 
    $ 7,336,553     $ 3,222,992  

 

 

XML 25 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1
7. Related party transactions and balances
12 Months Ended
Dec. 31, 2016
Related Party Transactions [Abstract]  
Related party transactions and balances

7.       Related party transactions and balances

 

  a) Related party transactions

 

           
      Year End December 31, 2016   Year End December 31, 2015
           
Related party transaction included within interest expense:          
Interest expenses on promissory notes issued to relatives of the Chairman & Chief Executive Officer of the Company   $ 288,426 $ 309,826
Interest expense on lines of credit payable to the Chairman & Chief Executive Officer of the Company and his spouse   $ 1,102,242

 

$

944,010
Stock based compensation related to stock options granted to the Chairman & Chief Executive Officer for increasing the borrowing limit on the line of credit available to the Company   $ 7,318,539

 

 

$

3,184,459
           
Related party transactions including within selling, general and administration expenses:          
Consulting fees to the Chairman & Chief Executive Officer of the Company accrued on the line of credit available to the Company   $ 189,600 $ 189,600
Consulting fees paid to the President of the Company   $ 15,500 $ 186,000

 

Interest on promissory notes payable to related parties, management compensation and compensation paid to a relative of a director have been recorded at the exchange amount, which is the amount agreed to by the parties. Options granted to related parties have been recorded at their estimated fair value.

 

  b) Related party balances

 

Included in accounts payable is $nil (2015: $15,529) due to a Director of the Company.

XML 26 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
8. Commitments and contingencies
12 Months Ended
Dec. 31, 2016
Compensation Related Costs [Abstract]  
Commitments and contingencies

8.       Commitments and contingencies

 

  a) Contingencies

 

The Company has had three judgments against it relating to overdue promissory notes and accrued interest and a fourth creditor has demanded repayment of an overdue promissory note and accrued interest. To date, the Company has not repaid any of these promissory notes and related accrued interest and could be subject to further action. The legal liability, totaling $1,076,168, of these promissory notes and related accrued interest have been fully recognized and recorded by the Company.

 

b) Commitments

 

The Company has a consulting arrangement with Mr. Sidney Chan, Chief Executive Officer and Chairman of the Board of Directors of the Company. Under the terms of the contract, Mr. Chan will be paid $180,000 per annum for services as Chief Executive Officer. The contract can be terminated at any time with thirty days’ notice and the payment of two years annual salary. Should the contract be terminated, all debts owed to Mr. Chan and his spouse must be immediately repaid. The initial term of the contract is for one year and automatically renews for continuous one year terms. Also under the terms of the contract are the following:

 

  i. Incentive Revenue Bonus

 

Mr. Chan will be entitled to a 1% net sales commission from the sales of any of the Company’s products at any time during his life, regardless if Mr. Chan is still under contract with the Company.

 

  ii. Sale of Business

 

If more than 50% of the Company’s stock or assets are sold, Mr. Chan will be compensated for entering into non-compete agreements based on the selling price of the Company or its assets as follows:

 

  - 2% of sales price up to $24,999,999 plus

 

  - 3% of sales price between $25,000,000 and $49,999,999 plus

 

  - 4% of sales price between $50,000,000 and $199,999,999 plus

 

  - 5% of sales price in excess of $200,000,000
XML 27 R15.htm IDEA: XBRL DOCUMENT v3.8.0.1
9. Financial instruments
12 Months Ended
Dec. 31, 2016
Disclosure Text Block Supplement [Abstract]  
Financial Instruments

9.       Financial instruments

 

The Company’s financial instruments consist of cash, accounts payable, interest payable, promissory notes payable to unrelated parties and promissory notes payable to related parties.

 

  a) Fair value

 

The fair values of cash and certain accounts payable and accrued liabilities approximate their carrying values due to the relatively short periods to maturity of these instruments.

 

Certain accounts payable have been outstanding longer than one year. The Company has recorded imputed interest at a rate of 1% per month over the period the payables have been outstanding for longer than one year, with a corresponding amount recognized in additional paid-in capital. The calculated amount represents the implicit compensation for the use of funds beyond a reasonable term for regular trade payables.

 

For the purposes of fair value analysis, promissory notes payable to related parties and promissory notes payable to unrelated parties can be separated into two classes of financial liabilities.

 

i.       Interest-bearing promissory notes, lines of credit and related interest payable

ii.       Non-interest-bearing promissory notes past due

 

The interest-bearing promissory notes payable are all delinquent and have continued to accrue interest at their stated rates. The Company currently does not have the funds to extinguish these debts and will continue to incur interest until such time as the liabilities are extinguished. There is not an active market for delinquent loans for a Company with a similar financial position. Management asserts the carrying values of the promissory notes and related interest payable are a reasonable estimate of fair value as they represent the Company’s best estimate of their legal obligation for these debts. As there is no observable market for interest rates on similar promissory notes, the fair value was estimated using level 2 inputs in the fair value hierarchy.

 

The Company has three non-interest-bearing promissory notes payable past due. The first is several years delinquent and there have been no renegotiated repayment terms. There is not an active market for default loans not bearing interest nor is there an observable market for lending to companies with a financial position similar to the Company. The Company has recorded imputed interest at a rate of 1% per month over the life of the promissory notes, with a corresponding amount recognized in additional paid-in capital representing the implicit compensation for the use of funds.  Management asserts the payment date for these amounts cannot be reasonably determined. Management further asserts there is not a determinable interest rate for arm’s-length borrowings based on the current financial position of the Company and asserts the carrying value is the best estimate of the Company’s legal liability and represents the fair value for the promissory note. This would be considered a level 2 input in the fair value hierarchy.

 

  b) Credit risk

 

Financial instruments that potentially subject the Company to credit risk consist of cash. The Company only has an immaterial cash balance and is not exposed to significant credit risk.

 

  c) Market risk

 

Market risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices.  Market risk comprises two types of risk: interest rate risk and foreign currency risk.

 

i.       Interest rate risk

 

Interest rate risk consists of two components:

 

a)        Cash flow risk

 

To the extent that payments made or received on the Company’s monetary assets and liabilities are affected by changes in the prevailing market interest rates, the Company is exposed to interest rate cash flow risk.

 

The Company is exposed to interest rate cash flow risk on promissory notes payable of $500,000, which incur a variable interest rate of prime plus 1%. A hypothetical change of 1% on interest rates would increase or decrease net loss and comprehensive loss by $5,000.

 

b)       Price risk

 

To the extent that changes in prevailing market interest rates differ from the interest rate on the Company’s monetary assets and liabilities, the Company is exposed to price risk.

 

The Company’s promissory notes payable consist of $500,000 of variable interest rate notes and $4,786,319 of fixed interest rate notes. All of these notes are past due and are currently due on demand while interest continues to accrue. Due to the delinquency of the fixed interest rate promissory notes payable, there is no active market for these instruments and fluctuations in market interest rates do not have a significant impact on their estimated fair values as of December 31, 2016.

 

At December 31, 2016, the effect on the net loss and comprehensive loss of a hypothetical change of 1% in market interest rate cannot be reasonably determined.

 

c) Foreign currency risk

 

The Company incurs certain accounts payable and expenses in Canadian dollars and is exposed to fluctuations in changes in exchange rates between the US and Canadian dollars. As at December 31, 2016, the effect on net loss and comprehensive loss of a hypothetical change of 10% between the US and Canadian dollar would not be material. The Company has not entered into any foreign currency contracts to mitigate risk.

 

XML 28 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1
10. Income taxes
12 Months Ended
Dec. 31, 2016
Income Tax Disclosure [Abstract]  
Income Taxes

10.       Income taxes

 

The provision for income taxes differs from the result that would be obtained by applying the statutory tax rate of 34% (2015 - 34%) to income before income taxes. The difference results from the following items:

 

         
   

December 31,

2016

 

December 31,

2015

         
Computed expected benefit of income taxes   $ (3,431,869 )   $ (2,141,596 )
Stock-based compensation     2,494,428       1,095,817  
Non-deductible interest expense     50,465       50,531  
Increase in valuation allowance     886,976       995,248  
                 
Income tax provision   $ —       $ —    

 

The components of the net deferred income tax asset, the statutory tax rate and the amount of the valuation allowance are as follows:

 

         
   

December 31,

2016

 

December 31,

2015

         
Net operating loss carried forward   $ 37,532,822     $ 34,924,072  
Tax rate     34 %     34 %
Deferred income tax assets     12,761,159       11,874,184  
Valuation allowance     (12,761,159 )     (11,874,184 )
                 
Net deferred income tax asset   $ —       $ —    

 

The potential benefit of the deferred income tax asset has not been recognized in these financial statements since it cannot be assured that it is more likely than not that such benefit will be utilized in future years. The Company believes that the available objective evidence creates sufficient uncertainty regarding the realizability of the deferred income tax assets such that a full valuation allowance has been recorded.

 

The operating losses amounting to $37,532,822 for utilization in the United States of America, the jurisdiction where they were incurred, will expire between 2019 and 2036 if they are not used. The following table lists the fiscal year in which the loss was incurred and the expiration date of the operating loss carry-forwards:

 

Fiscal Year   Amount Expiry Date
1999 $ 88,022 2019
2000   4,425,866 2020
2001   3,681,189 2021
2002   2,503,951 2022
2003   2,775,900 2023
2004   1,250,783 2024
2005   1,304,283 2025
2006   1,532,322 2026
2007   1,479,818 2027
2008   1,599,919 2028
2009   1,723,146 2029
2010   822,678 2030
2011   1,746,615 2031
2012   1,638,421 2032
2013   2,568,328 2033
2014   2,855,631 2034
2015   2,927,200 2035
2016   2,608,750 2036
Total $ 37,532,822  

 

XML 29 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1
11. Subsequent event
12 Months Ended
Dec. 31, 2016
Subsequent Events [Abstract]  
Subsequent Events

 

11.       Subsequent events

 

a)On January 27, 2017, the Company’s Board of Directors approved a 100:1 reverse share split of the Company’s common stock. The reverse share split is pending approval from the SEC and other regulatory bodies.

 

b)On November 27, 2017, the Company’s Board of Directors approved the grant of the option to 8,700,000 shares of common stock of the Company at a price of $0.015 per share for a term of five years. 2,200,000 of the approved options were to a director of the Company and 6,500,000 were to consultants of the Company.

 

c)On January 31, 2018, the Company’s Board of Directors approved the following grants:
·the option to acquire 47,000,000 shares of common stock of the Company at a price of $0.015 per share for a term of five years to 9 consultants of the Company, and
·the option to acquire 200,000 shares of common stock of the Company at a price of $0.015 per share until April 19, 2019 to 1 consultant of the Company.

 

Of the options granted with a term of five years, options to acquire a total of 11,000,000 shares of common stock were granted to three relatives of the Chairman of the Board.

XML 30 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1
2. Significant accounting policies (Policies)
12 Months Ended
Dec. 31, 2016
Significant Accounting Policies Policies  
a) Principles of consolidation
  a) Principles of consolidation

 

These consolidated financial statements include the accounts of the Company and its integrated wholly-owned subsidiary, Canada ALRTech Health Systems Inc., which was incorporated on April 15, 2008 in Canada. All significant inter-company balances and transactions have been eliminated.

b) Stock-based compensation
  b) Stock-based compensation

 

The Company follows the fair value method of accounting for stock-based compensation. The Company estimates the fair value of share-based payment awards on the date of grant using an option pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service period in the Company’s consolidated financial statements. The Company estimates the fair value of the stock options using the Black-Scholes Option Pricing Model. The Black-Scholes Option Pricing Model requires the input of highly subjective assumptions, including the option’s expected life and the price volatility of the underlying stock.

c) Income taxes
  c) Income taxes

 

Income taxes are accounted for under the asset and liability method. Deferred income tax assets and liabilities are recognized for the differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis, and operating loss carry-forwards that are available to be carried forward to future years for tax purposes.

 

Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred income tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. When it is not considered to be more likely than not that a deferred income tax asset will be realized, a valuation allowance is provided for the excess.

 

The Company follows the accounting requirements associated with uncertainty in income taxes using the provisions of Financial Accounting Standards Board (“FASB”) ASC 740, Income Taxes. Using that guidance, tax positions initially need to be recognized in the financial statements when it is more-likely-than-not the positions will be sustained upon examination by the tax authorities. It also provides guidance for derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. As of December 31, 2016, the Company has no uncertain tax positions that qualify for either recognition or disclosure in the financial statements.

d) Use of estimates

 

  d) Use of estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, the measurement of stock-based compensation, the fair value of financial instruments and the reported amounts of revenues and expenses during the reporting period. Management believes the estimates are reasonable; however, actual results could differ from those estimates.

e) Loss per share
  e) Loss per share

 

Basic loss per common share is calculated by dividing net loss by the weighted average number of common shares outstanding during the year. Diluted loss per common share is calculated by dividing the net loss by the sum of the weighted average number of common shares outstanding and the dilutive common equivalent shares outstanding during the year. Common equivalent shares consist of the shares issuable upon exercise of stock options and warrants calculated using the treasury stock method. Common equivalent shares are not included in the calculation of the weighted average number of shares outstanding for diluted loss per common shares when the effect would be anti-dilutive.

f) Comprehensive income
  f) Comprehensive income

 

Comprehensive income is the overall change in the net assets of the Company for a period, other than changes attributable to transactions with stockholders. It is made up of net income and other comprehensive income. Other comprehensive income consists of net income and other gains and losses affecting stockholders' equity that under generally accepted accounting principles are excluded from net income. The Company has no items of other comprehensive income (loss) in any period presented. Therefore, as presented in the Company's consolidated statements of loss, net loss equals comprehensive loss.

g) Fair value of financial instruments
  g) Fair value of financial instruments

 

The Company’s financial instruments include cash, accounts payable, promissory notes payable and lines of credit. The fair values of these financial instruments approximate their carrying values due to the relatively short periods to maturity of these instruments. For fair value measurement, U.S. GAAP establishes a three-tier hierarchy which prioritizes the inputs used in the valuation methodologies in measuring fair value:

 

Level 1 — observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.

 

Level 2 — include other inputs that are directly or indirectly observable in the marketplace.

 

Level 3 — unobservable inputs which are supported by little or no market activity.

h) Recently adopted and issued accounting pronouncements

h)      Recently adopted and issued accounting pronouncements

 

i.       Adopted

 

In August 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-15, “Presentation of Financial Statements – Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entitiy’s Ability to Continue as a Going Concern” (“ASU 2014-15”). ASU 2014-15 requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern for each annual and interim reporting period. If substantial doubt exists, additional disclosure is required. This new standard was effective for the Company for annual and interim periods beginning after December 15, 2016. Adoption of this pronouncement did not have a material impact on the Company’s consolidated financial statements.

 

In March 2016, the FASB issued ASU No. 2016-09, Compensation — Stock Compensation: Improvements to Employee Share-Based Payment Accounting (“ASU 2016-09”). The new guidance will change how companies account for certain aspects of share-based payments to employees. Under existing accounting guidance, tax benefits and certain tax deficiencies arising from the vesting of share-based payments are recorded in additional paid-in-capital. The new guidance will require such benefits or deficiencies to be recognized as income tax benefits or expenses in the statement of operations. Companies are required to apply the new guidance prospectively. This new standard was effective for the Company for annual and interim periods beginning after December 15, 2016. Adoption of this pronouncement did not have a material impact on the Company’s consolidated financial statements.

  

  ii. Issued

 

In January 2016, the FASB issued ASU 2016-01, Financial Instruments - Overall: Recognition and Measurement of Financial Assets and Financial Liabilities. This new standard provides guidance on how entities measure certain equity investments and present changes in the fair value. This standard requires that entities measure certain equity investments that do not result in consolidation and are not accounted for under the equity method at fair value and recognize any changes in fair value in net income. ASU 2016-01 is effective for fiscal years beginning after December 31, 2017.

 

In June 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The new standard requires financial assets measured at amortized cost be presented at the net amount expected to be collected, through an allowance for credit losses that is deducted from the amortized cost basis. The standard will be effective for the Company beginning January 1, 2020, with early application permitted. This standard is not expected to have a material impact on the Company’s financial position, results of operations or statement of cash flows upon adoption.

 

In August 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. The new standard will make eight targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. The standard will be effective for the Company beginning January 1, 2018, with early application permitted. The standard will require adoption on a retrospective basis unless it is impracticable to apply, in which case we would be required to apply the amendments prospectively as of the earliest date practicable.

 

The Company has implemented all new accounting pronouncements that are in effect and may impact its financial statements. The Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or statement of operations.

XML 31 R19.htm IDEA: XBRL DOCUMENT v3.8.0.1
3. Interest, advances and promissory notes payable (Tables)
12 Months Ended
Dec. 31, 2016
Interest Advancesand Promissory Notes Payable [Abstract]  
Schedule of Promissory Notes Payable - Relatives of Board of Directors

 

Promissory Notes Payable to Related Parties

 

December 31,

2016

 

December 31,

2015

     
         
Promissory notes payable to relatives of directors collateralized by a general security agreement on all the assets of the Company, due on demand:        
             
  i. Interest at 1% per month $ 580,619 $ 580,619
             
  ii. Interest at 1.25% per month   51,347   51,347
             
  iii. Interest at the U.S. bank prime rate plus 1%   100,000   100,000
             
  iv. Interest at 0.5% per month   695,000   695,00
         
Promissory notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, due on demand   1,465,000   1,465,000
Total Promissory Notes Payable to Related Parties $ 2,891,966 $ 2,891,966

 

Schedule of Activity of Promissory Notes Payable to Unrelated Lenders
Promissory Notes Payable to Unrelated Parties  

 

December 31,

  December 31,
    2016   2015
         
Unsecured promissory notes payable to unrelated lenders:        
             
  i. Interest at 1% per month, repayable on March 31, 2009, due on demand $ 450,000 $ 450,000
             
  ii. Interest at 1% per month, with $50,000 repayable on December 31, 2004, $75,000 repayable on August 18, 2007, $75,000 repayable on November 19, 2007 and the balance due on demand. All are due on demand, accruing interest at the same rate.   887,455   887,455
             
  iii. Interest at 0.625% per month, with $50,000 repayable on October 5, 2004, $40,000 repayable on December 31, 2004, and $60,000 repayable on July 28, 2006, all due on demand   150,000   150,000
             
  iv. Non-interest-bearing, repayable on July 17, 2005, due on demand   270,912   270,912
             
  v. Non-interest-bearing loan repayable at $25,000 per month beginning October 2009, none repaid to date   310,986   310,986
             
  vi. Interest at 0.667% per month, with $125,000 due January 15, 2011   125,000   125,000
           
Promissory notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month   200,000   230,000
Total Promissory Notes Payable to Unrelated Parties $ 2,394,353 $ 2,394,353

 

Schedule of Interest Payable

   
  $ 2,620,172  
    515,571  
       
    3,135,743  
    494,171  
       
  $ 3,629,913  

 

 

         
    December 31,   December 31,
    2016   2015
         
Related parties (relatives of the Chairman)   $ 1,956,403     $ 1,667,977  
Non-related parties     1,673,511       1,467,766  
                 
    $ 3,629,913     $ 3,135,743  

 

XML 32 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1
4. Lines of Credit (Tables)
12 Months Ended
Dec. 31, 2016
Linesof Credit Related Party [Abstract]  
Schedule Line of Credit Related Party

As of December 31, 2016, the Company has two lines of credit as follows:

 

Creditor Interest Rate Borrowing Limit Repayment Terms Principal Borrowed Accrued Interest

Total

Outstanding

Security Purpose
Chairman and CEO 1% per Month $8,500,000 Due on Demand $   7,628,219 $  2,490,958 $10,119,177 General Security over Assets General Corporate Requirements
Wife of Chairman 1% per Month $2,000,000 Due on Demand $   2,000,000 $  1,256,385 $ 3,256,385 General Security over Assets General Corporate Requirements
Total   $10,500,000   $   9,628,219 $  3,747,343 $13,375,562    

 

As of December 31, 2015, the Company has two lines of credit as follows:

 

Creditor Interest Rate Borrowing Limit Repayment Terms Principal Borrowed Accrued Interest

Total

Outstanding

Security Purpose
Chairman and CEO 1% per Month $7,000,000 Due on Demand $   6,626,993 $  1,628,716 $ 8,255,708 General Security over Assets General Corporate Requirements
Wife of Chairman 1% per Month $2,000,000 Due on Demand $   2,000,000 $  1,016,385 $ 3,016,385 General Security over Assets General Corporate Requirements
Total   $9,000,000   $   8,626,993 $  2,645,101 $11,272,093    

 

XML 33 R21.htm IDEA: XBRL DOCUMENT v3.8.0.1
6. Additional paid in capital (Tables)
12 Months Ended
Dec. 31, 2016
Stockholders' Equity Note [Abstract]  
Schedule of Share-based Compensation, Stock Options, Activity

 

     
  Year Ended Year Ended
  December 31, 2016 December 31, 2015
    Weighted Average   Weighted Average
  Number of Options

Exercise

Price

Number of

Options

Exercise

Price

Outstanding, beginning of period 579,000,200 $ 0.015 245,700,100 $ 0.030
Granted 4,390,001,300   0.002 334,500,100   0.015
Cancelled (6,700,000)   (0.030) -   -
Expired -   - (1,200,000)   (0.250)
Exercised -   - -   -
Outstanding, end of period 4,962,301,500 $ 0.004 579,000,200 $ 0.015
             
Exercisable, end of period 4,960,101,500 $ 0.004 575,650,200 $ 0.015
Schedule of Options Outstanding

 

           
    December 31, 2016   December 31, 2015
Expiry Date   Options   Exercise Price   Intrinsic Value   Options   Exercise Price Intrinsic Value
                       
May 4, 2016   - $ -   -   1,000,000 $ 0.050 -
May 23, 2016   - $ -   -   100,000 $ 0.030 -
May 27, 2017   400,000 $ 0.030   -   400,000 $ 0.030 -
May 31, 2017   500,000 $ 0.050   -   500,000 $ 0.050 -
August 16, 2017   250,000 $ 0.030   -   250,000 $ 0.030 -
December 28, 2017   1,000,000 $ 0.030   -   1,000,000 $ 0.030 -
January 28, 2018   1,500,000 $ 0.030   -   2,300,000 $ 0.030 -
March 26, 2018   500,000 $ 0.030   -   500,000 $ 0.030 -
April 9, 2018   1,000,000 $ 0.030   -   1,000,000 $ 0.030 -
October 1, 2018   - $ -   -   500,000 $ 0.030 -
February 7, 2019   - $ -   -   700,000 $ 0.030 -
April 18,2019   - $ -   -   2,000,000 $ 0.030 -
May 21, 2019   500,000 $ 0.030   -   500,000 $ 0.030 -
July 25, 2019   1,000,000 $ 0.030   -   1,000,000 $ 0.030 -
August 1, 2019   1,250,000 $ 0.030   -   1,250,000 $ 0.030 -
August 26, 2019   1,500,000 $ 0.030   -   1,500,000 $ 0.030 -
January 30, 2020   2,900,000 $ 0.030   -   4,500,000 $ 0.030 -
May 29, 2020   560,000,200 $ 0.002   -   560,000,200 $ 0.015 -
July 21, 2021   4,390,001,300 $ 0.002       - $ -  
Total   4,962,301,500 $ 0.002   -   579,000,200 $ 0.015 -

Weighted Average Remaining

Contractual Life

  4.81           4.37  

 

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

       
   December 31,
2016
  December 31,
2015
       
Risk-free interest rate   1.68%   1.68%
Expected life   5 years    5 years 
Expected dividends   0%   0%
Expected volatility   210%   194%
Forfeiture rate   0%   0%

 

Schedule of Recognized Compensation Cost, Vested Awards
    December 31, 2016  

December 31,

2015

         
Interest expense   $ 7,318,539     $ 3,184,459  
Product development expense     14,267       14,374  
Professional expense     577       3,806  
Selling, general and administration expenses:     3,170       20,355  
                 
    $ 7,336,553     $ 3,222,992  

 

 

XML 34 R22.htm IDEA: XBRL DOCUMENT v3.8.0.1
7. Related party transactions and balances (Tables)
12 Months Ended
Dec. 31, 2016
Related Party Transactions And Balances Tables  
Schedule of related party transactions

 

           
      Year End December 31, 2016   Year End December 31, 2015
           
Related party transaction included within interest expense:          
Interest expenses on promissory notes issued to relatives of the Chairman & Chief Executive Officer of the Company   $ 288,426 $ 309,826
Interest expense on lines of credit payable to the Chairman & Chief Executive Officer of the Company and his spouse   $ 1,102,242

 

$

944,010
Stock based compensation related to stock options granted to the Chairman & Chief Executive Officer for increasing the borrowing limit on the line of credit available to the Company   $ 7,318,539

 

 

$

3,184,459
           
Related party transactions including within selling, general and administration expenses:          
Consulting fees to the Chairman & Chief Executive Officer of the Company accrued on the line of credit available to the Company   $ 189,600 $ 189,600
Consulting fees paid to the President of the Company   $ 15,500 $ 186,000

 

XML 35 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1
10. Income taxes: (Tables)
12 Months Ended
Dec. 31, 2016
Income Tax Disclosure [Abstract]  
Schedule of Components of Income Tax Expense (Benefit)
         
   

December 31,

2016

 

December 31,

2015

         
Computed expected benefit of income taxes   $ (3,431,869 )   $ (2,141,596 )
Stock-based compensation     2,494,428       1,095,817  
Non-deductible interest expense     50,465       50,531  
Increase in valuation allowance     886,976       995,248  
                 
Income tax provision   $ —       $ —    

 

Schedule of Deferred Tax Assets and Liabilities

       
  

December 31,

2016

 

December 31,

2015

       
Net operating loss carried forward  $37,532,822   $34,924,072 
Tax rate   34%   34%
Deferred income tax assets   12,761,159    11,874,184 
Valuation allowance   (12,761,159)   (11,874,184)
           
Net deferred income tax asset  $—     $—   

 

Summary of Operating Loss Carryforwards

Fiscal Year   Amount Expiry Date
1999 $ 88,022 2019
2000   4,425,866 2020
2001   3,681,189 2021
2002   2,503,951 2022
2003   2,775,900 2023
2004   1,250,783 2024
2005   1,304,283 2025
2006   1,532,322 2026
2007   1,479,818 2027
2008   1,599,919 2028
2009   1,723,146 2029
2010   822,678 2030
2011   1,746,615 2031
2012   1,638,421 2032
2013   2,568,328 2033
2014   2,855,631 2034
2015   2,927,200 2035
2016   2,608,750 2036
Total $ 37,532,822  
XML 36 R24.htm IDEA: XBRL DOCUMENT v3.8.0.1
1. Basis of Presentation, Nature of Operations and Going Concern (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Basisof Presentation Natureof Operationsand Going Concern [Abstract]    
Working Capital Deficit $ 23,230,725 $ 20,621,972
Net Income (Loss) Attributable to Parent $ (10,093,733) $ (6,298,813)
XML 37 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
3. Interest, advances and promissory notes payable (Details) - Promissory Notes Payable - Relatives of Board of Directors - USD ($)
Dec. 31, 2016
Dec. 31, 2015
Promissory notes payable to relatives of directors collateralized by a general security agreement on all the assets of the Company, due on demand:    
i.Interest at 1% per month $ 580,619 $ 580,619
ii.Interest at 1.25% per month 51,347 51,347
iii.Interest at the U.S. bank prime rate plus 1% 100,000 100,000
iv. Interest at 0.5% per month 695,000 69,500
Promissory notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, due on demand 1,465,000 1,465,000
Total Related Promissory Notes $ 2,891,966 $ 2,891,966
XML 38 R26.htm IDEA: XBRL DOCUMENT v3.8.0.1
3. Interest, advances and promissory notes payable (Details) - Unsecured Promissory Notes Payable to Unrelated Leaders - USD ($)
Dec. 31, 2016
Dec. 31, 2015
Unsecured promissory notes payable to unrelated lenders:    
i. Interest at 1% per month, repayable on March 31, 2009, due on demand $ 450,000 $ 450,000
ii. Interest at 1% per month, with $50,000 repayable on December 31, 2004, $75,000 repayable on August 18, 2007, $75,000 repayable on November 19, 2007 and the balance due on demand. All are due on demand, accruing interest at the same rate. 887,455 887,455
iii. Interest at 0.625% per month, with $50,000 repayable on October 5, 2004, $40,000 repayable on December 31, 2004, and $60,000 repayable on July 28, 2006, all due on demand 150,000 150,000
iv. Non-interest-bearing, repayable on July 17, 2005, due on demand 270,912 270,912
v. Non-interest-bearing loan repayable at $25,000 per month beginning October 2009, none repaid to date 310,986 310,986
vi. Interest at 0.667% per month, with $125,000 due January 15, 2011 125,000 125,000
Promissory notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month 200,000 230,000
Total Promissory Notes Payable to Unrelated Parties $ 2,394,353 $ 2,394,353
XML 39 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1
3. Interest, advances and promissory notes payable (Details) - Summary of Interest Payable Activity - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Summary of Interest Payable Activity [Abstract]    
Beginning Balance $ 3,135,743 $ 2,620,172
Interest incurred on promissory notes payable 494,171 515,571
Ending Balance $ 3,629,913 $ 3,135,743
XML 40 R28.htm IDEA: XBRL DOCUMENT v3.8.0.1
3. Interest, advances and promissory notes payable (Details) - Interest Payable - USD ($)
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Interest Payable [Abstract]      
Relatives of directors $ 1,956,403 $ 1,667,977  
Non-related parties 1,673,511 1,467,766  
Total $ 3,629,913 $ 3,135,743 $ 2,620,172
XML 41 R29.htm IDEA: XBRL DOCUMENT v3.8.0.1
4. Lines of Credit (Details) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Principal Borrowed $ 9,628,219 $ 8,626,993
Accrued Interest 3,747,343 2,645,101
Total Outstanding $ 13,375,562 $ 11,272,093
Chairman and CEO    
Interest Rate 1.00% 1.00%
Borrowing Limit $ 8,500,000 $ 7,000,000
Repayment Terms Due on Demand Due on Demand
Principal Borrowed $ 7,628,219 $ 6,626,993
Accrued Interest 2,490,958 1,628,716
Total Outstanding $ 10,119,177 $ 8,255,708
Security General Security over Assets General Security over Assets
Purpose General Corporate Requirements General Corporate Requirements
Wife of Chairman    
Interest Rate 1.00% 1.00%
Borrowing Limit $ 2,000,000 $ 2,000,000
Repayment Terms Due on Demand Due on Demand
Principal Borrowed $ 2,000,000 $ 2,000,000
Accrued Interest 1,256,385 1,016,385
Total Outstanding $ 3,256,385 $ 3,016,385
Security General Security over Assets General Security over Assets
Purpose General Corporate Requirements General Corporate Requirements
XML 42 R30.htm IDEA: XBRL DOCUMENT v3.8.0.1
6. Additional paid in capital - Summary of Stock Option Activity (Details) - $ / shares
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Summary of Stock Option Activity [Abstract]    
Outstanding, beginning of period 579,000,200 245,700,100
Average Exercise Price, beginning $ 0.015 $ 0.030
Exercisable, end of period $ 0.002 $ 0.015
Granted 4,390,001,300 334,500,100
Granted, per share $ 0.002 $ 0.015
Cancelled (6,700,000)  
Cancelled per share $ (0.030)  
Expired   (1,200,000)
Expired pe share   $ (0.250)
Outstanding, end of period 4,962,301,500 579,000,200
Average Exercise price, ending $ 0.004 $ 0.015
XML 43 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1
6. Additional paid in capital - Options Outstanding (Details) - $ / shares
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Options Outstanding [Abstract]      
Options Outstanding 4,962,301,500 579,000,200 245,700,100
Exercise Price $ 0.002 $ 0.015  
Weighted Average Remaining Contractual Life 4 years 9 months 22 days 4 years 4 months 13 days  
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.8.0.1
6. Additional paid in capital - Fair Value Method Stock-Based Compensation (Details) - $ / shares
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Fair Value Method Stock-Based Compensation [Abstract]    
Risk-free interest rate 1.68% 1.68%
Expected life 5 years 5 years
Expected dividends 0.00% 0.00%
Expected volatility 210.00% 194.00%
Forfeiture rate $ 0 $ 0
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1
6. Additional paid in capital - Fair Value of Stock Options (Details) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Fair Value of Stock Options [Abstract]    
Interest expense $ 7,318,539 $ 3,184,459
Product development expense 14,267 14,374
Professional expense 577 3,806
Selling, general and administration expenses: 3,170 20,355
Total $ 7,336,553 $ 3,222,992
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.8.0.1
7. Related Party Transactions (Details) - USD ($)
Dec. 31, 2016
Dec. 31, 2015
Related party transaction included within interest expense:    
Interest expenses on promissory notes issued to relatives of the Chairman & Chief Executive Officer of the Company $ 288,426 $ 309,826
Interest expense on lines of credit payable to the Chairman & Chief Executive Officer of the Company and his spouse 1,102,242 944,010
Stock based compensation related to stock options granted to the Chairman & Chief Executive Officer for increasing the borrowing limit on the line of credit available to the Company 7,318,539 3,184,459
Related party transactions including within selling, general and administration expenses:    
Consulting fees to the Chairman & Chief Executive Officer of the Company accrued on the line of credit available to the Company 189,600 189,600
Consulting fees paid to the President of the Company $ 15,500 $ 186,000
XML 47 R35.htm IDEA: XBRL DOCUMENT v3.8.0.1
10. Income taxes: (Details) - Provision for Income Taxes - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Provision for Income Taxes [Abstract]    
Computed expected benefit of income taxes $ (3,431,869) $ (2,141,596)
Stock-based compensation 2,494,428 1,095,817
Non-deductible interest expense 50,465 50,531
Increase in valuation allowance 886,976 995,248
Income tax provision $ 0 $ 0
XML 48 R36.htm IDEA: XBRL DOCUMENT v3.8.0.1
10. Income taxes: (Details) - Net Deferred Income Tax Asset - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Net Deferred Income Tax Asset [Abstract]    
Net operating loss carried forward $ 37,532,822 $ 34,924,072
Tax rate 34.00% 34.00%
Deferred income tax assets $ 12,761,150 $ 11,874,184
Valuation allowance (12,761,150) (11,874,184)
Net deferred income tax asset $ 0 $ 0
XML 49 R37.htm IDEA: XBRL DOCUMENT v3.8.0.1
10. Income taxes: (Details) - Summary of Operating Loss Carryforwards - USD ($)
Dec. 31, 2036
Dec. 31, 2035
Dec. 31, 2034
Dec. 31, 2033
Dec. 31, 2032
Dec. 31, 2031
Dec. 31, 2030
Dec. 31, 2029
Dec. 31, 2028
Dec. 31, 2027
Dec. 31, 2026
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Summary of Operating Loss Carryforwards [Abstract]                                    
Opearting Loss Carryforward $ 2,608,750 $ 2,927,200 $ 2,855,631 $ 2,568,328 $ 1,638,421 $ 1,746,615 $ 822,678 $ 1,723,146 $ 1,599,919 $ 1,479,818 $ 1,532,322 $ 1,304,283 $ 1,250,783 $ 2,775,900 $ 2,503,951 $ 3,681,189 $ 4,425,866 $ 88,022
EXCEL 50 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 52 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 54 FilingSummary.xml IDEA: XBRL DOCUMENT 3.8.0.1 html 46 158 1 false 5 0 false 4 false false R1.htm 00000001 - Disclosure - Document And Entity Information Sheet http://alrt.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://alrt.com/role/ConsolidatedBalanceSheet Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://alrt.com/role/ConsolidatedBalanceSheet_Parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations Sheet http://alrt.com/role/ConsolidatedIncomeStatement Consolidated Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Change in Shareholders Deficit Sheet http://alrt.com/role/StatementsOfChangeInShareholdersDeficit Consolidated Statements of Change in Shareholders Deficit Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://alrt.com/role/ConsolidatedCashFlow Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - 1. Basis of Presentation, Nature of Operations and Going Concern Sheet http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcern 1. Basis of Presentation, Nature of Operations and Going Concern Notes 7 false false R8.htm 00000008 - Disclosure - 2. Significant accounting policies Sheet http://alrt.com/role/SignificantAccountingPolicies 2. Significant accounting policies Notes 8 false false R9.htm 00000009 - Disclosure - 3. Promissory notes interest payable Notes http://alrt.com/role/PromissoryNotesInterestPayable 3. Promissory notes interest payable Notes 9 false false R10.htm 00000010 - Disclosure - 4. Lines of Credit Sheet http://alrt.com/role/LinesOfCredit 4. Lines of Credit Notes 10 false false R11.htm 00000011 - Disclosure - 5. Capital Stock Sheet http://alrt.com/role/CapitalStock 5. Capital Stock Notes 11 false false R12.htm 00000012 - Disclosure - 6. Additional paid in capital Sheet http://alrt.com/role/AdditionalPaidInCapital 6. Additional paid in capital Notes 12 false false R13.htm 00000013 - Disclosure - 7. Related party transactions and balances Sheet http://alrt.com/role/RelatedPartyTransactionsAndBalances 7. Related party transactions and balances Notes 13 false false R14.htm 00000014 - Disclosure - 8. Commitments and contingencies Sheet http://alrt.com/role/CommitmentsAndContingencies 8. Commitments and contingencies Notes 14 false false R15.htm 00000015 - Disclosure - 9. Financial instruments Sheet http://alrt.com/role/FinancialInstruments 9. Financial instruments Notes 15 false false R16.htm 00000016 - Disclosure - 10. Income taxes Sheet http://alrt.com/role/IncomeTaxes 10. Income taxes Notes 16 false false R17.htm 00000017 - Disclosure - 11. Subsequent event Sheet http://alrt.com/role/SubsequentEvent 11. Subsequent event Notes 17 false false R18.htm 00000018 - Disclosure - 2. Significant accounting policies (Policies) Sheet http://alrt.com/role/SignificantAccountingPoliciesPolicies 2. Significant accounting policies (Policies) Policies 18 false false R19.htm 00000019 - Disclosure - 3. Interest, advances and promissory notes payable (Tables) Notes http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables 3. Interest, advances and promissory notes payable (Tables) Tables 19 false false R20.htm 00000020 - Disclosure - 4. Lines of Credit (Tables) Sheet http://alrt.com/role/LinesOfCreditTables 4. Lines of Credit (Tables) Tables http://alrt.com/role/LinesOfCredit 20 false false R21.htm 00000021 - Disclosure - 6. Additional paid in capital (Tables) Sheet http://alrt.com/role/AdditionalPaidInCapitalTables 6. Additional paid in capital (Tables) Tables http://alrt.com/role/AdditionalPaidInCapital 21 false false R22.htm 00000022 - Disclosure - 7. Related party transactions and balances (Tables) Sheet http://alrt.com/role/RelatedPartyTransactionsAndBalancesTables 7. Related party transactions and balances (Tables) Tables http://alrt.com/role/RelatedPartyTransactionsAndBalances 22 false false R23.htm 00000023 - Disclosure - 10. Income taxes: (Tables) Sheet http://alrt.com/role/IncomeTaxesTables 10. Income taxes: (Tables) Tables http://alrt.com/role/IncomeTaxes 23 false false R24.htm 00000024 - Disclosure - 1. Basis of Presentation, Nature of Operations and Going Concern (Details Narrative) Sheet http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative 1. Basis of Presentation, Nature of Operations and Going Concern (Details Narrative) Details http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcern 24 false false R25.htm 00000025 - Disclosure - 3. Interest, advances and promissory notes payable (Details) - Promissory Notes Payable - Relatives of Board of Directors Notes http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails-PromissoryNotesPayable-RelativesOfBoardOfDirectors 3. Interest, advances and promissory notes payable (Details) - Promissory Notes Payable - Relatives of Board of Directors Details http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables 25 false false R26.htm 00000026 - Disclosure - 3. Interest, advances and promissory notes payable (Details) - Unsecured Promissory Notes Payable to Unrelated Leaders Notes http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails-UnsecuredPromissoryNotesPayableToUnrelatedLeaders 3. Interest, advances and promissory notes payable (Details) - Unsecured Promissory Notes Payable to Unrelated Leaders Details http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables 26 false false R27.htm 00000027 - Disclosure - 3. Interest, advances and promissory notes payable (Details) - Summary of Interest Payable Activity Notes http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails-SummaryOfInterestPayableActivity 3. Interest, advances and promissory notes payable (Details) - Summary of Interest Payable Activity Details http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables 27 false false R28.htm 00000028 - Disclosure - 3. Interest, advances and promissory notes payable (Details) - Interest Payable Notes http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails-InterestPayable 3. Interest, advances and promissory notes payable (Details) - Interest Payable Details http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables 28 false false R29.htm 00000029 - Disclosure - 4. Lines of Credit (Details) Sheet http://alrt.com/role/LinesOfCreditDetails 4. Lines of Credit (Details) Details http://alrt.com/role/LinesOfCreditTables 29 false false R30.htm 00000030 - Disclosure - 6. Additional paid in capital - Summary of Stock Option Activity (Details) Sheet http://alrt.com/role/AdditionalPaidInCapital-SummaryOfStockOptionActivityDetails 6. Additional paid in capital - Summary of Stock Option Activity (Details) Details 30 false false R31.htm 00000031 - Disclosure - 6. Additional paid in capital - Options Outstanding (Details) Sheet http://alrt.com/role/AdditionalPaidInCapital-OptionsOutstandingDetails 6. Additional paid in capital - Options Outstanding (Details) Details 31 false false R32.htm 00000032 - Disclosure - 6. Additional paid in capital - Fair Value Method Stock-Based Compensation (Details) Sheet http://alrt.com/role/AdditionalPaidInCapital-FairValueMethodStock-basedCompensationDetails 6. Additional paid in capital - Fair Value Method Stock-Based Compensation (Details) Details 32 false false R33.htm 00000033 - Disclosure - 6. Additional paid in capital - Fair Value of Stock Options (Details) Sheet http://alrt.com/role/AdditionalPaidInCapital-FairValueOfStockOptionsDetails 6. Additional paid in capital - Fair Value of Stock Options (Details) Details 33 false false R34.htm 00000034 - Disclosure - 7. Related Party Transactions (Details) Sheet http://alrt.com/role/RelatedPartyTransactionsDetails 7. Related Party Transactions (Details) Details 34 false false R35.htm 00000035 - Disclosure - 10. Income taxes: (Details) - Provision for Income Taxes Sheet http://alrt.com/role/IncomeTaxesDetails-ProvisionForIncomeTaxes 10. Income taxes: (Details) - Provision for Income Taxes Details http://alrt.com/role/IncomeTaxesTables 35 false false R36.htm 00000036 - Disclosure - 10. Income taxes: (Details) - Net Deferred Income Tax Asset Sheet http://alrt.com/role/IncomeTaxesDetails-NetDeferredIncomeTaxAsset 10. Income taxes: (Details) - Net Deferred Income Tax Asset Details http://alrt.com/role/IncomeTaxesTables 36 false false R37.htm 00000037 - Disclosure - 10. Income taxes: (Details) - Summary of Operating Loss Carryforwards Sheet http://alrt.com/role/IncomeTaxesDetails-SummaryOfOperatingLossCarryforwards 10. Income taxes: (Details) - Summary of Operating Loss Carryforwards Details http://alrt.com/role/IncomeTaxesTables 37 false false All Reports Book All Reports alrt-20161231.xml alrt-20161231.xsd alrt-20161231_cal.xml alrt-20161231_def.xml alrt-20161231_lab.xml alrt-20161231_pre.xml http://fasb.org/us-gaap/2016-01-31 http://xbrl.sec.gov/dei/2014-01-31 true true ZIP 56 0001721868-18-000081-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001721868-18-000081-xbrl.zip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�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